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Abstract
Eating and maintaining optimal nutrition are essential to health and quality of life. In both
health and disease, eating is influenced by multiple factors including swallowing, oral health,
and saliva production. Perturbations to any, or all, of these inter-related factors may result in
consequences that negatively affect the health and wellness of an individual. Eating and
swallowing impairment are common symptoms of neurodegenerative diseases such as
dementia, and these symptoms are associated with a host of negative sequelae such as
malnutrition, dehydration, aspiration pneumonia, and reduced quality of life. The studies
reported in this dissertation explored elements of eating and swallowing, saliva production,
and saliva modulation in healthy individuals and in persons with Alzheimer’s disease (AD).
This dissertation is composed of three studies. First, a scoping review methodology was used
to examine literature that addressed autonomic nervous system and/or swallowing
dysfunction in individuals with AD. Then, systematic review and meta-analysis
methodologies were used to examine a potential effect of aging on saliva production. Finally,
a within-subjects methodology was used to examine the modulation of salivary flow by tooth
brushing in healthy older adults.
In the first study, swallowing dysfunction and autonomic nervous system dysfunction,
including salivary flow dysfunction, were found to occur in persons with AD. In the second
study, salivary flow was found to be reduced in adults aged 60 years and older who were free
of major systemic disease. In the third and final study, the use of manual and electric tooth
brushing was found to increase whole salivary flow rates in adults aged 60 years of age and
older who were free of major systemic disease.
The results of this dissertation have very important implications for the future research and
management of eating and swallowing, oral health, and saliva production in a variety of
populations, including aging individuals and persons with AD.
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Chapter 1

1

Introduction
1.1

Eating

The ability to eat in order to meet one’s metabolic requirements is a basic human need
(Maslow, 1954), an integral part of homeostatic regulation (Langhans & Geary, 2010),
and fundamental to survival. Eating and maintaining optimal nutrition are essential to
health (Waxman & World Health Assembly, 2004) and quality of life (Vailas, Nitzke,
Becker, & Gast, 1998). Being unable to eat results in dietary imbalances, which are
known to contribute to disease (Waxman & World Health Assembly, 2004), as well as
malnutrition, which can result in physical, mental, and social disability (La Rue et al.,
1997; Muhlethaler, Stuck, Minder, & Frey, 1995). The inability to eat often results in an
individual receiving nutrition via another route, such as parenterally (intravenous
nutrition) or enterally (tube feeding). Even when other routes are used to provide
nutrition, however, the inability to eat significantly detracts from an individual’s quality
of life (Winkler, 2005).
Eating disability, or the inability to eat, may occur as a symptom of many neurologic
(Bakke, Moller, Thomsen, Dalager, & Werdelin, 2007; Benfer et al., 2014), anatomic
(Patterson, McColl, Wilson, Carding, & Rapley, 2015), or psychological conditions and
diseases (Baijens, Koetsenruijter, & Pilz, 2013). Eating impairment is a common
symptom of neurodegenerative conditions such as dementia (Affoo, Foley, Rosenbek,
Shoemaker, & Martin, 2013) and may be characterized by distraction during meals,
refusal to eat, agitation/aggression at mealtimes, using food as nonfood play objects,
expectorating food/refusing to swallow, inability to masticate, choking, or aspiration
(Durnbaugh, Haley, & Roberts, 1996; Morris, Hope, & Fairburn, 1989; Priefer &
Robbins, 1997).
There are several physiological components that are fundamental to eating. Eating
involves transportation of food and fluid to the mouth, salivary secretion in order to
lubricate the mouth and initiate chemical digestion of starches, preparation of the material
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in the oral cavity such as mastication of solid food material, and swallowing to transport
food or fluid from the mouth to the stomach (Miller, 2013).

1.2

Swallowing

Swallowing is a fundamental component of eating and is the process by which saliva,
food, and fluid is safely transported from the mouth to the stomach. Swallowing involves
the integration of volitional and sensorimotor events. The process begins with the
preparation and softening of food or fluid into a bolus through mastication and
manipulation in the oral cavity. During this process, the salivary glands secrete saliva into
the oral cavity, which initiates the process of chemical digestion. Once formed, the bolus
is propelled through the oral cavity towards the pharynx and the ascending sensory
information associated with preparing and transporting the bolus trigger the pharyngeal
phase of swallowing. A complex and coordinated series of muscular contractions results
in airway closure and movement of the bolus through the pharynx and into the
esophagus, where it is eventually transported to the stomach (Matsuo, 2013).

1.3

Dysphagia

The term dysphagia refers to deficits in transporting saliva, food, or fluid from the mouth
to the stomach (Logemann, 1998). Dysphagia is a symptom of many congenital
abnormalities, acquired neurologic or physical dysfunctions, progressive degeneration,
and psychiatric disorders (Murry, 1999) and often contributes to impaired eating in these
populations. A host of negative physiological consequences are associated with
dysphagia, such as dehydration (Whelan, 2001), and malnutrition (Namasivayam &
Steele, 2015). Dysphagia may lead to aspiration, which is the misdirection of
oropharyngeal or gastric contents into the larynx and lower respiratory tract. Aspiration is
associated with aspiration pneumonia, which occurs when bacteria colonize the
misdirected contents and infect the lung (Marik, 2001), and results in suboptimal patient
outcomes and increased mortality (Foley, Affoo, & Martin, 2014). Dysphagia and eating
impairment often lead to an increased sense of isolation and loss of self-esteem,
avoidance of social eating situations, and anxiety or panic during mealtimes (Ekberg,
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Hamdy, Woisard, Wuttge-Hannig, & Ortega, 2002), all of which negatively impact a
person’s social and psychological well being, and quality of life.
Estimates of the prevalence of dysphagia vary by setting, population, disease state,
country, and manner in which dysphagia is assessed. The prevalence of self-reported
dysphagia in primary care patients has been found to be 22% (Wilkins, Gillies, Thomas,
& Wagner, 2007). Dysphagia prevalence has been reported anywhere from 0.35% to 55%
in the acute care in-patient setting (Altman, Yu, & Schaefer, 2010; Cabre et al., 2010) and
68% in long-term care (Steele, Greenwood, Ens, Robertson, & Seidman-Carlson, 1997).
Up to 78% of individuals experience dysphagia after a stroke (Martino et al., 2005),
between 35% and 82% of persons with Parkinson’s disease have dysphagia (Kalf, de
Swart, Bloem, & Munneke, 2012), and the prevalence of dysphagia in individuals with
Alzheimer’s disease is anywhere from 45% to 93% (Affoo et al., 2013).

1.4

Oral Health

The oral health of an individual is defined as “a state of being free of mouth and facial
pain, oral and throat cancer, oral infection and sores, birth defects such as cleft lip and
palate, periodontal disease, tooth decay and tooth loss, and other disease and disorders
that limit an individual’s capacity in biting, chewing, smiling, speaking, and
psychological wellbeing” (WHO, 1992). The relationship between oral health and overall
health is complex, however, links between poor oral health and oral preparatory and oral
stage dysphagia (Liedberg & Owall, 1991), malnutrition (Daly, Elsner, Allen, & Burke,
2003; Poisson, Laffond, Campos, Dupuis, & Bourdel-Marchasson, 2014), aspiration
pneumonia (Langmore et al., 1998), and increased mortality from pneumonia (Awano et
al., 2008) have been documented.

1.5

Saliva

One essential component necessary for adequate oral health is salivary flow. Saliva is
important for maintaining oral and general health (Mandel, 1989) and has many and
varied functions including protection against mechanical, thermal and chemical irritation,
reducing demineralization and facilitating remineralization of the teeth, facilitating
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antimicrobial actions and clearance of bacteria, initiating chemical digestion, and
facilitating taste (Whelton, 2004).
Saliva production is often limited by disease or pharmaceutical use (Sreebny, 2000).
Reduced saliva production results in rapid deterioration of oral health and increased
bacterial colonization in the oral cavity. Many of the diseases and disorders associated
with dysphagia may also be associated with reduced salivary flow. Additionally,
individuals with reduced salivary flow may experience dysphagia (Poisson et al., 2014).
In an individual experiencing hyposalivation and associated increased bacterial
colonization and oral pathology, the co-occurrence of dysphagia may increase the risk of
the individual aspirating bacteria-rich oral contents and developing aspiration pneumonia
(Ortega et al., 2014). Aspiration pneumonia is associated with increased risk of mortality
in certain populations (Foley et al., 2014). Thus, there appears to be a critical relationship
between factors associated with eating and swallowing function, oral health, and saliva
production. Perturbations to any, or all, of these factors may result in consequences that
negatively affect the health and wellness of an individual (Figure 1).
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Figure 1. Inter-Related Factors Associated with Impaired Eating and Swallowing,
Oral Health, Saliva Production, and Respiratory Health

1.6

Alzheimer’s Disease

Alzheimer’s disease (AD) and other dementias are a growing epidemic in Canada.
Alzheimer’s disease currently affects approximately 747,000 Canadians. This number is
expected to nearly double to 14 million Canadians by 2031 (Alzheimer Society of
Canada, 2012). Dysphagia (Affoo et al., 2013), poor oral health (Foley, Affoo, Siqueira,
& Martin, 2015 unpublished), and reduced saliva production (Ship, DeCarli, Friedland, &
Baum, 1990; Ship & Puckett, 1994) have been reported in individuals with AD. There is
also evidence to suggest that this population is at increased risk of pneumonia-associated
mortality (Foley et al., 2014), and it is well documented that pneumonia is the primary
cause of mortality in AD (Beard et al., 1996). Therefore, in individuals with AD, it
appears that impairments in eating and swallowing, oral health, and saliva production
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together increase the risk of morbidity, including aspiration pneumonia, as well as
suboptimal health outcomes and mortality (Figure 2).

Figure 2: Proposed Model of the Relationship between Reduced Salivary Flow, Poor
Oral Health, Dysphagia, and Suboptimal Outcomes

1.7
Eating and Swallowing, Oral Health, and Saliva
Production
Eating and swallowing, oral health, and saliva production are crucial factors for
maintaining a person’s overall health and an optimal quality of life (Sreebny & Vissink,
2010; Vailas et al., 1998; Waxman & World Health Assembly, 2004; WHO, 1992).
While published evidence suggests that these factors are inter-related in both health and
disease, there is a paucity of evidence that has explored these factors and their potential
relationships. Generating new knowledge of these factors and the relationships between
them has the potential to positively impact health care provision for a variety of patient
populations, including older adults and persons with dementia. Thus, the goal of the
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present research was to broaden current understanding of eating and swallowing function
and dysfunction, saliva production, and saliva modulation.
Three studies were conducted as part of this dissertation. In the first, eating and
swallowing dysfunction and autonomic nervous system dysfunction, including salivary
flow dysfunction, were examined in individuals with AD through a scoping review. In
addition to gaining a better understanding of the current knowledge on eating and
swallowing impairment and autonomic nervous system impairment in individuals with
AD, the study identified gaps in the literature. One gap that was identified pertained to
the rate of saliva production, or salivary flow rate, in individuals with AD. Saliva, a
secretion crucial for maintaining oral homeostasis and for completing the oral preparatory
and oral phases of swallowing, may be reduced as part of the disease process. This
finding led us to question whether salivary flow rate is reduced as a function of aging.
In the second study in this dissertation, published literature examining salivary flow rate
in adults of different ages was reviewed, described, and meta-analyzed in order to
determine whether aging is associated with a change in saliva production. We found that,
despite conflicting findings previously recorded in the literature, unstimulated and
stimulated whole and submandibular/sublingual salivary flow rates were decreased in
adults aged 60 years and older compared with younger adults aged 18 to 40 years.
Given that saliva is important for maintaining oral and general health (Mandel, 1989) and
salivary flow rates have been found to be decreased in older adults compared with
younger adults, it would be beneficial to elucidate whether salivary flow rates in older
individuals can be modulated. One approach to modulating salivary flow rates is to use
sensory stimulation. Previous studies examining the effects of sensory stimulation in the
oral cavity have found that oral stimulation is associated with increased salivary flow
rates (Karami Nogourani, Janghorbani, Kowsari Isfahan, & Hosseini Beheshti, 2012;
Ligtenberg, Brand, Bots, & Nieuw Amerongen, 2006; Papas et al., 2006). Therefore, in
the third study in this dissertation, the potential effects of manual and electric tooth
brushing on whole salivary flow rates were examined in adults 60 years of age and older
who were free of major systemic disease. We found that tooth brushing stimulates saliva

8

production for up to 5 minutes. A moderate, positive correlation was observed between
age and maximum salivary flow rate increase associated with tooth brushing.
The knowledge generated from the three studies presented in this dissertation has the
potential to improve the current understanding of oral physiology and inform the design
of future research. It also has important implications for preventative, acute, and
rehabilitative care for a number of patient populations, including aging individuals and
individuals with dementia.
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Chapter 2

2

Swallowing Dysfunction and Autonomic Nervous
System Dysfunction in Alzheimer’s Disease: A Scoping
Review of the Evidence

This scoping review aims to describe, synthesize, and interpret literature on swallowing
impairment (dysphagia) and autonomic nervous system (ANS) dysfunction in
*

Alzheimer’s disease (AD), and to identify gaps in the existing literature .

2.1 Introduction
Alzheimer’s disease (AD) is a neurodegenerative condition marked by cognitive and
behavioural decline (Wimo et al., 2013). Currently, AD affects more than 3.4 million
North Americans and its incidence is expected to exceed 5.5 million by 2030
(Alzheimer's Association, 2013; Rising tide: The impact of dementia on Canadian
society, 2010). People with AD experience significant eating problems, particularly as the
disease progresses (Njegovan, Hing, Mitchell, & Molnar, 2001). Although these eating
problems arise from deficits across a range of dimensions, swallowing impairment
(dysphagia) may be a critical factor; however, its impact is unknown. Understanding the
contribution of dysphagia to altered eating in AD is especially important since the risk of
AD increases with age and dysphagia in the elderly is associated with increased
morbidity, including pneumonia (Loeb, McGeer, McArthur, Walter, & Simor, 1999) and
malnutrition (Serra-Prat et al., 2012), and mortality (Groher & Crary, 2010).
Swallowing is regulated by both the somatic-voluntary nervous system and the
autonomic nervous system (ANS) (Jean, 2001; Miller, 1999). The somatic-voluntary
nervous system plays a fundamental role in the voluntary oral preparatory and oral stages
of swallowing, during which ingested material is formed into a bolus and transported
posteriorly across the tongue surface (Miller, 1999). The somatic-voluntary and ANS

*
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mediate the semi-automatic pharyngeal stage, during which the bolus is transported
through the pharynx as the airway closes to protect against entry of material into the
lower respiratory tract (Miller, 1999). The ANS then regulates contraction of the smooth
muscle esophagus during the esophageal stage of swallowing (Miller, 1999). However,
both animal and human studies have documented ANS involvement in all stages of
swallowing, including salivary secretion required for the oral breakdown and lubrication
of ingested material (Stuchell & Mandel, 1988), sensory processing of laryngeal and
esophageal inputs necessary for swallowing (Aziz et al., 2000; Kalia & Mesulam, 1980),
and esophageal peristalsis (Camilleri, 2004).
The AD literature has focused primarily on the voluntary nervous system, as documented
by several systematic reviews (Marlatt & Lucassen, 2010; Nordberg, Rinne, Kadir, &
Langstrom, 2010). Nevertheless, ANS dysfunction in AD has been reported, although
systematic reviews are lacking (Lampe et al., 1989; Otsuka et al., 1990).
Given (i) the probability that swallowing impairment contributes to eating problems in
AD, (ii) that ANS mechanisms play a fundamental role in swallowing regulation, and (iii)
ANS dysfunction occurs in AD, a broad literature review examining dysphagia and ANS
dysfunction in AD could provide important insights into these deficits and their potential
associations.
The objectives of this study were to (i) describe, synthesize, and interpret literature on
dysphagia/ANS dysfunction in AD, and (ii) identify gaps in the existing literature,
utilizing a scoping review, a technique aimed at mapping relevant literature in a broad
field of interest where several study designs may be represented (Arksey & O'Malley,
2005; Landa, 2011).

2.2 Methodology
Relevant studies were identiﬁed through a literature search encompassing the years 1978
to July 2012. Three searches of the PubMed, EBSCOhost, PsychINFO, Cochrane,
EMBASE, and Scopus databases were conducted to identify studies of (i) dysphagia in
AD, (search terms: dementia, Alzheimer’s disease, swallowing, deglutition disorders,
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aspiration pneumonia, choking, and dysphagia) (ii) ANS dysfunction in AD, (search
terms: dementia, Alzheimer’s disease, autonomic nervous system, parasympathetic
nervous system, sympathetic nervous system), and (iii) dysphagia and ANS dysfunction
in AD, combining the search terms above. Reference lists of the retrieved articles were
manually searched.
The inclusion criteria were: (i) clinical studies, (ii) physiological reports (including
neuroanatomical studies) wherein any portion of the sample met the study author’s
criteria for having AD, and ANS dysfunction or dysphagia was examined; (iii) reviews,
(iv) commentaries, or (v) case studies of dysphagia or ANS dysfunction in AD, and (vi)
English language studies. Animal studies, human trials examining pharmacological
treatment effects on dysphagia/ANS dysfunction, and studies on cerebral hemodynamics
were excluded. Two reviewers (RA and RM) evaluated the surviving literature.
Clinical and physiological reports were evaluated using the Oxford Centre for Evidence†

Based Medicine Levels of Evidence ("CEBM Levels of Evidence," 2009) (OCEBM)
criteria. Where possible, studies were classified as: treatment/prevention, prognosis,
diagnosis, prevalence, or decision making/economic evaluation. Following
categorization, the literature was synthesized and interpreted by the same two reviewers
in order to form conclusions and identify knowledge gaps. Results were categorized and
analyzed according to topics identified post hoc.
One expert in each of the fields of dysphagia, ANS physiology, and epidemiology was
then consulted to verify the completeness of the literature retained for final review, to
identify references that were not captured in the searches, and to comment on the
appropriateness of the literature synthesis, interpretation, and gap identification.

2.3 Results
The initial search returned 7,422 results of which 95 met the study criteria and were
reviewed (Figure 3). Summaries of all the included articles can be found in Appendix A –

†

CEBM Levels of Evidence 2009 (online). Available at http://www.cebm.net/index.aspx?o=1025
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D. Thirty-one studies examined dysphagia in AD, 64 examined ANS dysfunction in AD.
No studies were identified that examined both dysphagia and ANS dysfunction in AD.

Figure 3. Flow Chart of Scoping Review

2.3.1

Diagnosis of Alzheimer’s Disease

Eighty clinical reports addressed either dysphagia or ANS dysfunction in AD. In 56 of
these, the diagnosis of AD was based on (i) the National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders
Association (NINCDS-ARDRA) diagnostic criteria (Algotsson, Nordberg, Almkvist, &
Winblad, 1995; Algotsson, Viitanen, Winblad, & Solders, 1995; L. Allan, McKeith,
Ballard, & Kenny, 2006; L. M. Allan et al., 2007; L. M. Allan, Ballard, Rowan, &
Kenny, 2009; L. M. Allan et al., 2005; Andersson, Hansson, Minthon, Ballard, &
Londos, 2008; Benedetti et al., 2004; Durnbaugh et al., 1996; Elmstahl et al., 1992;
Elmstahl & Winge, 1993; Fotiou et al., 2009; Franceschi, Ferini-Strambi, Minicucci,
Sferrazza-Papa, & Smirne, 1986; Horner, Alberts, Dawson, & Cook, 1994; Idiaquez,
Alvarez, Villagra, & San Martin, 1994; Idiaquez, Rios, & Sandoval, 1997; Idiaquez,
Sandoval, & Seguel, 2002; Ikeda, Brown, Holland, Fukuhara, & Hodges, 2002; Pascualy
et al., 2000; Rainero, Vighetti, Bergamasco, Pinessi, & Benedetti, 2000; Ransmayr et al.,
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2008; Shinagawa et al., 2009; Ship et al., 1990; Taki, Yoshita, Yamada, & Tonami, 2004;
Vitiello et al., 1993; Wada et al., 2001; Watanabe et al., 2001; Zakrzewska-Pniewska,
Gawel, Szmidt-Salkowska, Kepczynska, & Nojszewska, 2012), (ii) the Diagnostic and
Statistical Manual of Mental Disorders (DSM) III or IV criteria (Borson, Barnes, Veith,
Halter, & Raskind, 1989; Davidson, Borrie, & Crilly, 1991; Del-Ser, Munoz, &
Hachinski, 1996; Guo, Viitanen, Fratiglioni, & Winbland, 1998; Lampe et al., 1989;
Morris et al., 1989; Raskind, Peskind, Halter, & Jimerson, 1984), (iii) both the NINCDSARDRA and DSM-III/IV criteria (Aharon-Peretz, Harel, Revach, & Ben-Haim, 1992;
Ahlskog et al., 1996; de Vilhena Toledo & Junqueira, 2008; Jhee, Sramek, Wardle, &
Cutler, 1995; Mehrabian et al., 2010; Passant, Warkentin, & Gustafson, 1997; Peskind et
al., 1998; Peskind et al., 1995; Toledo & Junqueira, 2010; Volicer et al., 1989; S. J. Wang
et al., 1994; Zulli et al., 2005), or (iv) neuropathology (Andin, Passant, Gustafson, &
Englund, 2007; Bonthius, Solodkin, & Van Hoesen, 2005; Burke, Coronado, Schmitt,
Gillespie, & Chung, 1994; Chu, Tranel, Damasio, & Van Hoesen, 1997; Orimo et al.,
2005; Rub et al., 2001; Shankle et al., 1993; Wakabayashi et al., 1999). Five (5) of the
studies used the NINCDS-ARDRA criteria as well as a score of < 5 on Hachinski’s Index
to rule out vascular pathology (Hornqvist, Henriksson, Back, Bucht, & Winblad, 1987;
Humbert et al., 2010; Humbert, McLaren, Malandraki, Johnson, & Robbins, 2011;
Otsuka et al., 1990; Priefer & Robbins, 1997). The remaining nineteen (19) studies
reported physician-specific diagnostic criteria (Bautmans, Demarteau, Cruts, Lemper, &
Mets, 2008; Chouinard, Lavigne, & Villeneuve, 1998; Edahiro et al., 2012; Eisdorfer &
Cohen, 1978; Feinberg, Ekberg, Segall, & Tully, 1992; Logemann et al., 2008; Robbins
et al., 2008; Suh, Kim, & Na, 2009) or did not report diagnostic criteria (Bordier, Colsy,
Robert, & Bourenane, 2007; Burge, 1994; Choi, Kim, & Kim, 2009; Correia, 2010;
Garon, Sierzant, & Ormiston, 2009; Grunberger et al., 1999; Khurana & Garcia, 1981;
Mizushima, 2005; Suski & Nielsen, 1989; Szili-Torok et al., 2001).

2.3.2

Dysphagia in Alzheimer’s Disease

Thirty-one studies addressed dysphagia in AD, including identification of dysphagia
(n=11), descriptions of swallowing difficulties (n=22), and treatment (n=3) (Figure 3). Of
22 clinical reports, nine employed an instrumental assessment of swallowing in
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individuals with AD. Seven studies used videofluoroscopic swallow studies (VFSS)
(Feinberg et al., 1992; Garon et al., 2009; Horner et al., 1994; Humbert et al., 2010;
Humbert et al., 2011; Priefer & Robbins, 1997; Suh et al., 2009) and two used
electromyography (EMG) following water injection into the pharynx (Mizushima, 2005;
Wada et al., 2001). In contrast, 10 clinical reports employed a clinical evaluation of
dysphagia or feeding difficulties (Burge, 1994; Chouinard et al., 1998; Correia, 2010;
Durnbaugh et al., 1996; Edahiro et al., 2012; Ikeda et al., 2002; Morris et al., 1989;
Shinagawa et al., 2009; Suski & Nielsen, 1989; Volicer et al., 1989) including
observation at mealtimes, caregiver interview, and questionnaire. Three studies examined
the treatment of dysphagia in AD (Bautmans et al., 2008; Logemann et al., 2008; Robbins
et al., 2008).

2.3.2.1

Dysphagia in Alzheimer’s Disease: Oxford Centre for
Evidence-Based Medicine Levels of Evidence (OCEBM)

Classification using the OCEBM system was possible for eight studies of dysphagia in
AD (Tables 1–3).

2.3.2.2

Studies Employing Instrumental Assessment of Swallowing
in Alzheimer’s Disease

The nine studies (Feinberg et al., 1992; Garon et al., 2009; Horner et al., 1994; Humbert
et al., 2010; Humbert et al., 2011; Mizushima, 2005; Priefer & Robbins, 1997; Suh et al.,
2009; Wada et al., 2001) that employed instrumental assessment of swallowing in AD
provide preliminary evidence to support the following conclusions:
1. The prevalence of dysphagia in moderate-to-severe AD is 84% (Horner et al., 1994) to
93% (Feinberg et al., 1992). Only one study failed to identify significant swallowing
dysfunction in AD (Mizushima, 2005); it examined swallow-related and cough-related
EMG responses to graded volumes of water injected into the pharynx through a nasal
catheter.
2. Dysphagia may occur early in AD. Three studies using VFSS documented swallowing
alterations in small groups of patients with mild AD, compared with healthy age-matched
controls (Humbert et al., 2010; Humbert et al., 2011; Priefer & Robbins, 1997).
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3. Dysphagia occurring early in AD may be associated with functional changes in the
cortical swallowing network (i.e., pre- and post-central gyrus, and frontal and Rolandic
operculum) as measured with functional magnetic resonance imaging (fMRI) (Humbert
et al., 2010; Humbert et al., 2011; Priefer & Robbins, 1997).
4. The oral and pharyngeal stages of swallowing may be affected in AD (Feinberg et al.,
1992; Garon et al., 2009; Horner et al., 1994; Humbert et al., 2010; Humbert et al., 2011;
Priefer & Robbins, 1997; Suh et al., 2009; Wada et al., 2001). Oral deficits include
prolonged bolus preparation and oral transit times. Pharyngeal deficits include delayed
pharyngeal swallow initiation, reduced hyo-laryngeal excursion, laryngeal penetration,
tracheal aspiration, and pharyngeal residue post swallow.
5. Dysphagia severity and AD severity may be associated. One study (Wada et al., 2001)
reported that subjects with severe AD demonstrated greater pharyngeal swallow delay
than patients with mild and moderate AD. Another study (Horner et al., 1994) identified a
non-significant trend wherein subjects with lower Mini-Mental State Examination
(MMSE) scores had more severe dysphagia.
Table 1. Clinical Reports Employing Instrumental Assessment of Swallowing in
Alzheimer's Disease (AD)
Conclusion

Supporting

Study Description

Studies
Prevalence of

Horner et al.

dysphagia in AD

1994

Level of
Evidence

Prospective Case Series

4

Retrospective Cohort

2b

Mizushima et al. Described/characterized dysphagia in AD

NA

Feinberg et al.
1992

2005

through comparison of two or more groups
of individuals
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Dysphagia occurs

Humbert et al.

Described/characterized dysphagia in AD

early in AD

2010

through comparison of two or more groups

Priefer &

NA

of individuals

Robbins 1997
Humbert et al.
2011
Dysphagia in early

Humbert et al.

Described/characterized dysphagia in AD

AD may be

2010

through comparison of two or more groups

associated with
functional change
of the cortical

Humbert et al.

NA

of individuals

2011

swallowing
network
Dysphagia occurs

Garon et al.

in both the oral

2009

and pharyngeal
phases of
swallowing

Horner et al.

Retrospective Cohort

2b

Prospective Case Series

4

Described/characterized dysphagia in AD

NA

1994
Suh et al. 2009
Wada et al. 2001

through comparison of two or more groups
of individuals

Priefer &
Robbins 1997
Humbert et al.
2010
Disease severity

Wada et al. 2001 Described/characterized dysphagia in AD

NA
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may be associated

through comparison of two or more groups

with dysphagia

of individuals

severity

Horner et al.

Prospective Case Series

4

1994
NA = not applicable. See Appendix A for more details.

2.3.2.3

Studies Employing Subjective Assessment of Swallowing in
Alzheimer’s Disease

Eleven studies (Burge, 1994; Chouinard et al., 1998; Correia, 2010; Durnbaugh et al.,
1996; Edahiro et al., 2012; Ikeda et al., 2002; Morris et al., 1989; Priefer & Robbins,
1997; Shinagawa et al., 2009; Suski & Nielsen, 1989; Volicer et al., 1989) assessed
eating or swallowing in AD through clinical assessments, including one clinical report
that also used an instrumental swallowing evaluation. These studies provide preliminary
support for the following conclusions:
1. Prevalence estimates of dysphagia in AD based on clinical assessments are lower than
estimates based on instrumental swallowing assessments. One study reported that 32% of
residents with AD living in a long-term care facility were observed to choke on food and
drink (Volicer et al., 1989). Another group (Chouinard et al., 1998) reviewed the health
records of 47 institutionalized patients with dementia (45% AD) who had died over a
two-year period and reported that 45% of the entire dementia sample had dysphagia,
which was correlated with death from pneumonia.
2. Dysphagia occurs in all stages of AD and may be a marker of disease severity. One study
(Correia, 2010) reported delayed swallowing and difficulty with ingestion of specific
consistencies in moderate to severe AD. Another study (Edahiro et al., 2012) found signs
of dysphagia in all stages of AD, although the frequency of signs increased in the
advanced stages.
3. Behavioural eating difficulties occur in all stages of AD. Individuals with mild AD
required and received significantly more cueing during a meal assessment compared to
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controls (Priefer & Robbins, 1997) and demonstrated problematic mealtime behaviors
such as attempting to eat pieces of food too big for the oral cavity (Durnbaugh et al.,
1996; Morris et al., 1989). Difficulty initiating a meal, as well as severity of AD,
significantly predicted eating dependence (Edahiro et al., 2012) and individuals with
severe AD in long-term care facilities tended to receive mechanically altered diets and
feeding assistance (Burge, 1994; Suski & Nielsen, 1989).
4. Eating and swallowing difficulties are less severe in AD than in other types of dementia.
Two studies compared caregiver perceptions of eating and swallowing difficulties in AD,
frontotemporal lobe dementia (Ikeda et al., 2002) and Lewy body dementia (Shinagawa et
al., 2009) at similar stages. Both reported that AD caregivers perceived fewer abnormal
eating and swallowing behaviours; however, AD caregivers also reported that eating and
swallowing problems appear to develop earlier in AD progression.
Table 2. Clinical Reports Employing Clinical Assessment of Swallowing in
Alzheimer's Disease (AD)
Conclusion

Supporting

Study Description

Studies

Level of
Evidence

Prevalence of

Volicer et al.

Described/characterized an aspect of eating NA

dysphagia in AD

1989

or swallowing dysfunction through the
examination of a single group of patients
with AD

Chouinard et al.

Retrospective Cohort

2b

NA

1998
Dysphagia may

Correia et al.

Described/characterized dysphagia in AD

occur in all stages

2010

through comparison of two or more groups

of AD

of individuals
Edahiro et al.
2012

Prospective Cohort Study

2b
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Behavioural eating Priefer &

Described/characterized dysphagia in AD

difficulties may

through comparison of two or more groups

Robbins, 1997

occur in all stages
of AD

NA

of individuals
Edahiro et al.

Prospective Cohort Study

2b

2012
Durnbaugh et al. Described/characterized an aspect of eating NA
1996
Morris et al.
1989

or swallowing dysfunction through the
examination of a single group of patients
with AD

Burge 1994
Suski & Nielsen
1989
Dysphagia and

Ikeda et al. 2002

eating difficulties
in AD may be less
severe than in

Shinagawa et al.
2009

Described/characterized dysphagia in AD

NA

through comparison of two or more groups
of individuals

other types of
dementia
NA = not applicable. See Appendix B for more details.

2.3.2.4

Treatment of Dysphagia in Alzheimer’s Disease

Three randomized trials assessed the efficacy of intervention strategies on outcomes
related to dysphagia in individuals with dementia (Bautmans et al., 2008; Logemann et
al., 2008; Robbins et al., 2008). These studies provide support for the following
conclusions:
1. Providing honey-thickened liquids to individuals with AD may eliminate thin liquid
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aspiration; however, this intervention may not reduce long-term morbidity or mortality.
One study (Logemann et al., 2008) compared the effects of chin-down posture during
swallowing, honey-thickened liquids, and nectar-thickened liquids, on thin liquid
aspiration during VFSS in patients with dementia (15% AD), Parkinson’s disease (PD),
or PD with dementia. Aspiration was most successfully eliminated through use of the
honey-thickened liquids for each diagnostic category. In a second study, the same authors
also reported a non-significant trend towards reduced incidence of pneumonia favouring
patients drinking nectar-thickened liquids compared to those drinking honey-thickened
liquids, as well as a longer median length of hospital stay for participants randomly
assigned to the honey-thickened liquid intervention who developed pneumonia (Robbins
et al., 2008).
2. A physiotherapist-administered cervical spine mobilization protocol may improve
“dysphagia limit” (defined as the maximum bolus of water that can be swallowed in a
single movement) in individuals with severe AD and altered neck posture, based on a
single crossover design randomized controlled trial (Bautmans et al., 2008). Dysphagia
limit improved significantly following one treatment session and remained improved one
week following the intervention.
Table 3. Clinical Reports Examining the Treatment of Dysphagia in Alzheimer's
Disease (AD)
Conclusion

Supporting

Study Description

Studies
Thickening liquids

Logemann et al.

to a honey-

2008

thickened
consistency may
eliminate thin
liquid aspiration in
individuals with

Robbins et al.
2008

Level of
Evidence

Randomized Clinical Trial

2b

Randomized Clinical Trial

2b
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AD, however this
intervention may
not affect longterm morbidity
and mortality
A physiotherapist

Bautmans et al.

administered

2008

Randomized Controlled Crossover Trial

2b

cervical spine
mobilization
protocol may
improve
“dysphagia limit”
in individuals with
severe AD and
altered neck
posture
See Appendix C for more details.

2.3.2.5

Reviews

One narrative review (Chouinard, 2000) and one systematic review (Alagiakrishnan,
Bhanji, & Kurian, 2013) were identified. While published 12 years apart, these reviews
came to similar conclusions: dysphagia may occur early in AD, however, studies
investigating prevalence, assessment, management and treatment of dysphagia in
individuals with dementia are lacking; the existing literature is heterogeneous in design,
methodology, type of assessment, and outcomes (Alagiakrishnan et al., 2013; Chouinard,
2000).

2.3.2.6

Commentaries

Four commentaries (Brush, Slominski, & Boczko, 2006; Clibbens, 1996; Kalia, 2003;
Sumer, Sumer, & Sumer, 2005) covered a wide array of topics associated with dysphagia
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and support the following conclusions:
1. The ethical issues surrounding eating and feeding in the final stages of AD are complex.
One author (Clibbens, 1996) suggested that evidence-based decision-making is vital when
providing clinical care to individuals with AD.
2. Dysphagia, aspiration pneumonia, and oral care are important issues when caring for
individuals with AD. One author (Kalia, 2003) reported that dysphagia and aspiration
pneumonia are severe and growing issues in the AD population. One group (Brush et al.,
2006) cited mealtime strategies and caregiver education as useful management strategies
for AD. Another group (Sumer et al., 2005) noted that diminishing cognitive function
results in neglect of oral hygiene leading to increased prevalence of dental problems;
reduced submandibular salivary flow, increased the risk of gingivitis, tooth decay, oral
infections, as well as dysfunctional speech, chewing, and swallowing.

2.3.2.7

Case Studies

Three (3) case studies (Asplund, Norberg, & Adolfsson, 1991; Barratt, 2000; Yamaguchi,
Maki, & Maki, 2010) described treatments for eating and swallowing impairments in five
individuals with AD:
1. One group (Asplund et al., 1991) examined sucking behaviour in two patients with severe
AD. Patients were observed to suck at different rates and pressures, and one
demonstrated improved sucking over time. The authors concluded that the sucking
method could be of value for end-of-life nutritional care in severe AD patients.
2. One case report (Barratt, 2000) described a 70-year-old woman with AD who exhibited
eating deficits and severe dysphagia yet minimal communication and mobility deficits.
She was treated with a percutaneous endoscopic gastrostomy for non-oral feeding, the
most ethical choice given the patient’s level of function.
3. Another group (Yamaguchi et al., 2010) reported 3 cases of concurrent dementia and
dysphagia, two of which had late-stage AD and severe dysphagia. Treatment with
dopamine agonists and angiotensin-converting enzyme inhibitors (ACEIs) resulted in
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positive outcomes in swallowing and feeding, with associated prolonged oral intake and
weight maintenance.

2.3.3

Autonomic Nervous System Dysfunction in Alzheimer’s
Disease

The review identified 64 studies that investigated autonomic function in AD (Figure 3).

2.3.3.1

Autonomic Nervous System Dysfunction in Alzheimer’s
Disease: Oxford Centre for Evidence-Based Medicine
Levels of Evidence (OCEBM)

Two studies met the OCEBM criteria for classification (Table 4).

2.3.3.2

Autonomic Nervous System Dysfunction in Alzheimer’s
Disease

Of the 51 clinical reports and seven physiological studies, 49 studies identified at least
one variable reflecting ANS dysfunction in AD (Aharon-Peretz et al., 1992; Ahlskog et
al., 1996; Algotsson, Nordberg, et al., 1995; Algotsson, Viitanen, et al., 1995; L. Allan et
al., 2006; L. M. Allan et al., 2007; L. M. Allan et al., 2009; Andersson et al., 2008; Andin
et al., 2007; Benedetti et al., 2004; Bonthius et al., 2005; Bordier et al., 2007; Borson et
al., 1989; Burke et al., 1994; Chu et al., 1997; Davidson et al., 1991; de Vilhena Toledo
& Junqueira, 2008; Del-Ser et al., 1996; Eisdorfer & Cohen, 1978; Elmstahl et al., 1992;
Elmstahl & Winge, 1993; Fotiou et al., 2009; Franceschi et al., 1986; Grunberger et al.,
1999; Guo et al., 1998; Hornqvist et al., 1987; Idiaquez et al., 1994; Idiaquez et al., 1997;
Idiaquez et al., 2002; Jhee et al., 1995; Kalman et al., 2002; Lampe et al., 1989;
Mehrabian et al., 2010; Otsuka et al., 1990; Pascualy et al., 2000; Passant et al., 1997;
Peskind et al., 1998; Peskind et al., 1995; Rainero et al., 2000; Ransmayr et al., 2008;
Raskind et al., 1984; Rub et al., 2001; Ship et al., 1990; Szili-Torok et al., 2001; Vitiello
et al., 1993; S. J. Wang et al., 1994; Zakrzewska-Pniewska et al., 2012; Zulli et al., 2005).
These included measurements of blood pressure, heart rate, baroreflex sensitivity,
vasomotor function, plasma norepinephrine levels, pupillary dilation, skin responses,
urinary incontinence, constipation, blood pressure and heart rate responses to pain
stimuli, and salivary flow. The remaining nine controlled studies failed to find significant
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differences in autonomic function in individuals with AD compared with controls or
patients with other types of dementia (L. M. Allan et al., 2005; Choi et al., 2009; Khurana
& Garcia, 1981; Orimo et al., 2005; Raskind, Peskind, Holmes, & Goldstein, 1999;
Shankle et al., 1993; Taki et al., 2004; Wakabayashi et al., 1999; Watanabe et al., 2001).
Twenty-eight studies were identified that provide evidence for the occurrence of
cardiovascular ANS dysfunction in AD, supporting the following conclusions:
1. Individuals with AD demonstrate blood pressure differences compared with controls
(Bordier et al., 2007; Burke et al., 1994; Elmstahl et al., 1992; Guo et al., 1998; Idiaquez
et al., 1997; Kalman et al., 2002; Lampe et al., 1989; Otsuka et al., 1990). These include
blunted diastolic pressor responses to thyrotropin stimulating hormone (Lampe et al.,
1989), higher baseline systolic blood pressure in bedridden patients with advanced AD
(Otsuka et al., 1990) and, in contrast, lower baseline systolic and diastolic blood pressure
was documented in mild to moderate AD (Elmstahl et al., 1992). Yearly systolic,
diastolic, and mean arterial blood pressures decreased in 3 AD subjects every year
following diagnosis (Burke et al., 1994) and lower systolic and diastolic blood pressures
were associated with greater AD severity and shorter survival (Guo et al., 1998).
2. AD patients exhibit orthostatic hypotension, that is, significant decreases in blood
pressure when transitioning from supine to standing position (L. M. Allan et al., 2007; L.
M. Allan et al., 2009; Andersson et al., 2008; Andin et al., 2007; Jhee et al., 1995;
Mehrabian et al., 2010; Passant et al., 1997; Vitiello et al., 1993; S. J. Wang et al., 1994;
Zakrzewska-Pniewska et al., 2012), which may contribute to the risk of falls (L. M. Allan
et al., 2009). Compared with controls, AD patients showed greater increases in heart rate,
and greater decreases in mean systolic blood pressure in response to a tilting test
(Elmstahl et al., 1992) and reduced change in diastolic blood pressure during an isometric
handgrip exercise (Kalman et al., 2002).
3. Resting heart rate variability is significantly reduced in AD (Aharon-Peretz et al., 1992;
Algotsson, Viitanen, et al., 1995; de Vilhena Toledo & Junqueira, 2008; Franceschi et al.,
1986; Idiaquez et al., 2002; Szili-Torok et al., 2001; Toledo & Junqueira, 2010; Zulli et
al., 2005). Although the interpretation of heart rate variability as a marker of sympathetic
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nervous system (SNS) function is debated (Eckberg, 1997), some studies reported
increased SNS activation (Aharon-Peretz et al., 1992; de Vilhena Toledo & Junqueira,
2008; Toledo & Junqueira, 2010) and decreased parasympathetic nervous system (PNS)
activation (Aharon-Peretz et al., 1992; de Vilhena Toledo & Junqueira, 2008), whereas
others reported decreased SNS and PNS activation in relation to heart rate variability
(Algotsson, Viitanen, et al., 1995; Franceschi et al., 1986).
4. Blood pressure and heart rate responses to pre-stimulus pain and stimuli delivered at just
above the pain threshold are blunted in AD (Rainero et al., 2000). Autonomic responses
to pain appear to be related to the severity of cognitive impairment, as measured by the
MMSE (Benedetti et al., 2004).
Twenty studies were identified that examined other aspects of ANS function in AD,
supporting the following conclusions:
1. ANS dysfunction in AD may be subtle compared with other types of dementia such as
Parkinson’s disease dementia or Lewy body dementia. Clinical complaints of ANS
dysfunction are less common among AD patients (L. Allan et al., 2006; L. M. Allan et
al., 2007).
2. Baseline plasma norepinephrine levels are significantly higher in severe AD patients
compared with moderate AD patients and controls (Pascualy et al., 2000; Raskind et al.,
1984). Basal plasma norephinephrine levels and plasma norepinephrine levels in response
to an alpha-2 adrenergic antagonist may be increased in AD, potentially indicating
increased SNS activation (Peskind et al., 1998; Peskind et al., 1995), however decreased
SNS activation in response to thyrotropin stimulating hormone has also been reported
(Lampe et al., 1989). Modulation of plasma norepinephrine levels following stimulation
with a cognitive task may be blunted in early AD (Borson et al., 1989).
3. Vasomotor function may be reduced in AD (Algotsson, Nordberg, et al., 1995; Hornqvist
et al., 1987; Kalman et al., 2002) in response to vasodilating substances, adrenergic
agonists, and maximal contraction. Skin vessel vasodilation in response to iontophoresis
of acetylcholine and isoprenaline was significantly reduced in AD (Algotsson, Nordberg,
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et al., 1995; Hornqvist et al., 1987). Decreased skin blood flow and increased change in
cutaneous vascular resistance was reported in AD subjects compared to age-matched
controls following an isometric handgrip exercise (Kalman et al., 2002).
4. Individuals with AD demonstrate anhydrosis (impaired sweating) (Elmstahl & Winge,
1993) following stimulation with a receptor agonist. Estimated mean sweat sodium
concentration was significantly higher among women with AD compared with healthy
controls and significantly more AD patients (27%) did not demonstrate a sweat response
following stimulation (Elmstahl & Winge, 1993).
5. Increased pupillary sensitivity to a parasympathomimetic receptor agonist and a
sympathomimetic receptor antagonist are seen in AD (Fotiou et al., 2009; Grunberger et
al., 1999; Idiaquez et al., 1994). Pupillary dilatation following application of
acetylcholine was greater in AD subjects at all measurement points (Grunberger et al.,
1999; Idiaquez et al., 1994), indicating AD-induced changes in post-junctional receptor
function. Functional stimulation with a pupil light reflex evaluation which engages the
integrated reflex response, revealed a significantly slower reflex among AD patients
compared to controls (Fotiou et al., 2009).
6. AD patients may experience constipation (Zakrzewska-Pniewska et al., 2012) and urinary
incontinence (Davidson et al., 1991; Del-Ser et al., 1996; Ransmayr et al., 2008),
indicating PNS dysfunction.
7. Individuals with AD may experience heightened cardiovascular arousal during learning
(Eisdorfer & Cohen, 1978).
8. Resting and stimulated submandibular salivary flow is reduced in AD (Ship et al., 1990).
Forty-six percent of a sample of AD patients had flow rates below the 10th percentile
compared to 11% of a control group.
Four studies examined AD neuropathology, supporting the following conclusions:
1. AD neuropathology may infiltrate central ANS structures, including the ventromedial
frontal cortex (Chu et al., 1997), pons (Rub et al., 2001) medial parabrachial nucleus,
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subpeduncular pigmented nucleus, and intermediate zone of the brainstem medullary
reticular formation (Burke et al., 1994).
2. Telencephalic structures such as the insula may also be affected (Bonthius et al., 2005).
Table 4. Clinical/Physiological Reports Examining Autonomic Nervous System
(ANS) Dysfunction in Alzheimer's Disease (AD)
Conclusion

Supporting

Study Description

Studies

Evidence

Individuals with

Lampe et al.,

Described/characterized ANS dysfunction

AD demonstrate

1989

in AD through comparison of two or more

blood pressure
differences at
baseline and

Otsuka et al.

Level of

NA

groups of individuals

1990

following

Elmstahl et al.

stimulation, as

1992

compared with
controls

Burke et al.

Retrospective chart review and

1994

neuroanatomical analysis of 3 postmortem

NA

AD subjects and characterization of an
aspect of ANS dysfunction in AD through
comparison of two or more groups of
individuals, one or more of these groups
being comprised of AD patients
Idiaquez et al.

Described/characterized ANS dysfunction

1997

in AD through comparison of two or more

NA

groups of individuals
Guo et al. 1998

Prospective cohort study

2b

Kalman et al.

Described/characterized ANS dysfunction

NA
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2002
Bordier et al.

in AD through comparison of two or more
groups of individuals

2007
Individuals with

Elmstahl et al.

Described/characterized ANS dysfunction

AD demonstrate

1992

in AD through comparison of two or more

significantly
greater falls in
blood pressure

Vitiello et al.

NA

groups of individuals

1993

(particularly

Wang et al.

systolic) when

1994

transitioning from
supine to standing

Jhee et al. 1995

Retrospective description of ANS

(orthostatic

dysfunction in AD through examination of

hypotension)

a single group of AD subjects

compared with
healthy agematched controls

Passant et al.

Described/characterized ANS dysfunction

1997

in AD through comparison of two or more

Kalman et al.

NA

NA

groups of individuals

2002
Andin et al.
2007
Allan et al. 2007
Andersson et al.
2008
Allan et al. 2009

Prospective Cohort Study

2b

Mehrabian et al.

Described/characterized ANS dysfunction

NA

2010

in AD through comparison of two or more
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Zakrzewska-

groups of individuals

Pniewska et al.
2012
Significantly less

Franceschi et al.

Described/characterized ANS dysfunction

heart rate

1986

in AD through comparison of two or more

variability has
been reported in
individuals with
AD

Aharon-Peretz

NA

groups of individuals

et al. 1992
Algotsson et al.
1995 a
Szili-Torok et
al. 2001
Idiaquez et al.
2002
Zulli et al. 2005
ZakrzewskaPniewska et al.
2012
Toledo and
Junqueira Jr,
2008

Individuals with

Toledo and

Described/characterized an aspect of ANS

Junqueira Jr.

dysfunction through the examination of a

2010

single group of patients with AD

Rainero et al.

Described/characterized ANS dysfunction

NA

NA

34

AD also

2000

demonstrate
altered blood
pressure and heart
rate responses to

groups of individuals
Benedetti et al.

Described/characterized an aspect of ANS

2004

dysfunction through the examination of a

nervous system
dysfunction

NA

single group of patients with AD

pain stimuli
Autonomic

in AD through comparison of two or more

Allan et al. 2007
Allan et al. 2006

Described/characterized ANS dysfunction

NA

in AD through comparison of two or more
groups of individuals

appears to be
subtle in patients
with AD when
compared with
other types of
dementia
Plasma

Borson et al.

Described/characterized ANS dysfunction

norepinephrine

1989

in AD through comparison of two or more

levels may be
altered in AD

Raskind et al.
1984
Lampe et al.
1989
Peskind et al.
1995
Ahlskog et al.
1996
Peskind et al.
1998

groups of individuals

NA
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Pascualy et al.
2000
Vasomotor

Algotsson et al.

Described/characterized ANS dysfunction

function may be

1995

in AD through comparison of two or more

reduced in
individuals with
AD

Kalman et al.

NA

groups of individuals

2002
Hornqvist et al.
1987

Individuals with

Elmstahl and

Described/characterized ANS dysfunction

AD may

Winge 1993

in AD through comparison of two or more

demonstrate an

NA

groups of individuals

impaired sweat
response
Pupillary

Idiaquez et al.,

Described/characterized ANS dysfunction

responses in AD

1994

in AD through comparison of two or more

are altered in AD

Grunberger et

NA

groups of individuals

al. 1999
Fotiou et al.
2009
Constipation and

Davidson et al.

Described/characterized an aspect of ANS

urinary

1991

dysfunction through the examination of a

incontinence may
occur in AD

NA

single group of patients with AD
Del-Ser et al.

Described/characterized ANS dysfunction

1996

in AD through comparison of two or more

NA

36

Ransmayr et al.

groups of individuals

2008
ZakrzewskaPniewska et al.
2012
Heightened

Eisdorfer and

Described/characterized an aspect of ANS

arousal during

Cohen in 1978

dysfunction through the examination of a

learning may

NA

single group of patients with AD

occur in AD
Salivary flow is

Ship et al. 1990

decreased in AD

Described/characterized ANS dysfunction

NA

in AD through comparison of two or more
groups of individuals

The

Chu et al. 1997

Neuroanatomical and Described/

neuropathology of

characterized ANS dysfunction in AD

AD may affect

through comparison of two or more groups

central ANS

of individuals

NA

control mediated
by the
ventromedial
frontal cortex
The

Rub et al. 2000

Neuroanatomical and Described/

neuropathology of

characterized an aspect of ANS

AD may affect

dysfunction through the examination of a

central ANS

single group of patients with AD

central control
mediated by the
pontine regions of

NA

37

the brainstem
The

Bonthius et al.

Neuroanatomical and Described/

neuropathology of

2005

characterized an aspect of ANS

AD may affect the

dysfunction through the examination of a

insula

single group of patients with AD

The

Burke et al. in

neuropathology of

1994

NA

See Above

See Above

NA

AD may affect the
C-1 neurons of the
rostral
ventrolateral
reticular nucleus
No significant

Khurana and

Described/characterized ANS dysfunction

differences

Garcia 1981

in AD through comparison of two or more

between
individuals with
AD and controls

groups of individuals
Shankle et al.

Neuroanatomical and Described/

1993

characterized ANS dysfunction in AD

Wakabayashi et
al. 1999
Taki et al. 2001
Allen et al. 2004

NA

through comparison of two or more groups
of individuals

Described/characterized ANS dysfunction

NA

in AD through comparison of two or more
groups of individuals

Orimo et al.

Neuroanatomical and Described/

2005

characterized ANS dysfunction in AD
through comparison of two or more groups
of individuals

NA

38

Choi et al. in

Described/characterized ANS dysfunction

2009

in AD through comparison of two or more

Watanabe et al.

NA

groups of individuals

2001
Raskind et al.
1999
NA = not applicable. See Appendix D for more details.

2.3.3.3

Reviews

Four non-systematic, narrative reviews (Borson et al., 1989; Idiaquez & Roman, 2011;
Kenny, Kalaria, & Ballard, 2002; Royall, 2008) were identified.
One review (Borson et al., 1989) described studies of ANS function in AD that were
published between 1978 and 1990 and concluded that:
1. SNS over-arousal may be a feature of advanced AD, whereas SNS arousal in mild to
moderate AD appears to be significantly reduced.
2. Studies of heart-rate variability in AD have indicated reduced SNS activity, as well as
SNS and PNS dysfunction.
3. Disordered vascular skin reactivity and reduced basal and stimulated salivary flow may
occur in AD.
One narrative review described “neurocardiovascular instability” among patients with
dementia, including AD, and suggested that this disorder may result in autonomic
dysregulation (Kenny et al., 2002). Another review reported on the association of right
cerebral hemisphere dysfunction, insular pathology, and mortality secondary to
cardiovascular and autonomic dysregulation in AD (Royall, 2008). One further review
suggested that dysautonomia is mild in AD and primarily manifests as cardiovascular and
urinary dysfunction (Idiaquez & Roman, 2011).
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2.3.3.4

Case Studies

Two case studies addressed ANS dysfunction in AD (Diamond & Diamond, 1991;
Novak, Novak, Li, & Remillard, 1994). One described a patient with AD who developed
thermoregulatory dysfunction (Diamond & Diamond, 1991). The other described an AD
patient in whom spontaneous hypotension, accompanied by cardio-acceleration, occurred
repeatedly in the supine position and/or during applied hyperventilation (Novak et al.,
1994).

2.3.4

Dysphagia and Autonomic Nervous System Dysfunction in
Alzheimer’s Disease

The literature search did not identify any studies that directly examined both dysphagia
and ANS dysfunction in AD. While one clinical report identified significantly decreased
submandibular salivary flow in AD (Ship et al., 1990), its potential impact on swallowing
was not examined. One commentary on oral health in AD suggested that reduced salivary
flow might result in dysfunctional swallowing (Sumer et al., 2005).

2.3.5

Gap Analysis

2.3.5.1

Dysphagia in Alzheimer’s Disease

1. Demographics – While there is preliminary evidence that dysphagia occurs in AD, few
studies have examined its prevalence, or variations in prevalence as a function of disease
progression.
2. Nature of dysphagia – While the evidence indicates that both the oral and pharyngeal
stages of swallowing may be affected in AD, studies examining the esophageal stage of
swallowing in AD are lacking.
3. Contribution of dysphagia to eating problems – The functional significance of dysphagia
to eating problems in AD has not been elucidated.
4. Assessment of dysphagia – A variety of assessment approaches have been employed to
examine dysphagia in AD. However, an optimized swallowing assessment,
contextualized with respect to the manifestations of AD, has not been examined.
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5. Treatment of dysphagia –Three studies have examined interventions for dysphagia in AD
patients. The treatment paradigms were limited and long-term outcomes were either not
measured or not identified. Sensory stimulation, or motor training approaches, to
dysphagia treatment that have been examined in other neurodegenerative conditions,
have not been examined in AD.
6. Relationship of dysphagia to other manifestations of AD – While there is preliminary
evidence suggesting that dysphagia severity may be related to overall AD severity, or
cognitive or executive dysfunction, associations between dysphagia and other signs of
AD, such as independence in activities of daily living (ADL), have not been elucidated.
7. Neural mechanisms underlying dysphagia – A small number of studies have shown that
changes in the cortical swallowing network occur early in AD and may be correlated with
early functional changes in swallowing. However, the neuropathophysiology of
dysphagia in AD is unclear.

2.3.5.2

Autonomic Nervous System Dysfunction in Alzheimer’s
Disease

1. Demographics – While a substantial literature has identified ANS dysfunction in AD, its
prevalence remains unclear.
2. Relationships between ANS functions – The relative extent of impairment across a range
of ANS functions in AD is not understood.
3. Functional significance of ANS dysfunction – The functional significance of ANS
dysfunction in AD in terms of, for example, ability to perform ADLs, including eating, is
unclear.
4. Neuropathophysiology of ANS dysfunction – The neural mechanisms that contribute to
ANS dysfunction, how they relate to the disease process, and whether the severity
changes as the disease progresses, remain unclear.
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2.3.5.3

Dysphagia and Autonomic Nervous System Dysfunction in
Alzheimer’s Disease

Although it is known that ANS function is important in regulating swallowing, the
relationship between oropharyngeal dysphagia and ANS dysfunction in AD has not been
examined directly. No study has examined oropharyngeal dysphagia in relation to
swallow-related ANS functions such as salivary flow, or esophageal smooth muscle
function.

2.4

Discussion

This scoping review was undertaken to (i) describe, synthesize, and interpret literature on
dysphagia and/or ANS dysfunction in AD, and (ii) identify gaps in the existing literature.
The review identified an emergent literature on dysphagia in AD, with 31 articles
matching our search criteria. These articles provide preliminary evidence on the
prevalence, nature, and treatment of dysphagia in AD. The available prevalence data
suggest that oropharyngeal dysphagia may be a significant problem in AD, even early in
the disease progression. However, knowledge gaps were also identified with respect to
demographics, nature of dysphagia including the potential of an esophageal component,
significance in relation to eating problems, assessment, treatment, and underlying
mechanisms of dysphagia in AD.
The review identified 64 articles that examined ANS dysfunction in AD. While the
literature on ANS dysfunction in AD is larger and broader than the literature on
dysphagia in AD, there are inconsistent findings regarding the presence, severity, and
nature of ANS dysfunction. Current evidence suggests that a variety of ANS functions,
particularly cardiovascular regulation, may be impaired in AD, but the impact of
dysfunction among multiple ANS systems remains unknown. Knowledge gaps were
identified with respect to demographics, functional significance, relationships between
ANS functions, and underlying neural mechanisms. No systematic reviews of ANS
dysfunction in AD have been published previously.
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No studies were identified that examined both dysphagia and ANS dysfunction in AD.
Given the, albeit limited, evidence that salivary flow is reduced in AD, a relationship
between oropharyngeal dysphagia and ANS dysfunction might be expected.

2.5

Conclusions

A scoping review of the literature revealed that dysphagia, as well as ANS dysfunction,
may occur in AD. However, the potential relationship between dysphagia and ANS
dysfunction in AD has not been explored. Moreover, the functional significance of
dysphagia and eating-related ANS dysfunction, for example, reduced saliva, to eating
problems in AD is not clear.
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Chapter 3

3

A Meta-Analysis of Salivary Flow Rates in Young and
Older Adults

This meta-analysis aims to determine whether salivary flow decreases as a function of
‡

aging .

3.1 Introduction
Saliva plays a vital role in maintaining oral homeostasis (Mandel, 1989). Saliva is a clear,
slightly acidic oral fluid composed of more than 99% water. The remaining 1% is
composed of a variety of electrolytes including sodium and potassium, proteins, and
nitrogenous products such as urea and ammonia (Humphrey & Williamson, 2001). The
electrolytes and proteins in saliva modulate pH levels in the oral cavity. Proteins
contribute to cleaning the oral cavity and metabolizing dental plaque (i.e., oral biofilm).
Calcium, phosphate and proteins combine to interfere in demineralization and promote
remineralization of the teeth. Immoglobulins and proteins combine to provide
antibacterial protection (Humphrey & Williamson, 2001). Decreased salivary flow, or
hyposalivation, leads to drying of the oral mucosa, inefficient food bolus formation and
transport, demineralization of dentition, mucosal ulceration, altered oral flora, dysphonia,
impaired taste and smell while eating, and discomfort (Baum, 1989).
Saliva is secreted from three pair of major salivary glands: the parotid, submandibular,
and sublingual glands, as well as numerous minor salivary glands. Another constituent of
saliva is an exudate called gingival crevicular fluid (Sreebny & Vissink, 2010). The
combination of all these fluids, as well as oral bacteria, and their products, is referred to
as whole saliva. Glandular saliva is secreted in response to neurotransmitter stimulation
from innervating sympathetic and parasympathetic nerves. The minor salivary glands
function continuously day and night (Eliasson & Carlen, 2010) during wake and sleep.
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The major salivary glands, in contrast, secrete in response to low-grade mechanical
stimulation associated with movements of the tongue and lips, and in response to mucosal
dryness to lubricate and protect the oral cavity (Baum, 1987; Ekstrom, Khosravani,
Castagnola, & Messana, 2012). Although this major salivary gland basal, or resting
secretion is produced in response to nervous activity, it is known as “unstimulated
salivary flow rate” (Ekberg, 2012; Ekstrom et al., 2012). Approximately 75% of
unstimulated, whole saliva is derived from the submandibular/sublingual glands, about
15-20% from the parotid, and 5-8% from the minor salivary glands (Edgar, 1992;
Humphrey & Williamson, 2001; Sreebny, 2000). At mealtimes, in response to taste,
smell, visual, and mechanical stimuli, salivary flow rates increase by 5 to 50 times. The
percentage contribution from the parotid gland increases to more than 50% of total
salivary secretions. This increased flow rate is referred to as “stimulated salivary flow
rate”.
Age-related degenerative changes in the cellular structure of the submandibular and the
parotid salivary glands have been previously identified (Scott, 1977; Scott, Flower, &
Burns, 1987). A 20-40% decrease in the volume of cells responsible for saliva secretion
and a corresponding increase by fatty and fibrous tissue in the glandular area has been
reported (Baum, 1989; Scott, 1977; Scott et al., 1987; Sreebny, 2000). Comparable
changes have been described for the labial minor glands (Drummond & Chisholm, 1984;
Syrjanen, 1984). This evidence of age-related salivary gland degeneration suggests that
functional reductions of salivary flow may also occur. Many studies have examined
salivary flow rates in the context of aging. The results, however, are conflicting. Some
authors have reported significantly decreased salivary flow with age (Ben-Aryeh, Miron,
Szargel, & Gutman, 1984; Billings, Proskin, & Moss, 1996; Chang, Chang, Kim, Lee, &
Kho, 2011; Cowman, Frisch, Lasseter, & Scarpace, 1994; Fenoll-Palomares et al., 2004;
Flink, Bergdahl, Tegelberg, Rosenblad, & Lagerlof, 2008; Ghezzi, Lange, & Ship, 2000;
Ghezzi & Ship, 2003; Gutman & Ben-Aryeh, 1974; Hershkovich, Shafat, & Nagler,
2007; Johnson, Yeh, & Dodds, 2000; Marotta et al., 2012; Meurman & Rantonen, 1994;
Moritsuka et al., 2006; Nagler & Hershkovich, 2005a, 2005b; Navazesh, Mulligan,
Kipnis, Denny, & Denny, 1992; Pedersen, Schubert, Izutsu, Mersai, & Truelove, 1985;
Percival, Challacombe, & Marsh, 1994; Sawair, Ryalat, Shayyab, & Saku, 2009; Smith et
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al., 2013; Streckfus, Bigler, & O'Bryan, 2002; Tanida et al., 2001; Toida et al., 2010; X.
P. Wang et al., 2012; Yaegaki, Ogura, Kameyama, & Sujaku, 1985; Yeh, Johnson, &
Dodds, 1998; Yeh et al., 2000), while others have not (Bakke et al., 2004; Baum, 1981;
Baum, Costa, & Izutsu, 1984; Ben-Aryeh et al., 1986; Bourdiol, Mioche, & Monier,
2004; Chauncey, Feller, & Kapur, 1987; Eliasson, Birkhed, Heyden, & Stromberg, 1996;
Fischer & Ship, 1997, 1999; Gandara, Izutsu, Truelove, Ensign, & Somers, 1985; Heft &
Baum, 1984; Malhotra, Wood, & Sachse, 2009; Ogura et al., 1983; Parvinen & Larmas,
1982; Salvolini et al., 2000; Shern, Fox, & Li, 1993; Ship & Baum, 1990; Ship &
Fischer, 1997; Sonnenberg et al., 1982; Takada, Suzuki, Okada, Nakashima, & Ohsuzu,
2006; Tylenda, Ship, Fox, & Baum, 1988; Yoshikawa et al., 2012). Variations in study
designs, saliva collection methods, and selection of outcome measures may account for
the lack of consistent findings among studies. This variation has been acknowledged in
several narrative reviews, which themselves have drawn conflicting conclusions (Baum,
Ship, & Wu, 1992; de Almeida Pdel, Gregio, Machado, de Lima, & Azevedo, 2008;
Dodds, Johnson, & Yeh, 2005; Ekstrom et al., 2012; Eliasson & Carlen, 2010; Sreebny,
2000). The results from some reviews suggest that the flow of unstimulated whole saliva
and unstimulated and stimulated submandibular/sublingual saliva (Dodds et al., 2005;
Sreebny, 2000) decreases with increasing age. Other reviews have suggested that no agerelated decreases in either unstimulated or stimulated parotid saliva occur. (Baum et al.,
1992) Still other reviews have reported no age-related effects on any type of salivary flow
(de Almeida Pdel et al., 2008; Ekstrom et al., 2012). To date, the issue remains
unresolved, in part, because no pooled analyses have been undertaken. Therefore, the
objective of this study was to determine whether there is an effect of age on salivary flow
rates, using a meta-analytic approach. We hypothesized that salivary flow rates decrease
with advancing age.

3.2

Methodology

Potentially relevant studies that examined salivary flow rate in adults of different ages
were identiﬁed through literature searches of the PubMed, EBSCOhost, Web of Science,
Cochrane, EMBASE, Dissertations and Theses, and Scopus databases, published from
the inception of the databases through June 2013. Although search terms varied slightly
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across databases, the terms “saliva” and “salivation” or “secretion” and “aged” or “aging”
and “normal” or “disease-free” were used as MeSH terms, key words, or subject headings
(Appendix E). Hand searching of the bibliographies of the included studies was
conducted to identify potentially relevant articles not recovered using the search terms.
Inclusion/Exclusion Criteria: Our inclusion criteria were intentionally broad to capture as
many studies as possible. Studies were included if saliva had been collected on at least
one occasion, among participants aged 18 to 60 + years who had been classified in some
manner to form “younger” and “older” groups. Additional inclusions were a sample size
of at least 6 participants, studies published in the English language and sufficient
reporting detail to enable extraction (or calculation) of data needed for pooled analysis.
Studies that examined salivary flow rates from any/all sources (whole, parotid,
submandibular/sublingual, and/or minor glands), in either physiological condition
(stimulated and/or unstimulated condition), and using any established collection method
(draining, expectoration, cotton rolls, suction, Carlson Crittenden/Curby/Lashley cup,
mastication stimulated, or gustatory stimulated) were included. Studies that examined a
therapy or medication were used if baseline measures of salivary flow rates were
conducted prior to the introduction of the intervention, and reported. Normal aging was
not defined a priori; instead studies were included if the participants were described as
“healthy” by the authors, or if the participants were free of major systemic diseases.
Reviews, commentaries, opinion pieces, case reports, case series, studies examining
salivary flow in individuals with disease, and animal studies were excluded.
Two authors (RA and RG) independently reviewed titles and abstracts to determine initial
eligibility. If an abstract was in question by either reviewer, the full article was retrieved
and reviewed. Following this initial screen, the same authors reviewed the full text of the
remaining articles to determine final eligibility. A third author (NF) resolved
discrepancies. The degree of agreement between the two independent reviewers was
calculated using a kappa value.
One author (RA) extracted data on trial design, sample sizes, participant characteristics,
salivary flow rate (volume/collection time) for each of the salivary sources of interest
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under unstimulated and stimulated conditions for the young and the older groups, as well
as method of saliva collection, health status, and medication use from each study, and a
second reviewer verified them for accuracy.
To enable comparisons of young and older subjects, the age groups operationally defined
in individual studies were used. The two comparison groups were: (i) subjects closest in
age to 18 – 40 years (i.e., young); and (ii) subjects closest to >60 years (i.e., old). Studies
where little separation between age data occurred (e.g. young subjects were aged 18 to 64
years, and old subjects were aged 65 years and older) were excluded. Differences in
salivary flow rates between age groups were calculated for each salivary source and
condition and the results pooled using the software Comprehensive Meta-Analysis
§

(version 2, Biostat Inc., 2007) . This software enables the calculation of a pooled
estimate of a treatment effect using differing forms of summary level data. Standardized
mean differences (SMDs), standard errors (SEs), and 95% confidence interval (CIs) was
calculated using the reported means and standard deviations of the two groups, or using
the formula (Standardized Difference equals 2 times the correlation divided by the square
root of 1, minus the correlation squared) for conversion when a Pearson’s correlation coefficient for salivary flow rates across the age continuum was reported. Separate analyses
were conducted for each salivary source and condition, with subgroup analyses
completed for collection method, gender, and health status, providing at least four studies
were available for analysis. A separate analysis including subjects from studies where
authors excluded those taking prescription and/or nonprescription medication was also
conducted. The younger subject group data were used as the basis of comparison;
therefore, differences between the younger and older subject groups observed to be
greater than zero indicated that younger subjects had greater salivary flow rates than the
older subjects. Cohen has suggested the following guide to interpretation of effect sizes:
0.80 = large; 0.50 = moderate; 0.20 = small (Cohen, 1988). A Cohen’s d value of zero
indicates no effect. Where possible, the effect size was also converted to more clinically
interpretable measurement (mL/min) using a standard technique (Lipsey & Wilson,

§

Suppliers Version 2; Biostat Inc, 14 N. Dean St, Englewood, NJ 07631.
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2001). A random effects model was used to address two sources of potential variance:
within-study error in estimating the effect in each study, as well as the variation in the
true effects across studies (Borenstein, 2009). In order to examine the observed
dispersion in true effect sizes, and to estimate both the true variance and random error
within the observed dispersion, a standardized weighted sum of squares (Q) was
calculated and compared with the expected weighted sum of squares in order to yield a
test of the null. Heterogeneity was considered statistically significant if p < 0.05. An
estimate of the variance (T2), the standard deviation (T), and confidence intervals of the
true effects were calculated. Additionally, the proportion of true variance found within
the observed variance was also calculated (I2) (Borenstein, 2009). A rough guide to the
interpretation of the I2 statistic is: 0 to 40% may not be important, 30 to 60% may
represent moderate heterogeneity, 50 to 90% may represent substantial heterogeneity, 75
to 100% considerable heterogeneity (Higgins et al., 2011).
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3.3

Results

Figure 4. Flow Chart of Meta-Analysis
The initial search returned 7,030 results, of which 187 were selected for full review
(Figure 4). After elimination of an additional 138 articles, 51 studies remained, four of
which reported duplicate data. Forty-seven studies met the inclusion criteria and were
included (Bakke et al., 2004; Baum, 1981; Baum et al., 1984; Ben-Aryeh et al., 1984;
Ben-Aryeh et al., 1986; Billings et al., 1996; Bourdiol et al., 2004; Chang et al., 2011;
Chauncey et al., 1987; Cowman et al., 1994; Eliasson et al., 1996; Fenoll-Palomares et
al., 2004; Fischer & Ship, 1997, 1999; Flink et al., 2008; Gandara et al., 1985; Ghezzi et
al., 2000; Ghezzi & Ship, 2003; Gutman & Ben-Aryeh, 1974; Heft & Baum, 1984;
Henkin, Velicu, & Papathanassiu, 2007; Hershkovich et al., 2007; Johnson et al., 2000;
Malhotra et al., 2009; Marotta et al., 2012; Meurman & Rantonen, 1994; Moritsuka et al.,
2006; Nagler & Hershkovich, 2005a, 2005b; Navazesh et al., 1992; Ogura et al., 1983;
Parvinen & Larmas, 1982; Pedersen et al., 1985; Percival et al., 1994; Salvolini et al.,
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2000; Sawair et al., 2009; Shern et al., 1993; Ship & Baum, 1990; Ship & Fischer, 1997;
Smith et al., 2013; Sonnenberg et al., 1982; Streckfus et al., 2002; Takada et al., 2006;
Tanida et al., 2001; Toida et al., 2010; Tylenda et al., 1988; X. P. Wang et al., 2012;
Yaegaki et al., 1985; Yeh et al., 1998; Yeh et al., 2000; Yoshikawa et al., 2012).
Agreement between raters as to which studies should be retained was good to excellent
(kappa: κ=0.836, SE=0.420).
The details of all studies included in the analyses are presented in Appendix F and
summarized in Table 5. The 47 studies included sample sizes ranging from 15 to 1427
participants, arranged into two to seven age groupings. Young subjects ranged in age
from 15 to 59 years and elderly subjects ranged in age from 60 to 97 years. Twenty-four
studies examined the salivary flow rates of males and females separately.
Thirty-five studies described the included participants as “healthy” or “generally
healthy”, or included a healthy control group, or reported excluding participants with
health problems that could affect salivary flow, such as history of treatment for cancer, or
systemic disease. Other studies reported that participants with common illnesses such as
hypertension and compensated diabetes were not excluded, while other studies reported
using data from cohorts of community-dwelling volunteers, or recruiting participants
from dental clinic registries where older individuals appeared to be free of major
systemic disease, but may have had some common age-related conditions.
Twenty-six studies excluded subjects taking certain medications. Some studies reported
excluding subjects taking any medications, while others excluded subjects taking
prescription medications and antihistamines or any saliva-affecting medications, but not
hormone replacement therapy or birth control. We referred to participants in these
studies, who were taking either no medications or minimal medications, as being
“medication-free”. Twenty-one studies reported that individuals taking routine
medications were included in the study or did not report the medication status of the
participants.
The 47 studies included 33 trials examining unstimulated whole salivary flow rates; 23
trials examining stimulated whole salivary flow rates; eight trials examining unstimulated
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parotid salivary flow rates; 19 trials examining stimulated parotid salivary flow rates; six
trials examining unstimulated submandibular/sublingual (SMSL) salivary flow rates;
seven trials examining stimulated SMSL salivary flow rates; and four each examining
unstimulated minor buccal salivary flow rates, unstimulated minor palatal salivary flow
rates, and unstimulated minor labial salivary flow rates. Some studies included more than
one trial.
Of all studies included in the meta-analysis (N=47), 21 reported no significant differences
in mean salivary flow between younger and older subjects, 15 reported age-related
declines in salivary flow, one reported both age-related decreases and increases in
salivary flow, and 10 studies reported equivocal results (i.e. in studies in which more than
one result was reported, significant and nonsignificant results were reported in the same
study).
Separate analyses for each of the salivary sources are presented below.

3.3.1

Whole Salivary Flow Rate

Whole salivary flow rate (Figure 5) was significantly reduced in the elderly group (SMD
= 0.551, SE = 0.056, 95% CI = 0.423–0.678, p < 0.001). In subgroup analysis including
the results from 33 studies, whole salivary flow rate in the unstimulated condition was
significantly lower in the elderly group (SMD = 0.611, SE = 0.075, 95% CI = 0.464–
0.758, p < 0.001). Similarly, subgroup analyses examining stimulated whole salivary
flow rate (n = 23) revealed significantly lower flow rate in the elderly group (SMD =
0.367, SE = 0.131, 95% CI = 0.110–0.625, p = 0.005). Moderate and small effect sizes
were identified, respectively.
Heterogeneity:
The results of the heterogeneity analysis indicated that the included studies did not share
a common effect size (Q = 277.4, p < 0.001). The variance and standard deviation of the
true difference between the whole salivary flow rates of young and older individuals
indicated that the range of true differences crossed the no difference line, despite the
summary effect being statistically significant (T2 = 0.187, T = 0.432, 95% CI = -0.296 –
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1.398). Eighty percent of the observed variance was found to be true variance of the
effect size (I2 = 80.17%).
The results of the heterogeneity analysis for whole salivary flow rate in the unstimulated
condition indicated significant heterogeneity (Q = 80.70, p < 0.001). The range of true
effects, although wider than the confidence interval of the summary interval, did not
cross the no difference line (T2 = 0.091, T = 0.301, 95% CI = 0.021 – 1.201). Sixty
percent of the observed variance was found to be true variance of the effect size (I2 =
60.35%).
The results of the heterogeneity analysis for whole salivary flow rate in the stimulated
condition also indicated significant heterogeneity (Q = 195.37, p < 0.001). The range of
true effects was observed to cross the no difference line, despite the summary effect
being statistically significant (T2 = 0.303, T = 0.551, 95% CI = -0.713 – 1.447). Eightyeight percent of the observed variance was found to be true variance of the effect size (I2
= 88.74%).
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Yaegaki et al., 1985
Chang et al., 2011
Hershkovich et al., 2007
Marotta et al., 2012
Tanida et al., 2001
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Figure 5: Forest Plot of the Difference in Whole Salivary Flow Rate Between Older
and Younger Subjects
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The first (left) column lists studies by primary author and publication date. An “f”
or “m” following the primary author and date of publication indicates data that
were reported separately for males and females in the same study. The second
column indicates the subgrouping by condition (stimulated and unstimulated). The
forest plot is illustrated in the right column. The solid squares illustrate the
standardized mean difference (SMD) and the lines represent the 95% confidence
intervals (CI). The younger subject group data were used as the basis of
comparison, therefore, differences between younger and older subject groups
observed to be greater than zero are represented on the right hand side of the lineof-no-difference, and indicate that younger subjects had greater salivary flow rates
than the older subjects. The solid diamonds represent the pooled SMD and 95% CI.

3.3.2

SMSL Salivary Flow Rate

SMSL salivary flow rate (Figure 6) was significantly reduced in the elderly group (SMD
= 0.582, SE = 0.123, 95% CI = 0.341–0.823, p < 0.001). Subgroup analyses indicated
that both unstimulated (n = 6) and stimulated (n = 7) SMSL salivary flow rates were
significantly reduced in the elderly group (unstimulated: SMD = 0.569, SE = 0.159, 95%
CI = 0.257–0.881, p < 0.001; and stimulated: SMD = 0.600, SE = 0.193, 95% CI =
0.222–0.978, p = 0.002). Moderate effect sizes were identified.
Heterogeneity:
The results of the heterogeneity analysis indicated that the included studies did not share
a common effect size (Q = 31.12, p = 0.002). The variance and standard deviation of the
true difference between the SMSL salivary flow rates of young and older individuals
indicated that the range of true effects, although wider than the confidence interval of the
summary interval, did not cross the no difference line (T2 = 0.084, T = 0.290, 95% CI =
0.014 – 1.150). Sixty-one percent of the observed variance was found to be true variance
of the effect size (I2 = 61.44%).
The results of the heterogeneity analysis for SMSL salivary flow rate in the unstimulated
condition did not reveal significant heterogeneity (Q = 10.51, p = 0.062). The range of
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true effects, although wider than the confidence interval of the summary interval, did not
cross the no difference line (T2 = 0.073, T = 0.290, 95% CI = 0.014 – 1.150). Fifty-two
percent of the observed variance was found to be true variance of the effect size (I2 =
52.41%).
The results of the heterogeneity analysis for SMSL salivary flow rate in the stimulated
condition indicated significant heterogeneity (Q = 20.45, p = 0.002). The range of true
effects was observed to cross the no difference line, despite the summary effect being
statistically significant (T2 = 0.169, T = 0.411, 95% CI = -0.206 – 1.406). Seventy
percent of the observed variance was found to be true variance of the effect size (I2 =
70.66%).
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Figure 6: Forest Plot of the Difference in Submandibular/Sublingual Salivary Flow
Rate Between Older and Younger Subjects

3.3.3

Parotid Gland Salivary Flow Rate

Parotid gland salivary rate was not significantly reduced in the elderly group (SMD =
0.023, SE = 0.063, 95% CI = -0.099–0.146, p = 0.71).
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Heterogeneity:
The results of the heterogeneity analysis for parotid salivary flow rate did not reveal
significant heterogeneity (Q = 37.31, p = 0.07). The variance and standard deviation of
the true difference between the parotid salivary flow rates of young and older individuals
indicated that the range of true differences crossed the no difference line (T2 = 0.029, T =
0.169, 95% CI = -0.101 – 0.561). Thirty percent of the observed variance was found to be
true variance of the effect size (I2 = 30.32%).

3.3.4

Minor Gland Salivary Flow Rate

Only unstimulated, minor gland salivary flow rate was analyzed because an insufficient
number of studies examining stimulated minor gland flow rates were identified.
Unstimulated buccal (n = 4, SMD = -0.143, SE = 0.392, 95% CI = -0.912–0.626, p =
0.715), labial (n = 4, SMD = 0.069, SE = 0.213, 95% CI = -0.348–0.485, p = 0.747), and
palatal (n = 4, SMD = 0.250, SE = 0.416, 95% CI = -0.566–1.065, p = 0.548) minor
gland salivary flow rates were not significantly reduced in the elderly group.
Heterogeneity:
The results of the heterogeneity analysis for unstimulated buccal salivary flow rate
indicated that the included studies did not share a common effect size (Q = 10.47, p =
0.015). The variance and standard deviation of the true difference between the buccal
salivary flow rates of young and older individuals indicated that the range of true
differences crossed the no difference line (T2 = 0.436, T = 0.660, 95% CI = -1.437 –
1.151). Seventy-one percent of the observed variance was found to be true variance of the
effect size (I2 = 71.34%).
The results of the heterogeneity analysis for unstimulated labial salivary flow rate did not
reveal significant heterogeneity (Q = 3.288, p = 0.349). The variance and standard
deviation of the true difference between the labial salivary flow rates of young and older
individuals indicated that the range of true differences crossed the no difference line (T2

66

= 0.016, T = 0.127, 95% CI = -0.180 – 0.318). Eight percent of the observed variance
was found to be true variance of the effect size (I2 = 8.77%).
The results of the heterogeneity analysis for unstimulated palatal salivary flow rate
indicated that the included studies did not share a common effect size (Q = 8.506, p =
0.037). The variance and standard deviation of the true difference between the palatal
salivary flow rates of young and older individuals indicated that the range of true
differences crossed the no difference line (T2 = 0.438, T = 0.662, 95% CI = -1.048 –
1.548). Sixty-four percent of the observed variance was found to be true variance of the
effect size (I2 = 64.73%).

3.3.5

Analysis of “Medication-Free” Subjects

When the analysis was limited to studies that excluded subjects taking medications (n =
26), a moderate effect size was observed for unstimulated whole salivary flow rate (n =
17, SMD = 0.641, SE = 0.155, 95% CI = 0.388–0.944, p < 0.001) (Figure 7). Similarly,
moderate effect sizes were observed for unstimulated (n = 5, SMD = 0.668, SE = 0.189,
95% CI = 0.297–1.039, p < 0.001) and stimulated (n = 6, SMD = 0.646, SE = 0.249, 95%
CI = 0.158–1.133, p = 0.01) SMSL salivary flow rates (Figure 8).
Heterogeneity:
The results of the heterogeneity analysis for whole salivary flow rate in the unstimulated
condition indicated significant heterogeneity (Q = 48.88, p < 0.001). The range of true
effects was observed to cross the no difference line, despite the summary effect being
statistically significant (T2 = 0.212, T = 0.460, 95% CI = -0.261 – 1.543). Sixty-seven
percent of the observed variance was found to be true variance of the effect size (I2 =
67.27%).
The results of the heterogeneity analysis for SMSL salivary flow rate in the unstimulated
condition did not reveal significant heterogeneity (Q = 6.587, p = 0.159). The range of
true effects, although wider than the confidence interval of the summary interval, did not
cross the no difference line (T2 = 0.070, T = 0.264, 95% CI = 0.151 – 1.185). Thirty-nine
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percent of the observed variance was found to be true variance of the effect size (I2 =
39.28%).
The results of the heterogeneity analysis for SMSL salivary flow rate in the stimulated
condition indicated significant heterogeneity (Q = 16.61, p = 0.005). The range of true
effects was observed to cross the no difference line, despite the summary effect being
statistically significant (T2 = 0.258, T = 0.508, 95% CI = -0.350 – 1.642). Sixty-nine
percent of the observed variance was found to be true variance of the effect size (I2 =
69.89%).
Stimulated whole salivary flow rate (Figure 7), and unstimulated and stimulated parotid
salivary flow rates (data not shown), were not significantly different between groups. The
analysis could not be completed for unstimulated minor gland salivary flow rate due to
small sample sizes (n < 4).
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Figure 7: Forest Plot of the Difference in Whole Salivary Flow Rate Between
"Medication-Free" Older and Younger Subjects
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Figure 8: Forest Plot of the Difference in SMSL Salivary Flow Rate Between
"Medication-Free" Older and Younger Subjects
Table 5: Summary of Results
Effect Size
Source

Condition

Trials

Subjects

Collection Method

Standardized Mean

n

in

Difference, 95%

Analysis

Confidence Interval

n
Whole

All

56

5870

0.551, 95% CI 0.423

Salivary
Flow

– 0.678*
Un-

33

2687

Draining Method: (Bakke et

0.611, 95% CI 0.464

stimulated

al., 2004; Flink et al., 2008;

– 0.758*

Whole

Navazesh et al., 1992;
Sonnenberg et al., 1982; X.
P. Wang et al., 2012)
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Spitting Method: (BenAryeh et al., 1984; BenAryeh et al., 1986; Chang et
al., 2011; Fenoll-Palomares
et al., 2004; Gandara et al.,
1985; Gutman & BenAryeh, 1974; Hershkovich
et al., 2007; Marotta et al.,
2012; Meurman &
Rantonen, 1994; Nagler &
Hershkovich, 2005b;
Percival et al., 1994;
Salvolini et al., 2000;
Sawair et al., 2009; Yaegaki
et al., 1985; Yeh et al.,
1998; Yeh et al., 2000)
Cotton Rolls or the Saxon
Test: (Bourdiol et al., 2004;
Malhotra et al., 2009; Ogura
et al., 1983; Takada et al.,
2006; Tanida et al., 2001;
Yoshikawa et al., 2012)
Suction Method of Bertram:
(Billings et al., 1996)
Stimulated
Whole

23

3183

Mastication: (Bourdiol et

0.367, 95% CI 0.110

al., 2004; Chang et al.,

– 0.625*

2011; Flink et al., 2008;
Gandara et al., 1985;
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Meurman & Rantonen,
1994; Moritsuka et al.,
2006; Navazesh et al., 1992;
Parvinen & Larmas, 1982;
Shern et al., 1993; Smith et
al., 2013; Streckfus et al.,
2002; Takada et al., 2006;
Toida et al., 2010)
Gustatory Stimulus: (BenAryeh et al., 1984; BenAryeh et al., 1986; Billings
et al., 1996; Tanida et al.,
2001).
Whole

Un-

Salivary

stimulated

Flow –

Whole

“MedicationFree”

Stimulated

17

899

0.641, 95% CI 0.338
– 0.944*

13

850

0.268, 95% CI -

Whole

0.239 – 0.775

Participants
Sub-

All

13

1314

0.582, 95% CI 0.341

mandibul
ar/Sublingual
Salivary
Flow

– 0.823*
Un-

6

637

SMSL saliva was collected

0.569, 95% CI 0.257

stimulated

with a micropipette and light – 0.881*

SMSL

suction (Cowman et al.,
1994; Ghezzi et al., 2000;
Johnson et al., 2000;
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Tylenda et al., 1988; Yeh et
al., 1998; Yeh et al., 2000),
or with an originally
designed collection device
fitted with a micropipette
and dropper bulb (Pedersen
et al., 1985)
Stimulated

7

677

SMSL

Gustatory Stimulus:

0.600, 95% CI 0.222

(Cowman et al., 1994;

– 0.978*

Ghezzi et al., 2000; Johnson
et al., 2000; Pedersen et al.,
1985; Tylenda et al., 1988;
Yeh et al., 1998; Yeh et al.,
2000)
Sub-

Un-

mandibul

stimulated

ar/Sub-

SMSL

lingual
Salivary
Flow –

Stimulated

5

238

0.668, 95% CI 0.297
– 1.039*

6

278

0.646, 95% CI 0.158

SMSL

– 1.133*

“MedicationFree”
Participants
Parotid

All

27

1856

0.023, 95% CI -

Salivary
Flow

0.099 – 0.146
Un-

8

433

Parotid saliva was collected

0.045, 95% CI -
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stimulated

with a modified Carlson

Parotid

Crittenden, Curby, or

0.161 – 0.250

Lashley cup
(Ben-Aryeh et al., 1986;
Bourdiol et al., 2004;
Cowman et al., 1994;
Fischer & Ship, 1999; Heft
& Baum, 1984; Yeh et al.,
1998)
Stimulated

19

1423

Parotid

Gustatory Stimulus: (Baum,

0.011, 95% CI -

1981; Baum et al., 1984;

0.142 – 0.165

Ben-Aryeh et al., 1986;
Bourdiol et al., 2004;
Chauncey et al., 1987;
Cowman et al., 1994;
Fischer & Ship, 1999;
Gandara et al., 1985; Ghezzi
et al., 2000; Heft & Baum,
1984; Johnson et al., 2000;
Percival et al., 1994; Ship &
Baum, 1990; Sonnenberg et
al., 1982; Yeh et al., 1998;
Yeh et al., 2000)
Parotid

Un-

Salivary

stimulated

Flow –

Parotid

MedicationFree

Stimulated
Parotid

5

197

0.101, 95% CI 0.266 – 0.468

10

535

0.103, 95% CI 0.075 – 0.280
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Participants
Minor

Un-

Gland
Salivary
Flow

4

Minor gland saliva was

0.250, 95% CI -

stimulated

collected via the Periotron

0.566 – 1.065

Palatal

method or with

Un-

4

77

105

chromatography paper

stimulated

0.069, 95% CI 0.348 – 0.485

Labial
Un-

4

105

stimulated

-0.143, 95% CI 0.912 – 0.626

Buccal
(*p < 0.05)

3.3.6

Translating Effect Size to the Original Metric

When converted to a traditional metric, the mean differences in salivary flow rates
between young and old subjects were: 0.168 mL/min for unstimulated whole salivary
flow rate; 0.293 mL/min for stimulated whole salivary flow rate; 0.015 mL/min for
unstimulated SMSL salivary flow rate; and 0.040 mL/min for stimulated SMSL salivary
flow rate. These rates represent a 40% reduction in flow rate for older participants for
unstimulated whole saliva; a 15% reduction for stimulated whole saliva; an 11%
reduction for unstimulated SMSL saliva; and a 9% reduction for stimulated SMSL saliva.

3.4

Discussion

The results from the present meta-analysis suggest that salivary flow decreases with age.
Although this effect was evident for whole saliva, not all subcomponents of saliva
showed decreased flow. Specifically, SMSL salivary flow rates in both the unstimulated
and stimulated conditions were lower in older adults, whereas parotid gland and minor
gland salivary flow rates were not different in young and older adults. These findings are
consistent with the view that aging is associated with decreased salivary flow in a gland-
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specific manner. Moreover, the age-related decrease in salivary flow was not fully
explained on the basis of medication or disease.

3.4.1

Mechanisms

Both unstimulated and stimulated whole mean salivary flow rates were significantly
lower in older adults compared to younger adults. The difference in unstimulated whole
salivary flow rate was approximately 66% greater than the difference in stimulated whole
salivary flow rate. This finding of greater reduction of unstimulated whole salivary flow
rate associated with age is consistent with the present finding of decreased SMSL
salivary flow. The SMSL salivary glands contribute 70% of the overall volume of
unstimulated whole saliva, but less than 50% of stimulated whole saliva. The present
finding of a lack of an age effect for parotid salivary flow rate would be consistent with
this supposition.
A decline in the functional output of the SMSL glands in elderly subjects could be related
to degenerative changes in their cellular structure, as has been reported previously,
(Baum, 1989; Scott, 1977) although these anatomical changes do not explain why agerelated decreases in parotid gland salivary flow rates were not found in the present study.
The differential effects of age on SMSL and parotid flow rates may be due to inherent
neuroanatomical and physiological differences between the glands. It has been speculated
that specific age-related neuroanatomical changes may result in differential gland
dysfunction (Baum, 1987). The secretory reserve hypothesis, which proposes that
younger persons may possess an excess of salivary secreting cells beyond what is
required for normal function, (Scott et al., 1987) may explain the relative age-related
stability of parotid gland salivary flow in that age-related degeneration of these “reserve”
cells may result in a decrease in saliva production without functional changes in salivary
flow rate.
Although the difference in unstimulated whole salivary flow rate was greater than the
difference in stimulated whole salivary flow rate, stimulated flow was found to decrease
with age. Age related changes to oral motor function may result in reduced bite strength
(Mioche, Bourdiol, Monier, Martin, & Cormier, 2004), potentially resulting in reduced
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stimulation and reduced salivary flow rate during masticatory stimulated salivary
collection (Baum, 1979). This mechanism may have influenced any significant decreases
in salivary flow rates for older adults observed following mastication stimulation.

3.4.2

Contributions of Effect Modifiers

Potential sources of heterogeneity among studies, which may have affected effect size
estimates, included the collection method, gender, medication use, and health status.
Where feasible, we examined the SMDs between younger and older participants grouped
by collection method, by gender, and by health status. Despite the fact that substantial
heterogeneity was observed for the differences in whole, SMSL, and buccal and palatal
minor gland salivary flow rates between young and older adults, and moderate
heterogeneity was observed for the differences in parotid and labial minor gland salivary
flow rates between young and older adults, little variability could be attributed to any of
these potential sources of variability using this technique, given the overlapping CIs
among the subgroups (data not shown). Certain salivary collection methods are
associated with less reliability and greater variability in flow rate (Navazesh &
Christensen, 1982). There is also evidence to suggest that women have lower mean
salivary flow rates than men (Inoue et al., 2006; Percival et al., 1994), which may be
related to smaller gland sizes in women (Inoue et al., 2006). However, the present
analysis examined the salivary flow rates between age groups, so it can only be stated
that the age-related decline was proportional between the sexes. Medication use did not
appear to explain the difference in SMSL and unstimulated whole salivary flow rates
between the young and older adults. This was an unexpected finding, given that many
medications, such as antidepressants, diuretics, analgesics, antihistamines, antihypertensives, anti-anxiety medications, and appetite suppressants are known to reduce
salivary flow. Polypharmacy is also more common with increasing age.
Other potential sources of variability that could not be explored in the present study due
to lack of reporting details included timing of salivary collection, and interval between
gustatory stimulation and collection. Salivary flow rates are known to vary with circadian
rhythm (Aps & Martens, 2005). Given that the majority of studies included in this metaanalysis reported that saliva was collected within a specific temporal window (e.g.
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between 8:00-11:00 am), timing of collection was not considered to be a major source of
variability. Variation in the time of year when salivary collection occurred may have
contributed to variability in effect sizes across studies. This information was not
generally reported and could not be explored. There is evidence to suggest that the timing
of the interval between stimulus presentation and collection may affect salivary flow rates
in older adults. Wu and colleagues (1995) reported that older adults demonstrated
reduced SMSL salivary flow rates when increasing periods of time were observed
between stimulation and collection (Wu, Baum, & Ship, 1995). If researchers did not
employ a standard protocol of saliva collection post stimulation, differences specific to
the elderly group could have contaminated the results. The majority of studies included in
this meta-analysis, however, reported that saliva was collected immediately post
stimulation, or during stimulation, for all participants.

3.4.3

Limitations and Strengths

A variety of age ranges, and age groupings, were used in the included studies, which
prevented us from developing an a priori definition of younger and older participants and
distinct age groups. Although we were often able to form young and older groups based
on ages 18 to 40 years, and >60 years, respectively, this group assembly was not always
possible (Ben-Aryeh et al., 1986; Chauncey et al., 1987; Gandara et al., 1985; Johnson et
al., 2000; Yeh et al., 1998).
A relative strength of this work is the number of studies included in each pooled analysis.
Identification and inclusion of many relevant studies allowed us to pool the data for a
large number of participants allowing us to identify a more precise estimate of the effect
size.
A post-hoc sensitivity analysis was conducted after noting the results from a single study
examining unstimulated and stimulated whole saliva were almost 4 standard deviations
above the pooled mean (Tanida et al., 2001). Removal of the outlier resulted in an 11%
reduction of the effect size for unstimulated whole salivary flow and a 3% reduction of
the effect size for stimulated whole salivary flow, although the overall effect sizes
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remained significant in both cases. An explanation for the inflated effect size was not
obvious after reviewing the study’s inclusion criteria and methods.
We excluded a study with insufficient separation between age groups (e.g. “young”
subjects were aged 18 to 64 years and “elderly” subjects were aged 65 years and older) to
reduce the risk of underestimating of effect sizes.

3.4.4

Future Directions

The results of the present study suggest that older adults have reduced salivary flow rates
compared to younger adults. This new evidence provides a strong rationale for future
longitudinal studies to confirm that the aging process may contribute to the decline in
whole and glandular salivary flow rates. Further investigation into the mechanisms
underlying the declines in SMSL salivary flow rates, and the relative stability of parotid
gland salivary flow, with age would be beneficial in the understanding of the
neurophysiologic correlates of salivary gland aging and in exploring potential treatment
options. Saliva plays many important roles in maintaining oral homeostasis. The optimal
volume of saliva to maintain function may not be equivalent across roles. Future research
should focus on identifying the minimal volumes necessary to maintain the vital
functions that saliva performs.

3.4.5

Clinical Significance

A difference between the whole and SMSL salivary flow rates of older and younger
adults was identified and quantified. A moderate decrease of 0.168 mL/min was
identified for unstimulated whole salivary flow rate, a small decrease of 0.293 mL/min
was identified for stimulated whole salivary flow rate, a moderate decrease of 0.015
mL/min was identified for unstimulated SMSL salivary flow rate, and a moderate
decrease of 0.040 mL/min was identified for stimulated SMSL salivary flow rate.
Researchers can use these values to determine sample size calculations for future studies.
The heterogeneity analysis revealed that the studies included in this analysis did not share
a common effect size and the magnitude of dispersion of the true effect of age on salivary
flow rate was observed to be large. This perceived variability suggests that not all adults
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will experience a clinically significant reduction in salivary flow rate as they age. The
reasons for this heterogeneity may be related to factors such as gender, diet, and health
status. Variability in the results of the studies examined here may also have been related
to the different salivary collection methods employed.
The clinical relevance of the current finding that whole and SMSL salivary flow rates are
decreased with increasing age remains unknown. While it is known that SMSL salivary
flow protects the oral tissues, primarily during non-alimentary functions at rest through
salivary mucins and other constituents (Prakobphol, Levine, Tabak, & Reddy, 1982;
Wong, 2008), it is not known at what point reductions in the level of production affect
function. Theoretically, age-related decreases of whole and SMSL salivary flow rates
could contribute to oral infection, inflammation, and mechanical oral wear (Tabak, 1995).
In contrast, no age-related reductions in parotid or minor gland salivary flow, which are
integral for rinsing the oral cavity, neutralizing acids, forming the biofilm found on
enamel, and digestion, (Dawes & Wood, 1973; Siqueira, Salih, Wan, Helmerhorst, &
Oppenheim, 2008; Wong, 2008) were found. This finding suggests that older adults may
tend to experience preserved digestive salivary functions.

3.5

Conclusion

Despite conflicting findings previously reported in the literature, unstimulated and
stimulated whole and SMSL salivary flow rates are decreased in older adults compared
with younger adults. In contrast, parotid gland and minor gland salivary flow rates do not
appear to be significantly reduced in older subjects. Medication effects do not fully
explain the age-related reduction in SMSL and unstimulated whole salivary flow rates.
These findings have important clinical implications for maintaining optimal oral health in
older adults.
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Chapter 4

4

The Effects of Oral Stimulation Associated with Manual
and Electric Tooth Brushing on Whole Salivary Flow
Rates in Healthy Older Adults

This study aims to examine the effects of manual and electric tooth brushing on salivary
flow in older adults free of major systemic disease.

4.1 Introduction
Decreased salivary flow, or hyposalivation, results in profound deterioration of oral
homeostasis. Increased susceptibility to dental caries and infections, decreased regulation
and control of the oral microflora, and impaired swallowing may occur (Sreebny &
Vissink, 2010). Salivary gland hypofunction can be caused by developmental or
congenital disorders (Eveson, 2008), increased medication usage (Sreebny & Schwartz,
1997), systemic disorders such as Sjögren’s syndrome (Fox, Stern, & Michelson, 2000),
radiotherapy-induced damage to salivary acinar tissue (Henson, Inglehart, Eisbruch, &
Ship, 2001), and anxiety (Bergdahl & Bergdahl, 2000). A recent meta-analysis
demonstrated that aging is associated with decreased whole salivary flow rate in healthy
older adults (Affoo et al., 2015). It also showed that, while unstimulated and stimulated
submandibular/sublingual (SMSL) salivary flow rates were significantly decreased in
healthy older adults compared with healthy young adults, parotid gland flow rate did not
differ across age groups. Thus, decreased SMSL salivary flow appeared to underlie the
reduction in whole salivary flow rates (Affoo et al., 2015). Decreased SMSL and parotid
salivary gland flow rates have been reported in the context of certain diseases, such as
Alzheimer’s disease (Ship et al., 1990; Ship & Puckett, 1994).
The paired parotid salivary glands, submandibular salivary glands, and sublingual
salivary glands are the major routes through which saliva is secreted into the oral cavity.
The parotid salivary glands are located opposite the maxillary first molars, and the
submandibular and sublingual glands are located in the floor of the mouth. Humans also
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have numerous minor salivary glands located in the lower lip, tongue, palate, cheeks, and
pharynx (Roth & Calmes, 1981).
There are three types of salivary secretion: spontaneous, resting, and stimulated secretion.
The minor salivary glands spontaneously secrete saliva in the absence of exogenous
stimuli, however, these glands are innervated and secretion rates increase in response to
afferent stimuli (Emmelin, 1967). The oral tissues are among the most richly innervated
of any in the human body, in terms of the number and variety of peripheral receptors that
they contain (Haggard & de Boer, 2014). Both slowly and rapidly adapting sensory
receptors in the tongue, periodontal ligament, gingiva, and palate convey an extensive
range of sensory information including touch, pressure, vibration, proprioception, pain,
and temperature (Dong, Shiwaku, Kawakami, & Chudler, 1993; Nordin & Hagbarth,
1989; Trulsson & Johansson, 2002). Resting and stimulated salivary secretion are nervemediated reflexes (Proctor & Carpenter, 2007). Information from mechanical afferent
stimulation associated with oral rest conditions, such as contact between different
surfaces in the mouth, and stimulated conditions, such as mastication, is conveyed by the
sensory branches of the trigeminal and glossopharyngeal cranial nerves to the trigeminal
sensory nuclei within the medulla. The salivatory nuclei are also located in the medulla
and receive central information from areas of the brain such as the hypothalamus, as well
as the incoming sensory information from the periphery. The superior salivatory nucleus
contains the preganglionic autonomic motor neurons of the facial nerve, which sends
secretomotor input to the submandibular, sublingual, and minor salivary glands, whereas
the inferior salivatory nucleus contains the preganglionic autonomic motor neurons of the
glossophyarngeal nerve, which sends secretomotor input to the parotid glands (WilsonPauwels, 2010). In response to the sensory stimuli, efferent parasympathetic and
sympathetic secretomotor nerves conduct excitatory signals to the salivary glands
resulting in secretion (Proctor & Carpenter, 2007) (Figure 9). Some studies have
documented that increased oral cavity stimulation is associated with increased salivary
secretion. Salivary secretion increases with the hardness and the size of an object being
chewed, as well as the forces generated by the chewing muscles (Anderson & Hector,
1987; Hector & Linden, 1987; Rosenhek, Macpherson, & Dawes, 1993; Yeh et al., 2000).
Increased saliva secretion has also been reported following the application of vibration
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stimuli to the facial skin overlying the bilateral belly of the masseter muscles, possibly
due to the tonic vibration reflex resulting in contraction of the masseter muscles and/or
the vibration activating various types of mechanoreceptors through the skin and mucosa
(Hiraba, Yamaoka, Fukano, Fujiwara, & Ueda, 2008). Thus it appears that mechanical
stimulation involving stretch, pressure and vibration of the oral cavity have the capacity
to stimulate saliva production.

Figure 9: Salivation in Response to Mechanical Stimuli.
Peripheral sensory information is transduced by oral mechanoreceptors located in
the tongue, periodontal ligament, gingiva, and palate. Sensory information from the
face, tongue, teeth, and oral cavity is conveyed through the sensory component of
the trigeminal cranial nerve (V) and sensory information from the posterior third of
the tongue, tonsil, soft palate, fauces, and uvula is conveyed through the sensory
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component of the glossopharyngeal cranial nerve (IX). Afferent information is
conveyed to the trigeminal sensory nuclei within the medulla. The salivatory nuclei
are also located in the medulla and receive central information from areas of the
brain such as the hypothalamus as well as the incoming sensory information. The
superior salivatory nucleus contains the preganglionic autonomic motor neurons of
the facial nerve, which sends secretomotor input to the submandibular, sublingual
and minor salivary glands, whereas the inferior salivatory nucleus contains the
preganglionic autonomic motor neurons of the glossophyarngeal nerve, which sends
secretomotor input to the parotid glands. Cortex mediated efferent signals are
conveyed through the sympathetic and parasympathetic pathways to stimulate the
parotid and submandibular and sublingual glands resulting in salivary secretion.
The use of tooth brushing as a mechanical form of whole salivary flow stimulation has
been examined previously in healthy young adults (Hoek, Brand, Veerman, &
Amerongen, 2002; Ligtenberg et al., 2006) and in older adults with clinically significant
hyposalivation (Papas et al., 2006). Hoek and colleagues (2002) examined 14 healthy
adults (Mean age = 32 years, SD = 11 years) to determine whether the volume and/or
composition of saliva were altered by the mechanical stimulation associated with manual
tooth brushing. A transient increase in salivary flow rate in the initial 5 minutes
immediately following the mechanical stimulation was identified. Ligtenberg et al.
(2006) examined the effects of tooth brushing among 80 healthy student volunteers who
brushed their teeth with a manual toothbrush and water or dentifrice. Salivary flow rates
increased significantly following tooth brushing with water and after brushing with
toothpaste, and remained increased for 60 minutes post stimulation. In older adults with
clinically significant hyposalivation, Papas et al. (2006) examined electric and manual
tooth brushing as a technique for salivary stimulation in a longitudinal study design and
reported that an electric toothbrush tended to stimulate greater salivary flow rates up to
45 minutes post stimulation.
Salivary flow rate has been reported to be decreased in healthy older adults compared to
younger adults (Affoo et al., 2015). Disease and medication use are also associated with
reduced salivary flow (Fox et al., 2000; Sreebny & Schwartz, 1997). Given the
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detrimental effects of decreased salivary flow on oral and overall health, it would be
beneficial to examine a non-invasive, low-cost, and non-pharmacologic method of
stimulating salivary flow. As discussed above, mechanical stimulation is an effective way
to stimulate salivary secretion. Tooth brushing has the capacity to produce pressure,
stretch, and vibratory mechanical stimulation on the tongue, periodontal ligament
(through pressure on the teeth), gingiva, and palate. Tooth brushing is an inexpensive and
simple technique that stimulates the oral cavity and cleanses it at the same time. At this
time however, the literature examining tooth brushing as a form of saliva stimulation is
limited and the results are conflicting with regard to the duration of the increased salivary
flow rate post stimulation. A clearer understanding of the effects of tooth brushing on
salivary flow would inform consideration of the feasibility of this form of stimulation as
an oral health intervention. In addition, differing study designs have been used
previously, and no study has examined the salivary responses to tooth brushing in older
adults without clinically significant hyposalivation.
Therefore, the present study aimed to: (i) examine whether manual and electric tooth,
tongue, and palate brushing modulates whole salivary flow rates in older adults free of
major systemic disease; (ii) ascertain the duration of the tooth/tongue/palate-brushingrelated modulation in salivary flow rates; (iii) compare the salivary flow rate modulation
associated with manual and electric tooth brushing; and (iv) examine the perceived
acceptability and comfort of tooth brushing in older adults. We hypothesized that tooth,
tongue, and palate brushing would result in a salivary flow rate increase. The duration of
this increase was anticipated to last between 5 to 30 minutes post tooth brushing, based
on the studies completed by Hoek et al. (2002), Ligtenberg et al. (2006), and Papas et al.
(2006). We hypothesized that the modulation of salivary flow rates would be greater for
the electric toothbrush intervention compared to the manual toothbrush intervention due
to increased vibration and associated greater afferent stimulation. Additionally, we
hypothesized that the maximum salivary flow rate increase in response to stimulation
would decrease with increasing age.
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4.2
4.2.1

Methodology
Participants

Twenty-one non-smoking adults who were free of major systemic disease volunteered as
subjects. Volunteers were recruited through advertisements at a walking group for retired
seniors. Candidates were excluded if they had less than 20 natural teeth, complained of
xerostomia or dry mouth, or had been to the dentist in the seven days immediately prior
to the experimental session. A sample size power calculation indicated that a sample of
20 subjects was sufficient to detect a difference of one standard deviation (d = 1.0), or a
large effect, of a two-level, within-subjects independent variable 80.8% of the time, using
a 0.01 alpha level and assuming a within-subject correlation of 0.30.
The effects of two tooth brushing interventions on salivary flow rate were examined in
the present study: manual tooth brushing and electric tooth brushing. The order of the two
interventions was counterbalanced, with participants randomly assigned to one of two
groups. Group one used the manual toothbrush in the first experimental session and the
electric toothbrush in the second experimental session. Group two used the electric
toothbrush in the first experimental session and the manual toothbrush in the second
experimental session. Each subject completed the two sessions a minimum of one day
apart and a maximum of three weeks apart.
Relevant subject data relating to age, medical history, and dental history was collected
during a brief interview prior to the experimental session (Appendix I). The participants
were instructed to eat a typical breakfast and complete their morning oral hygiene routine
(including tooth brushing) by 8:00 am and to refrain from eating or drinking prior to the
study session. Each session commenced at 9:00 am and lasted approximately 120
minutes. Each subject gave written, informed consent before participating in the study,
which was approved by the Western University Research Ethics Board for Health
Sciences research involving human subjects (Appendix F).
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4.2.2

Materials

Tooth brushing interventions were completed with a Colgate Sensitive Pro-Relief manual
toothbrush and a Colgate Sonic Power electric toothbrush.

4.2.3

Protocol

For the duration of the experimental session, the subjects sat in a chair (approximately 45
cm in height) that was stationed in front of a table (approximately 41 cm in height). At
the beginning of the experimental session, a brief visual inspection of the oral cavity was
completed to ensure there were no gross anatomic abnormalities and to ensure each
participant had at least 20 natural teeth. Participants then rinsed their mouths with
distilled water and expectorated into a receptacle.
Three transducers were positioned on the subject: belt-mounted movement sensors
positioned around the subject’s neck (Model 1585, CT2 Pediatric Piezo Respiratory
Effort Sensor, Pro-Tech Services, Inc., License No. 69444) and upper abdomen (Model
1582, CT2 Adult Piezo Respiratory Effort Sensor, Pro-Tech Services, Inc., License No.
69444), recorded neck and respiratory movements, respectively. An omnidirectional
electret microphone (F-SM Snore Electret Microphone, Pro-Tech Services, Inc., License
No. 69446) affixed to the subject’s neck with medical tape, monitored the acoustic signal
arising from the upper airway through the tissues of the neck. These physiologic signals
were recorded continuously throughout the experimental session using an AS40 Comet
Series PSG/EEG Portable System (Astro-Med Inc., License No. 65827). A video
recording in the lateral plane at a camera-to-subject distance of approximately 120 cm
was also made. These video images included the subject’s head, facial profile, neck,
shoulders, and chest. The video images and physiologic signals enabled the researchers to
observe whether participants swallowed during the saliva collection periods. The use of
physiologic signals to identify swallowing events is a validated method that has been
used previously in the literature (Lowell et al., 2013). The addition of video images to
identify swallowing events has also been used previously in the literature (Abe et al.,
2014)
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Each of the two study sessions was comprised of a habituation period, a control
condition, an experimental condition, a washout period, and 11 salivary collection
periods (Figure 10). During the 5-minute habituation period, the subjects sat quietly
making minimal orofacial movements as video recordings and neck movement,
respiratory, and acoustic data were collected.
Subjects provided saliva samples using the previously validated draining method
(Navazesh & Christensen, 1982; Navazesh, 1993), as follows. While seated comfortably
in a chair with eyes open and head tilted slightly forward, subjects swallowed to clear
their mouths of residual saliva and then allowed their saliva to drain into a pre-weighed
autoclaved beaker for 5 minutes while making minimal orofacial movements. After 5
minutes, subjects were instructed to collect any remaining saliva in the mouth and
expectorate it into the beaker. Beakers containing saliva were immediately weighed after
each saliva-draining period and whole salivary flow rates were calculated in grams per
minute. Saliva was assumed to have a constant density of approximately
0.978kg/m3(Lamey & Nolan, 1994). The subjects were instructed not to swallow their
saliva during the draining period. Following the study, the video and physiologic signals
were reviewed by RHA for evidence of swallow-related respiratory and laryngeal
movement patterns and swallowing events to verify that swallowing did not occur during
saliva collection. Five-minute saliva-draining collections were collected at baseline
following the habituation period, and at 0 to 5 minutes, 10 to 15 minutes, 20 to 25
minutes, and 30 to 35 minutes following the control condition and experimental
intervention.
Participants completed the control condition by placing either the manual or electric
toothbrush in the oral cavity (without dentifrice, bristles down touching the superior
surface of the tongue) and holding it unmoving for 2 minutes. The experimental
stimulation condition involved the participant actively brushing his or her teeth, tongue,
and palate (without dentifrice) for 2 minutes. Subjects were instructed not to swallow
their saliva during the control and experimental tooth brushing conditions. Immediately
following both conditions, subjects expectorated their saliva into a pre-weighed beaker.
These salivary collections will be referred to as the salivary flow rates collected “during”
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the control and experimental conditions. Participants sat quietly for a 5-minute washout
period between the control condition and the experimental intervention.
Participants were instructed to use a standardized tooth brushing protocol when
completing each 2-minute oral cavity stimulation intervention with either the manual or
electric toothbrush. For the manual toothbrush intervention, participants were instructed
to use a modified Bass technique (Bass, 1954) and systematically brush the outer, inner,
and chewing surfaces of each quadrant of the mouth for 25-seconds each. On the inner
and outer surfaces of the molars, subjects were directed to place the toothbrush at the
gum margin at a 45-degree angle and use circular brushing motions followed by rolling
the toothbrush down and away from the gums. Participants were instructed to use a backand-forth brushing motion on the inner surfaces of the incisors and on the chewing
surfaces of the molars. The final 10 seconds of the intervention was spent gently brushing
the tongue and palate. The electric toothbrush intervention was similar to the manual
toothbrush intervention except, instead of active brushing, participants were instructed to
hold the bristles against the teeth and move from tooth to tooth slowly. The instructions
for each of the standardized tooth brushing protocols were presented in an instructional
video immediately prior to the experimental intervention.
A paper-and-pencil 10 cm visual analog scale (VAS) assessment of mouth comfort was
presented to the participants at six different times during the experimental session
(Appendix G and Figure 10). The VAS scale was anchored with the terms “normal
comfort level” at 5 cm, “less comfortable” at 0 cm, and “more comfortable” at 10 cm.
At the end of the experimental session, each participant completed a questionnaire
focusing on the ease of use of the tooth brushing protocol and the feasibility of
implementing the protocol in the participant’s daily oral hygiene routine (Appendix H).
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Figure 10: Experimental Protocol

4.2.4

Data Analysis

Relevant subject data relating to age, medical history, and dental history was analyzed by
RHA.
All beakers were weighed immediately prior to the experiment and immediately
following each saliva-draining period. Whole salivary flow rate at 0 to 5 minutes, 10 to
15 minutes, 20 to 25 minutes, and 30 to 35 minutes following the control condition and
experimental intervention were calculated by dividing the weight of the saliva in grams
by the 5-minute timeframe. Whole salivary flow rate during the control and experimental
conditions were calculated by finding the weight in grams of the amount expectorated
immediately following either the control, or experimental, condition and dividing that
weight by the 2-minute timeframe.
A research assistant (RA) scored each of the VAS forms by measuring the length in
centimeters between the far left of the VAS (0 cm) and the point where the participant
had placed the mark indicating current mouth comfort. The length in centimeters
represented the VAS score, with higher scores representing greater mouth comfort. VAS
scores were analyzed by RHA.
Subject questionnaires were analyzed by RHA.
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4.2.5

Statistical Analysis

Whole salivary flow rates were calculated for each collection period in g/min. Planned
contrasts were completed using paired samples t-tests and a Holm-Bonferroni sequential
procedure to correct for familywise error (pcorr<0.0045) (Holm, 1979). The comparisons
of interest included: i) baseline rates compared to the flow rates during the control and
experimental conditions; ii) baseline rates compared to the flow rates from 0 to 5
minutes, 10 to 15 minutes, 20 to 25 minutes, and 30 to 35 minutes after the experimental
condition; and iii) flow rates during the control condition compared to the flow rates
during the experimental condition, and from 0 to 5 minutes, 10 to 15 minutes, 20 to 25
minutes, and 30 to 35 minutes after the experimental condition, for both the manual and
electric toothbrush experimental protocols. The effects of the control and treatment
conditions on salivary flow rate were estimated using Cohen’s d.
Potential differences between the effects of the manual and the electric toothbrush were
examined through descriptive comparisons of the effect sizes (Cohen’s d) calculated for
the manual and electric toothbrush stimulation. Additionally, the maximum salivary flow
rate change (i.e., the difference between salivary flow rate during tooth brushing and
baseline flow rate) associated with the two types of tooth brushing were compared using
a paired samples t-test (p < 0.05). A potential relationship between the maximum salivary
flow rate change associated with the manual and electric tooth brushing interventions was
also examined using a Pearson’s correlation coefficient (p < 0.05).
The influence of age on the maximum salivary flow rate change was examined using
Pearson’s correlation coefficient (p < 0.05). Medication use was explored using
descriptive statistics, as well as a chi-square test (p < 0.05) to determine whether equal
numbers of participants were taking no, one, two, or three or more medications.
The effects of the control and experimental conditions on mouth comfort, measured using
the VAS, were examined using a repeated measures ANOVA. The results of the
feasibility questionnaire were examined for trends and are reported descriptively.
Statistical analyses were completed using SPSS (SPSS 2012) and Microsoft Excel.
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4.3
4.3.1

Results
Subject Characteristics

Twenty-one subjects participated in the study (62–83 years of age, M = 71.33 years, SD
= 6.46 years; 11 female). All participants had at least 20 natural teeth (Range = 22–28, M
= 25.67, SD = 1.93). No participants were observed to swallow during the salivary
collection periods. Using Sreebny and Vissink’s “Classification of Xerogenic Drugs”
(Sreebny & Vissink, 2010), 7 of the 21 subjects reported taking no medications with
potential xerogenic effects and 14 of the 21 subjects were observed to be taking
xerogenic medications (Range of xerogenic medications= 0–4, M = 1.25, SD = 1.11)
(Figure 11). The results of a chi square test (χ2 = 3.19, p = 0.36) indicated that the
numbers of participants in each category (no, one, two, or three or more xerogenic
medications) were not significantly different. Xerogenic medications taken by the study
participants included antihyperlipidemic agents, anti-ulcer agents, antihypertensive
agents, and anti-inflammatory agents.

Figure 11: The Numbers of Study Participants Taking Different Numbers of
Xerogenic Medications at the Time of the Study
The mean ages of participants taking no, one, two, or three or more xerogenic
medications were similar (Figure 12).
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Figure 12: The Mean Age (in years) of Study Participants Taking Different
Numbers of Xerogenic Medications at the Time of the Study

4.3.2

Effects of Manual and Electric Tooth Brushing on Whole
Salivary Flow Rate

The mean whole salivary flow rates for each collection period are presented for the
experiment using the manual toothbrush (Figure 13) and using the electric toothbrush
(Figure 14).
Planned contrasts were completed using paired samples t-tests. The Holm-Bonferroni
sequential procedure was used to correct for familywise error (pcorr < 0.0045) (Table 6).
Of the 22 completed planned comparisons, the data associated with four comparisons
were not normally distributed as assessed by the Shapiro-Wilk’s test (p < 0.05); these
were the comparison between baseline rates and the flow rates during the manual
toothbrush control condition; between baseline rates and the flow rates from 0 to 5
minutes and 10 to 15 minutes after the manual toothbrush experimental condition; and
between the flow rates during the electric toothbrush control condition and the flow rates
from 30 to 35 minutes after the electric toothbrush experimental condition. Nevertheless,
a paired samples t-test was used, as this test is robust to violations of normality
(Herrendorfer, Rasch, & K.D., 1983; Posten, 1979; Rasch & Guiard, 2004).
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4.3.2.1

Effects of Manual Tooth Brushing on Whole Salivary Flow
Rate

There was a significant, large increase (d = 2.50) in salivary flow rates collected during
the 2 minutes of manual tooth brushing compared with baseline salivary flow rate (M =
0.63, SD = 0.34, p < 0.0045) and compared with the salivary flow rate collected during
the control condition (M = 0.58, SD = 0.33, p < 0.005). Although the salivary flow rate
was observed to decrease immediately following the manual tooth brushing, the salivary
flow rate collected from zero to five minutes post manual tooth brushing was found to be
significantly, moderately increased (d = 0.661) compared with baseline salivary flow rate
(M = 0.07, SD = 0.07, p < 0.0055).
Salivary flow rates collected during the periods 10 to 15 minutes, 20 to 25 minutes, and
30 to 35 minutes after manual tooth brushing were not significantly different from
baseline flow rates. Similarly, salivary flow rates collected during the periods 0 to 5
minutes, 10 to 15 minutes, 20 to 25 minutes, and 30 to 35 minutes after manual tooth
brushing were not significantly different compared with salivary flow rates collected
during the manual tooth brushing control condition.

4.3.2.2

Effects of Electric Tooth Brushing on Whole Salivary Flow
Rate

There was a significant, moderate increase (d = 0.672) in salivary flow rate during the 2minute control condition compared with baseline salivary flow rate during the electric
toothbrush protocol (M = 0.07, SD = 0.08, p < 0.006). There was a significant, large
increase (d = 2.54) in salivary flow rates collected during the 2 minutes of electric tooth
brushing compared with baseline salivary flow rate (M = 0.78,SD = 0.37, p < 0.0045) and
compared with the salivary flow rate collected during the control condition (M = 0.71,SD
= 0.35, p < 0.005). Although the salivary flow rate was observed to decrease immediately
following electric tooth brushing, the salivary flow rate collected from 0 to 5 minutes
post electric tooth brushing was found to be significantly, moderately increased (d =
0.681) compared with baseline salivary flow rate (M = 0.08, SD = 0.08, p < 0.0055).
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Salivary flow rates collected during the periods 10 to 15 minutes, 20 to 25 minutes, and
30 to 35 minutes after electric tooth brushing were not significantly different from
baseline flow rates. Similarly, salivary flow rates collected during the periods 0 to 5
minutes, 10 to 15 minutes, 20 to 25 minutes, and 30 to 35 minutes after electric tooth
brushing were not significantly different compared with salivary flow rates collected
during the electric tooth brushing control condition.
Table 6: Significant Salivary Flow Rate Comparisons and the Holm-Adjusted p
Values
Comparison

Mean Difference

Holm-Adjusted p

Baseline – During Brushing

0.63

0.0045

During Control – During Brushing

0.58

0.0050

Baseline – 0 to 5 Minutes Post

0.07

0.0055

Baseline – During Brushing

0.78

0.0045

During Control – During Brushing

0.71

0.0050

Baseline – 0 to 5 Minutes Post

0.08

0.0055

0.07

0.0060

Manual Toothbrush

Brushing
Electric Toothbrush

Brushing
Baseline – During Control
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Figure 13: Mean Whole Salivary Flow Rate Collected at 11 Different Time Points
Before, During, and Following Control and Manual Tooth Brushing Conditions
Mean flow rate (g/min) is represented by the bars and the error bars indicate SE.

103

Figure 14: Mean Whole Salivary Flow Rate Collected at 11 Different Time Points
Before, During, and Following Control and Electric Tooth Brushing Conditions
Mean flow rate (g/min) is represented by the bars and the error bars indicate SE.

4.3.3

Manual Compared to Electric Tooth Brushing

The salivary flow rates collected during the manual and electric tooth brushing protocols
were compared using descriptive comparisons of their respective effect sizes (manual: d
= 2.40; electric: d = 2.54). This analysis indicated that the effect sizes were similar. The
maximum salivary flow rate change (i.e., difference between salivary flow rate during
tooth brushing and baseline flow rate) associated with the two types of tooth brushing
were also not significantly different (M = 0.15, SD = 0.42, p = 0.129). There was a small
correlation between the maximum salivary rate changes associated with the manual and
electric tooth brushing protocols (r (19) = 0.30, p = 0.184).

4.3.4

Age and Salivary Flow Rate

The influence of age on baseline salivary flow rate was examined. Baseline salivary flow
rate data for the manual toothbrush protocol were not normally distributed, as assessed by
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Shapiro-Wilk’s test (p = 0.001), however baseline data for the electric toothbrush
protocol were normally distributed (p > 0.05). Therefore, a Spearman rank-order
correlation was completed with the manual toothbrush data and a Pearson’s correlation
coefficient was completed with the electric toothbrush data. Age was not significantly
correlated with baseline salivary flow rate for the manual rs (19) = 0.05, p = 0.84 or
electric toothbrush protocols r (19) = 0.1, p = 0.68.
The influence of age on maximum salivary flow rate change (i.e., the difference between
salivary flow rate during tooth brushing and baseline flow rate) was examined using a
Pearson’s correlation coefficient. Age and the maximum salivary flow rate change
associated with manual tooth brushing was normally distributed, as assessed by ShapiroWilk’s test (p > 0.05). Age was moderately correlated with the maximum salivary flow
rate change (r (19) = 0.55, p = 0.01) for the manual toothbrush condition (Figure 15).
The influence of age on maximum salivary flow rate change associated with electric
tooth brushing was also normally distributed, as assessed by Shapiro-Wilk’s test (p >
0.05). A small, non-significant correlation was observed (r (19) = 0.18, p = 0.44) for the
electric toothbrush condition (Figure 16).
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Figure 15: Scatterplot Illustrating the Correlation Between Age (in years) and the
Maximum Salivary Change Associated with Manual Tooth Brushing
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Figure 16: Scatterplot Illustrating the Correlation Between Age (in years) and the
Maximum Salivary Change Associated with Electric Tooth Brushing

4.3.5

Mouth Comfort and Feasibility

Mouth comfort data, as measured by the VAS, were not normally distributed, as assessed
by Shapiro-Wilk’s test (p < 0.05). Outliers were observed, as assessed by inspection of a
boxplot. In addition, Mauchly’s Test of Sphericity indicated that the data violated the
assumption of sphericity (manual: χ2 (2) = 53.81, p < 0.001; electric: χ2 (2) = 129.46, p <
0.001). Despite the fact that the data violated these assumptions, a one-way repeated
measures ANOVA was used to examine mouth comfort scores throughout the manual
and electric toothbrush experiments due its robustness to violations of normality (Glass,
Peckham, & Sanders, 1972). No significant differences in mouth comfort were detected
for either the manual or electric toothbrush experiments.
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The responses to the feasibility questionnaires suggested that 95% of the participants
reported that the instructions for both the manual and electric tooth brushing methods
were easy to understand and the methods themselves were easy to complete. Ninety
percent of the participants reported being amenable to incorporating the standardized
tooth brushing method, with either the manual or electric toothbrush, into their daily oral
hygiene routine. Ten percent of the respondents reported being resistant to change their
oral hygiene routine at this point in their lives.

Figure 17: VAS Scores Recorded at 6 Different Time Points During the Manual
Toothbrush Experiment
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Figure 18: VAS Scores Recorded at 6 Different Time Points During the Electric
Toothbrush Experiment

4.4

Discussion

The results of the current study suggest that oral cavity stimulation with a manual or
electric toothbrush temporarily increases whole salivary flow rates in older adults.
Specifically, we found that whole salivary flow rates were increased significantly for up
to 5 minutes following either manual, or electric brushing of the teeth, tongue, and palate
in healthy adults aged 60 years and older. The increase in salivary flow rate immediately
following the 2-minute brushing period was large, whereas the increase in salivary flow
rate 5 minutes following brushing was moderate. The present study also found that
holding a de-activated electric toothbrush in a stationary position in the oral cavity
resulted in an immediate, transient increase in whole salivary flow rate.

109

These results are similar to those of Hoek et al. (2002), who reported that brushing the
teeth without dentifrice induced an increase in the saliva flow rate during the initial 5
minutes after tooth brushing, which was following by a decrease after 15 minutes. Our
results are not consistent with those of Ligtenberg et al. (2006), however, who reported
that, after brushing with water, the salivary secretion rate increased significantly for 60
minutes. Secretion rates were also significantly increased after brushing with toothpaste.
This inconsistency may be because the stimulation protocol used by Ligtenberg and
colleagues (2006) required subjects brush their teeth with water or dentifrice, either of
which could have caused gustatory or temperature stimulation in addition to the
mechanical stimulation associated with tooth brushing. This additional stimulation could
have influenced the duration of increased salivary flow rates post stimulation.
In the present study, the greatest increase in salivary flow rate was observed immediately
following manual or electric tooth brushing. We observed a mean salivary increase of
0.63 g/min (SD = 0.34 g/min) immediately following manual tooth brushing and a mean
increase of 0.78 g/min (SD = 0.37 g/min) immediately following electric tooth brushing.
Previous studies have documented that increased oral cavity stimulation is associated
with increased salivary secretion. Salivary secretion increases with the hardness and the
size of an object being chewed, as well as with the forces generated by the chewing
muscles (Anderson & Hector, 1987; Hector & Linden, 1987; Rosenhek et al., 1993; Yeh
et al., 2000). Additionally, Papas et al., (2006) reported that Sonicare electric toothbrush
users tended to have increased salivary flow rates at each 15-minute interval collection
period up to 45 minutes post stimulation compared with manual toothbrush users. In
contrast, Hiraba et al. (2008) found that increasing the frequency of vibratory stimuli
applied to the facial skin overlying the belly of the masseter muscles bilaterally did not
result in greater salivation possibly because individual mechanoreceptors differ in their
threshold sensitivity to vibration.
We hypothesized that the modulation of whole salivary flow rates would be greater for
electric tooth brushing compared with manual tooth brushing due to increased vibration
and associated greater afferent stimulation. We found no significant differences,
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however, between the two tooth brushing protocols with regard to increasing whole
salivary flow rate. Although it is possible that other brands of electric toothbrushes might
result in greater salivary stimulation compared with manual tooth brushing, our findings
appear to suggest that the increased vibration associated with electric toothbrushes
compared with manual toothbrushes may not result in a greater salivary response.
In our post hoc analysis, we examined a potential relationship between age and the
maximum salivary flow rate change (i.e., the maximum difference between salivary flow
rate during baseline and tooth brushing conditions). We hypothesized that, given that
older adults have lower unstimulated whole salivary flow rates and lower stimulated and
unstimulated SMSL salivary flow rates (Affoo et al., 2015) compared with younger
adults, we would observe that, as age increased, maximum salivary flow rate change
would decrease. This, however, was not the case. A moderate, positive correlation was
observed between age and maximum salivary flow rate change. That is, as age increased,
so too did the maximum salivary flow rate increase observed during tooth brushing. The
positive relationship between age and maximum salivary flow rate change was found to
be moderate for manual tooth brushing but small for electric tooth brushing. In order to
explain this phenomenon, we hypothesized that the older participants experienced
reduced baseline salivary flow rates compared with the younger participants. A lower
baseline salivary flow rate might increase the potential for response to stimulation,
resulting in a stimulated salivary flow rate similar to the younger participants. However,
when the relationship between age and baseline salivary flow rates was examined, no
significant correlations were identified. It appears, therefore, that the oldest adults in our
sample demonstrated a more robust salivary response to tooth brushing than did the
younger subjects. While reports confirm that parotid and minor salivary flow rates do not
decline with increasing age (Affoo et al., 2015) and aspects of somatosensation, such as
two-point discrimination, also do not decline with advancing age, (Calhoun, Gibson,
Hartley, Minton, & Hokanson, 1992; Fukunaga, Uematsu, & Sugimoto, 2005) this does
not explain why we observed a positive relationship between age and maximum salivary
flow rate change. Older subjects were not observed to have more teeth than younger
subjects (data not shown), younger subjects were not observed to be taking more
xerogenic medications than older subjects, and males and females were found to be
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equally distributed with regards to age (data not shown). It is currently unclear why we
observed a positive relationship between age and maximum salivary flow rate change.
With regards to the finding that the degree of correlation between age and maximum
salivary flow increase was different for the manual and electric toothbrushes, this is a
provocative finding given that comparison of the salivary flow rate increases associated
with the two types of brushing revealed no statistically significant differences. When the
relationship between maximum salivary flow rate changes associated with manual and
electric tooth brushing was explored, a small correlation was identified. These findings
suggest, that while there appears to be similarity between the two types of brushing, there
are also differences between the two types of brushing resulting in differences in the
physiological salivary response.
Mouth comfort remained relatively consistent throughout the experimental protocols
using the electric and manual toothbrushes. These results are consistent with those of
Papas et al. (2006) who reported that 96.4% of participants felt that the Sonicare electric
toothbrush was comfortable to use. Ninety percent of the participants in the present study
were amenable to incorporating a standardized brushing protocol, with either a manual or
electric toothbrush, into their daily oral hygiene routine suggesting that participants found
this method of stimulation to be acceptable for daily use.

4.4.1

Strengths and Limitations

Epithelial cells are continually being shed from the oral mucosa into saliva and it has
been estimated that the surface cells stay attached for only about three hours before being
desquamated (Dawes, 2003). Participants in our study reported completing their early
morning oral hygiene routine at least one hour prior to the experiment and all participants
rinsed their oral cavities with distilled water immediately prior to participating. The
elements of the present experimental protocol reduce the likelihood of epithelial cells
making a significant contribution to the salivary collection and adding to the weight of
the saliva samples. Nevertheless, it is possible that epithelial cells as well as plaque and
residual food debris in the mouth, displaced by tooth brushing, may have contributed to
the weight of the saliva samples.
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One limitation of this study is that we did not complete a comprehensive dental exam on
participants prior to study enrollment. We do not therefore have detailed information
regarding the periodontal status of our participants.
Participants were mainly recruited from an exercise program, introducing a potential bias
in that the participants may have been more health-conscious than the general population.
The electric toothbrush used in the experiment had a brush shaped similarly to the manual
toothbrush and was not circular in shape. A circular brush is a popular shape among name
brand electric toothbrushes. Therefore, we may not have employed a representative
electric toothbrush.
Glandular saliva was not collected in the present study. Thus, it is unclear which glands
contributed more saliva to the increased flow rates in response to the tooth brushing.
Based on previous work in this area, however, showing that the percentage contribution
from the parotid gland increases to more than 50% of total salivary secretions during
stimulation (Edgar, 1992; Humphrey & Williamson, 2001; Sreebny, 2000), we would
predict that that the parotid glands contributed the greatest percentage of saliva to the
increased flow rates observed.
We observed limited response variability on the VAS scale measuring mouth comfort.
Additionally, 40% of participants commented that they felt completing the VAS scale
was the most difficult component of the experiment, possibly due to the complex and
abstract nature of conceptualizing mouth comfort in individuals who do not experience
oral discomfort on a regular basis. It is possible that the design of the VAS scale may
have limited the response variability and in the future we may need to pilot VAS scales
using different anchor terminology.

4.4.2

Clinical implications:

In the present study, we showed that tooth brushing is associated with an increase in
salivary flow for up to 5 min post stimulation among adults aged 60 years and older who
have at least 20 teeth and who do not complain of dry mouth or xerostomia. Although we

113

identified only a transient increase in salivary flow rates, this increase would be expected
to contribute to reducing the bacterial load in the mouth and increasing oral lubrication.
Saliva is present throughout the oral cavity as a very thin film known as a biofilm.
According to Collins et al. (1987), given an average volume of saliva in the mouth of
about 1 ml, and given that the surface area of the adult mouth is just over 200 cm2, saliva
must be present as a film averaging about 0.1 mm or less in thickness between adjacent
surfaces (Collins & Dawes, 1987). We observed a mean increase in whole salivary flow
rates of 0.63 g/min (SD = 0.34 g/min) during manual tooth brushing and a mean increase
of 0.78 g/min (SD = 0.37 g/min) during electric tooth brushing. These volumes could
contribute substantially to the oral biofilm in the mouth, promoting optimal oral
homeostasis, and potentially increasing oral comfort.
Increasing salivary volume also may affect salivary clearance in that the volume of oral
saliva contributes to triggering of the pharyngeal stage of swallowing (Dawes, 1983) in
addition to increasing the rate of swallowing (Lagerlof & Dawes, 1984). Swallowing of
secreted saliva reduces the concentration of exogenous substances in the oral cavity. A
rapid salivary clearance of harmful substances is beneficial for oral health (Dawes, 2004).
An increase in salivary volume, stimulating increased salivary clearance in an individual
with harmful substances (such as cariogenic substances) in the oral cavity, could have
beneficial effects on oral and overall health.
We observed a moderate, positive correlation between age and maximum salivary flow
rate increase, suggesting that the older adults in our sample tended to have greater
salivary responses to stimulation. This finding suggests that older adults aged
approximately 75 years and older could potentially benefit from tooth brushing more than
their younger counterparts. This finding could have important implications for future
studies examining saliva stimulation interventions.

4.4.3

Future Directions

In order to continue to broaden our understanding of oral physiology for eating and
swallowing management and rehabilitation, future work in this field should focus on the
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use of oral stimulation as a means of modulating salivary flow in a large sample of older
adults. Examining the effects of increased saliva in the oral cavity on outcomes such as
swallowing efficiency and safety would provide important clinical information. A study
powered to compare salivary responses in age stratifications from 60 years of age to 90
years and older would be helpful to replicate the results presented here with regard to the
moderate, positive correlation observed between age and maximum salivary flow rate
change. This study would also be beneficial for determining whether the effect continues
into the older age groups (84 years of age and older) that were not examined in the
present study.
Future research should investigate the relative salivary contributions from each major
salivary gland during tooth brushing. Additionally, examining other brands of electric
toothbrushes to explore whether different brands result in different salivary stimulation
profiles would provide practical information in terms of clinical translation.
Further research exploring the physiology of saliva secretion and the nerve-mediated
reflex pathway in response to manual and electrical tooth-brushing stimulation would be
beneficial as our results suggest the potential for some stimulatory differences between
the two different types of tooth brushing.

4.5

Conclusion

The present study suggests that tooth brushing stimulates saliva production for up to 5
minutes in adults aged 60 years and older who are free of systemic disease. Older
participants had a more robust salivary response to the tooth brushing compared with
younger participants, suggesting that older adults may particularly benefit from tooth
brushing to stimulate salivary secretion. Given that aging is associated with reduced
salivary flow (Affoo et al., 2015) and reduced salivary flow may lead to impaired oral
health (Baum, 1989), older adults are at greater risk of developing poor oral health. The
ability to increase salivary secretions has important clinical implications with regard to
improving the oral health of older adults.
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Chapter 5

5

Conclusion

In this dissertation, we used a scoping review technique to examine swallowing
dysfunction and autonomic system dysfunction, including salivary flow dysfunction, in
individuals with AD. We found that no studies have directly examined the effect of
reduced salivary flow on swallowing function in AD despite the fact that salivary flow is
crucial for optimal oral preparatory and oral phase swallowing (Matsuo, 2013) and may
be reduced as part of the disease process (Ship et al., 1990; Ship & Puckett, 1994).
Salivary flow may be reduced in people with AD (Ship et al., 1990; Ship & Puckett,
1994). Previous research on the effect of aging on saliva production, however, is
conflicting. As a result, we performed the second study of this dissertation to examine the
effect of aging on saliva production, and we found that whole and SMSL salivary flow
rates were reduced in older adults compared with younger adults.
In the third and final study in this dissertation, in order to examine the potential for
modulating salivary flow rates in older adults, we examined the effects of manual and
electric tooth brushing on whole salivary flow rates in adults 60 years of age and older
who were free of major systemic disease. We found that tooth brushing is associated with
increased salivary flow rates for up to 5 minutes. The older participants had a more robust
salivary response to the mechanical stimulation compared with the younger participants.
Eating, swallowing, and maintaining optimal nutrition is essential to health (Waxman &
World Health Assembly, 2004) and quality of life (Vailas et al., 1998). There appears to
be a critical relationship between factors associated with eating and swallowing function,
oral health, and saliva production. The studies reported in this dissertation were aimed at
broadening the current understanding of these inter-related factors, both in healthy
individuals and in individuals with AD. The results provide foundational information
about eating and swallowing, saliva production, and saliva modulation and may incite
future research, in many different patient populations, examining each of these individual
elements and the critical relationship between them.
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Appendices
Appendix A: Clinical Reports Employing Instrumental Assessment of Swallowing in
Alzheimer's Disease (AD)
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Moderate,

into the

reflex” was

through

and Severe)

Pharynx

examined in

comparison

and EMG to individuals

of two or

Record the

more

Swallow

groups of
individuals

with AD
In the severe
AD group,
latency of the
reflex was
significantly
longer

NA
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compared to
the mildmoderate AD
group
No significant
difference was
observed
between the
mild and the
moderate AD
group
Priefer &

See Above

See Above

See Above

See Above

Robbins

See
Above

1997
Horner et

See Above

See Above

See Above

See Above

al. 1994
Disease

Wada et al.

severity

2001

may be
associated
with

Horner et

See
Above

See Above

See Above

See Above

See Above

See
Above

See Above

See Above

See Above

See Above

al. 1994

See
Above

dysphagia
severity

Appendix B: Clinical Reports Employing Clinical Assessment of Swallowing in
Alzheimer's Disease (AD)
Conclusion

Supporting

Study

Type of

Method of

Results

Level
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Studies

Description

Dementia

Assessment

of
Evidence

Prevalence

Volicer et

Described/

Alzheimer’s

Quest-

Investigators

of

al. 1989

characteriz

Disease

ionnaire

examined

dysphagia

ed an

(Stage Not

completed

eating

in AD

aspect of

Specified)

by care staff difficulties in a

eating or

group of AD

swallowing

patients in a

dysfunction

long-term care

through the

facility

examinatio

NA

23 (32.4%) of

n of a

the residents

single

were observed

group of

to choke on

patients

food or drink,

with AD

some of these
were also
known to
refuse food

Chouinard

Retro-

Alzheimer’s, Chart

Investigators

et al. 1998

spective

Disease

completed

Cohort

(Severe),

retrospective

Multi-Infarct

chart review of

Dementia,

individuals

Other/Non-

with advanced

Specified

dementia who

review

died of
pneumonia

2b
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21 of 47
patients had
Alzheimer’s
disease (45%).
21 of 47
patients had
significant
swallowing
abnormalities
(45%).
Swallowing
abnormalities
were described
as: difficulty
taking liquids,
presence of
coughing/chok
ing, poor
tongue control,
forgetting to
swallow, and
absence of
chewing.
The presence
of swallowing
disorders
tended to
correlate with

134

death from
pneumonia
Dysphagia

Correia et

Described/c Alzheimer’s

Quest-

Swallowing

may occur

al. 2010

haracterize

Disease

ionnaire

and feeding

in all stages

d

(Moderate

completed

problems were

of AD

dysphagia

and Severe)

by caregiver characterized

in AD

and meal

in a group with

through

assessment

AD subjects

comparison

using the

with moderate

of two or

Swallowing

or severe AD

more

Rating

groups of

Scale

individuals

The moderate
AD group
demonstrated
passivity,
distraction, and
refusal to eat.
The severe AD
group
demonstrated
distraction,
passivity, and
inappropriate
feeding
velocity
5 of the 18
subjects with
moderate AD
(27.8%) and

NA
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23 of the 32
individuals
with severe
AD (71.9%)
had difficulty
with the
ingestion of
specific
consistencies
12 individuals
with severe
AD (37.5%)
with delayed
swallowing
Severe
swallowing
problems were
observed in 7
of the
individuals
from the
severe AD
group
(21.87%)
Edahiro et

Prospective

Alzheimer’s

Meal

Factors

al. 2012

Cohort

Disease

Assessment

affecting self-

(Mild,

s completed

feeding in

Moderate,

by

elderly

and Severe)

researchers

subjects with

2b

136

AD were
examined
Signs of
dysphagia and
behavioural
eating deficits
were observed
in individuals
with mild,
moderate and
severe AD
Logistic
regression
identified the
following
factors as
predictors of
decreased
eating
independence:
difficulty
beginning a
meal, presence
of dysphagia
signs, and the
severity of
dementia
Behavioura

Priefer &

Described/c Alzheimer’s

Meal

Investigators

l eating

Robbins,

haracterize

Assessment

examined

Disease

NA

137

difficulties

1997

d

(Mild)

s completed

swallowing

may occur

dysphagia

by

durations and

in all stages

in AD

researchers

self-feeding

of AD

through

dependency in

comparison

healthy elderly

of two or

and early stage

more

AD

groups of
individuals

16 partnerinitiated cued
behaviours
and/or
assistance
were directed
at 4 subjects
with AD
8 subjectinitiated cued
behaviours
were
completed by 7
subjects with
AD
Both partnerinitiated cues
and subjectinitiated cues
occurred
significantly
more

138

frequently
compared to
controls
Durnbaugh

Described/c Alzheimer’s

Feeding

Feeding

et al. 1996

haracterize

Disease

Behaviour

behavior was

d an aspect

(Mid-Stage)

Inventory

examined in 20

of eating or

completed

subjects with

swallowing

by nursing

AD

dysfunction

staff

through the
examinatio
n of a
single
group of

11 of the 20
(55%) subjects
were on
mechanically
altered diets

patients

The most

with AD

common
mealtime
behavioral
problems
were:
distraction at
meals, eating
non-finger
food with
hands, playing
with food,
eating pieces
that are too
big, preference
for sweet

NA

139

foods,
incorrect use
of utensils,
staring without
eating,
impatient
behaviours
demonstrated
during or prior
to mealtime,
eating other
residents’
food, refusing
meals
Morris et al. Described/c Alzheimer’s

Caregiver

Investigators

1989

haracterize

Disease

semi-

evaluated the

d an aspect

(mild,

structured

eating habits of

of eating or

moderate,

interview

33 patients

swallowing

and severe),

with dementia

dysfunction Multi-Infarct

(27 having

through the

Dementia,

AD)

examinatio

and Mixed

n of a

Dementia

single
group of
patients
with AD

63% of the
sample
demonstrated
reduced food
intake, 26%
demonstrated
increased food
intake, 37%
showed

NA
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changed food
preferences,
60%
demonstrated
abnormal
utensil use,
and 26%
demonstrated
aberrant oral
eating
behaviour such
as eating
inappropriate
non-food
items.
Edahiro et

See Above

See Above

See Above

See Above

al. 2012
Burge 1994

See
Above

Described/c Alzheimer’s

Meal time

Eating

haracterize

Disease

observation

behavior was

d an aspect

(Severe) and

s

examined in a

of eating or

Vascular

group of

swallowing

Dementia

individuals

dysfunction
through the
examinatio
n of a
single
group of
patients
with AD

with dementia
Slightly less
than half of
150 patients
received some
form of a
texture

NA

141

modified diet
22% of all
patients were
totally
dependent for
feeding and, of
these patients,
all received a
modified diet
regardless of
the presence of
a swallowing
problem
Suski &

Described/c Alzheimer’s

Comprehen

Nutritional

Nielsen

haracterize

Disease

sive

intake and

1989

d an aspect

(Severe)

nutritional

feeding

assessment

difficulties

of eating or
swallowing

were recorded

dysfunction

in 19 women

through the

with advanced

examinatio

AD

n of a

NA

19 of the 19

single

subjects

group of

(100%)

patients

required diet

with AD

modifications

Dysphagia

Ikeda et al.

Described/c Fronto

Quest-

Frequency and

and eating

2002

haracterize

ionnaire

characteristics

temporal

NA

142

difficulties

d

Lobe

completed

in AD may

dysphagia

Dementia

by caregiver problems were

be less

in AD

and

recorded

severe than

through

Alzheimer’s

through

in other

comparison

Disease

caregiver

types of

of two or

(Mild,

questionnaires

dementia

more

Moderate,

groups of

and Severe)

individuals

of eating

Caregivers of
AD patients
reported lower
frequencies of
swallowing
problems,
appetite
changes, food
preferences,
and eating
habits as
compared to
the caregivers
of patients
with
frontotemporal
lobe dementia.
AD caregivers
reported that
58.1% of the
AD patients
demonstrated
at least one
symptom of

143

eating and
swallowing
difficulties
AD caregivers
report that
swallowing
problems
appear early in
the disease
process
Shinagawa

Described/c Lewy Body

Quest-

Frequency and

et al. 2009

haracterize

Dementia

ionnaire

characteristics

d

and

completed

of eating

dysphagia

Alzheimer’s

by caregiver problems were

in AD

Disease

recorded

through

(Mild and

through

comparison

Moderate)

caregiver

of two or
more
groups of
individuals

questionnaires
Caregivers of
patients with
Lewy body
dementia
reported
significantly
greater/more
severe eating
and
swallowing
difficulties

NA

144

compared with
caregivers of
AD patients
The AD
caregivers
reported a
number of
eating and
swallowing
abnormalities

Appendix C: Clinical Reports Examining the Treatment of Dysphagia in
Alzheimer's Disease (AD)
Conclusion

Supporting

Study

Dementia

Studies

Description

Studied

Method

Results

Level
of
Evidence

Thickening

Logemann

Prospective

Dementia

711 thin

Immediate

liquids to a

et al. 2008

Randomize

with

liquid

elimination of

honey-

d Clinical

Alzheimer’s

aspirators

aspiration on

thickened

Trial

disease,

(confirmed

thin liquids

consistency

Dementia

during

occurred most

may

due to single

VFSS) were often with

eliminate

or

included in

honey-

thin liquid

multistroke,

the study

thickened

aspiration

Dementia

and

liquids for

in

(general),

received 3

patients in

individuals

Parkinson’s

intervention

each

2b
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with AD,

disease, and

s (chin-

diagnostic

however

Parkinson’s

down

category

this

disease with

posture,

intervention

dementia

nectar-

may not

thickened

affect long-

liquids, or

term

honey-

morbidity

thickened

and

liquids) in a

mortality

random

This
intervention
was least
preferred by
the patients

order,
during
VFSS
Robbins et

Prospective

Dementia

504 thin

No statistically

al. 2008

Randomize

with

liquid

significant

d Clinical

Alzheimer’s

aspirators

differences in

Trial

disease,

(confirmed

outcome were

Dementia

during

identified

due to single

VFSS) were following the

or

randomly

use of the three

multistroke,

assigned 1

interventions

Dementia

of 3

(general),

intervention

Parkinson’s

s (chin-

disease, and

down

Parkinson’s

posture,

disease with

nectar-

dementia

thickened
liquids, or
honey-

2b
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thickened
liquids) and
followed
until death
or four
months
A

Bautmans

Prospective

Alzheimer’s

15 nursing

Following the

physiothera

et al. 2008

Randomize

Disease

home

treatment

pist

d

(Severe)

residents

paradigm the

administere

Controlled

were

subjects

d cervical

Trial with

randomized

demonstrated

spine

Cross-Over

to

improved

mobilizatio

Design

participate

“dysphagia

n protocol

in either an

limit” (the

may

intervention

maximum

improve

condition

sized bolus of

“dysphagia

(cervical

water that can

limit” in

spine

be swallowed

individuals

mobilizatio

in a single

with severe

n) followed

movement)

AD and

by a wash-

altered

out period

neck

followed by

posture

a control
condition,
or a control
period
followed by
a washout
period

2b
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followed by
a treatment
condition

Appendix D: Clinical Reports Examining Autonomic Nervous System (ANS)
Dysfunction in Alzheimer's Disease (AD)
Conclusion

Supporting

Study Description

Results

Studies

Level
of
Evidence

Individuals

Lampe et

Described/characterized

Investigators examined

with AD

al., 1989

ANS dysfunction in AD

changes in blood pressure,

demonstrate

through comparison of

plasma norepinephrine

blood pressure

two or more groups of

(NE), serum prolactin,

differences at

individuals

luteinizing hormone, and

baseline and

follicle-stimulating

following

hormone associated with

stimulation, as

infusions of 2 thyrotropin-

compared with

releasing doses in 10 men

controls

with early onset AD and in
9 age-matched controls
Diastolic pressor responses
to thyrotropin-releasing
hormone (TRH) were
substantially blunted in AD
subjects relative to controls,
even at the higher dose of
TRH

NA
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There was a trend towards
attenuation of the systolic
and plasma NE response as
well
Otsuka et

Described/characterized

Blood pressure and heart

al. 1990

ANS dysfunction in AD

rate measurements were

through comparison of

recorded in 31 elderly

two or more groups of

hospitalized patients, who

individuals

were classified into 4
groups: group D comprised
8 bedridden patients with
AD; group R comprised 7
bedridden patients that did
not have dementia; group N
comprised 9 normotensive,
ambulatory patients; and
group H comprised 7
hypertensive, ambulatory
patients
For group D, mean systolic
blood pressure over a 24hour period was statistically
higher compared with
group R
Also, in group D, the
circadian rhythm of blood
pressure was abnormal,
showing no nocturnal

NA

149

decrease as compared to the
control groups
Elmstahl et

Described/characterized

Investigators studied 24

al. 1992

ANS dysfunction in AD

women with late-onset AD

through comparison of

and 54 age-matched healthy

two or more groups of

controls using tilting and

individuals

breathing tasks

NA

AD patients had lower
baseline mean systolic and
diastolic blood pressure
compared with control
patients
After tilting, the AD
patients had a greater
increase in heart rate, and
the mean systolic blood
pressure fell significantly
compared with the controls
Acceleration indices were
significantly higher in the
AD patients and brake
indices were significantly
lower
Burke et al.

Retrospective chart

Chart review of 3 patients

1994

review and

with autopsy-confirmed AD

neuroanatomical

indicated that yearly

analysis of 3

systolic, diastolic, and mean

postmortem AD

arterial blood pressures

NA

150

subjects and

decreased in all patients

characterization of an

following the year of

aspect of ANS

diagnosis

dysfunction in AD
through comparison of
two or more groups of
individuals, one or more

Up to 30% of C-1 neurons
were atrophied in sections
from the same AD patients

of these groups being

The number of C-1 neurons

comprised of AD

correlated strongly with

patients

mean arterial pressure and
systolic blood pressure
Hypothalamic
phenylethanolamine Nmethyl-transferase activity
was significantly decreased
in 5 AD patients compared
with controls
Neuropathology analysis
documented neurofibrillary
tangles in the
paraventricular nucleus of
an individual with
Alzheimer’s disease but not
in a control subject

Idiaquez et

Described/characterized

Investigators studied 7 AD

al. 1997

ANS dysfunction in AD

subjects and 23 controls

through comparison of

before and after a meal to

two or more groups of

identify the presence/degree

individuals

of postprandial hypotension

NA
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in AD
70% of 10 AD patients
experienced postprandial
hypotension compared to
26% of 23 controls.
Guo et al.
1998

Prospective cohort study Investigators examined a
relationship between low
blood pressure and
increased mortality in 202
patients with dementia (112
with AD)
There was a positive linear
relationship between blood
pressure and Mini Mental
State Exam score (every 10
mm Hg increase in systolic
pressure was related to a 0.6
unit increase in score) for
the total sample of
individuals with dementia
(results are not specific to
dementia type, individuals
with AD comprised 55.4%
of the sample)
Patients with moderate and
severe dementia had
significantly lower systolic
and diastolic blood pressure

2b

152

than did those with
questionable and mild
dementia
When the sample was
examined as a whole,
patients with low blood
pressures had shorter
survival time than did those
with higher blood pressures
Kalman et

Described/characterized

Cutaneous active

al. 2002

ANS dysfunction in AD

vasodilation was assessed

through comparison of

in 22 patients with AD and

two or more groups of

20 age-matched controls

individuals

using an isometric handgrip
exercise
A significantly smaller
reduction of R wave
intervals (i.e., a measure of
heart rate) was observed in
the AD group
Static exercise was
associated with increased
variation in both systolic
blood pressure and diastolic
blood pressure in both
groups, but the systolic
blood pressure change was
significantly smaller in AD

NA

153

patients
Significantly higher
cutaneous vascular
resistance and decreased
skin blood flow were
observed following the
stimulus in the AD group
The resting R wave interval
was significantly correlated
with the Mini Mental State
Exam score and a highly
significant negative
correlation was calculated
for the resting skin blood
flow and age for all AD
subjects
Bordier et

Described/characterized

10 (30%) of AD subjects

al. 2007

ANS dysfunction in AD

had positive carotid sinus

through comparison of

massage, with prolonged

two or more groups of

ventricular standstill in two

individuals

subjects (6.7%)
The response to carotid
sinus massage did not
predict increased risk in
bradycardia-mediated
syncope
Syncope was identified in 3
AD subjects during follow-

NA

154

up (10%)
Individuals

Elmstahl et

with AD

al. 1992

demonstrate
significantly
greater falls in
blood pressure
(particularly
systolic) when
transitioning
from supine to
standing
(orthostatic

See Above

See Above

See
Above

Vitiello et

Described/characterized

Investigators measured the

al. 1993

ANS dysfunction in AD

autonomic nervous system

through comparison of

in AD using lying and

two or more groups of

standing blood pressure,

individuals

pulse and plasma
epinephrine and
norepinephrine in 60 AD
subjects and 20 normal
elderly controls

hypotension)

Following a supine to

compared with

standing task, mean systolic

healthy age-

BP decreased in the

matched

subjects with AD but

controls

increased in the controls
In AD patients with
depression, during
orthostasis, systolic BP was
significantly decreased
compared to AD patients
with no signs of depression
The non-depressed AD
patients had significantly
lower systolic BP during
orthostasis as compared to
the controls

NA
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Subjects with AD
demonstrated no differences
in basal or standing plasma
levels of norepinephrine
and epinephrine
Wang et al.

Described/characterized

Authors investigated

1994

ANS dysfunction in AD

cardiovascular autonomic

through comparison of

function in 23 AD subjects

two or more groups of

and 23 age-matched

individuals

controls

NA

Subjects with AD had
significantly lower systolic
and mean blood pressure
levels in the supine position
and 3 min after standing
compared with controls
There was a tendency
toward lower systolic blood
pressure in the patients with
more severe disease
Jhee et al.

Retrospective

Authors conducted a

1995

description of ANS

retrospective analysis of

dysfunction in AD

blood pressures and heart

through examination of

rates of 31 patients with AD

a single group of AD
subjects

Significant mean decreases
in systolic and diastolic
blood pressures were noted

NA

156

in AD patients
While the investigators
report that these decreases
were noted to be
significantly different from
baseline pressures, there
was no comparison with
healthy controls
The mean decreases are
consistent with other
clinical reports that
demonstrated significantly
greater pressure drops in
AD patients as compared to
controls, when transitioning
from sitting to standing
Passant et

Described/characterized

Investigators examined the

al. 1997

ANS dysfunction in AD

prevalence of orthostatic

through comparison of

hypotension, low blood

two or more groups of

pressure, dizziness, falls

individuals

and fractures in patients
with dementia (46 with AD)
The mean supine/resting
systolic blood pressure was
generally lower than in
normal healthy aged
population (i.e., compared
to norms as there was no

NA
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control group in this study)
18 of the 46 AD patients
demonstrated orthostatic
hypotension (a blood
pressure decrease of 20 mm
Hg or more)
Only 39% of the AD
patients with orthostatic
hypotension experienced
clinical symptoms of
dizziness; 50-56% of those
AD patients with orthostatic
hypotension had
experienced falls and more
than one fracture
53% of the patients with
AD and orthostatic
hypotension experienced
blood pressure falls after 3
min of standing or later,
however, 27% didn’t
experience the maximum
blood pressure drop until
after 10 min of standing
All AD patients
demonstrated highly
significant heart rate
increases from supine to

158

standing position
Kalman et

See Above

See Above

al. 2002

See
Above

Andin et al.

Described/characterized

Investigators

2007

ANS dysfunction in AD

retrospectively studied 22

through comparison of

AD cases with white matter

two or more groups of

disease and 22 AD cases

individuals

without white matter

NA

disease, both based on
neuropathology analysis
Reports of hypertension,
orthostatic hypotension, and
dizziness/unsteadiness were
significantly more frequent
in the AD group with white
matter disease compared
with the AD group without
white matter disease
Allan et al.

Described/characterized

Investigators compared

2007

ANS dysfunction in AD

cardiovascular autonomic

through comparison of

function in subjects with

two or more groups of

AD (39), vascular

individuals

dementia, Lewy body
dementia, Parkinson’s
disease dementia, and
controls
AD patients demonstrated a
significantly greater mean

NA

159

fall in systolic blood
pressure on standing when
compared to an age
matched group
These AD patients also
demonstrated a significantly
greater prevalence of
sustained orthostatic
hypotension as well as a
greater median time for
return of systolic blood
pressure to baseline
AD patients were also more
likely to have an autonomic
neuropathy and severe,
definite and atypical
autonomic neuropathy,
using the Ewing
classification, as compared
to controls
Individuals with AD
demonstrated the least
amount of autonomic
dysfunction as compared to
individuals with other types
of dementia
Andersson

Described/characterized

Investigators aimed to

et al. 2008

ANS dysfunction in AD

determine whether

NA

160

through comparison of

orthostatic hypotension is

two or more groups of

more common in patients

individuals

with dementia (235 having
AD) as compared to 62
elderly controls
Orthostatic hypotension
occurred in 42% of the AD
patients compared with
only 13% of the controls

Allan et al.
2009

Prospective Cohort

Investigators aimed to
identify potentially
modifiable predictors of
falls in older people with
mild-moderate dementia
(38 with AD) compared to
39 controls
Univariate predictors of
falls in dementia, stratified
by diagnosis, were noted to
include duration of
dementia, history of falls or
recurrent falls in the
preceding 12 months, use of
cardioactive medication,
autonomic symptom scale
greater than 7 and time
taken for blood pressure to
return to baseline on
standing

2b

161

Multivariate predictors of
falls in dementia, stratified
by diagnosis, were noted to
be symptomatic orthostatic
hypotension, and use of
cardioactive medications
Physical activity was noted
to be protective in both
models
Mehrabian

Described/characterized

Investigators examined the

et al. 2010

ANS dysfunction in AD

relationship between

through comparison of

orthostatic hypotension and

two or more groups of

cognitive function in a

individuals

group of 495 consecutive
elderly made up of those
with normal cognitive
function, mild cognitive
impairment, AD, or
vascular dementia
Orthostatic hypotension
was identified in 15% of the
sample of 233 AD patients
There was a significant
relationship between
orthostatic hypotension and
cognitive status. Greater
mean fall in systolic blood
pressure after standing was

NA

162

observed in patients with
vascular dementia or AD as
compared to those with
normal cognitive function
Zakrzewska

Described/characterized

Investigators evaluated

-Pniewska

ANS dysfunction in AD

clinical dysautonomia in 54

et al. 2012

through comparison of

AD patients and 37 healthy

two or more groups of

age-matched controls using

individuals

clinical autonomic
assessment, functional
assessment, the sympathetic
skin response and the R-R
interval variation test
Clinical symptoms of
dysautonomia were found
in 66% of a group of 54 AD
patients but were relatively
mild
In AD patients, orthostatic
hypotension was observed
in 34.5%, constipation in
17.2%, and urinary
incontinence in 13.8
Sympathetic skin response
was abnormal in 27% of
AD patients and heart rate
variability was abnormal in
88% of cases as compared

NA

163

with controls
Significantly

Franceschi

Described/characterized

Study examined cardiac

less heart rate

et al. 1986

ANS dysfunction in AD

ANS function during sleep

variability has

through comparison of

in 16 AD patients compared

been reported in

two or more groups of

with 7 healthy controls

individuals with

individuals

AD

NA

The mean body movement
ratio (body movement
related heart rate variation)
during non-REM and REM
sleep was significantly
lower for AD patients
compared with the controls

Aharon-

Described/characterized

Investigators examined

Peretz et al.

ANS dysfunction in AD

heart rate variability in AD

199270

through comparison of
two or more groups of
individuals

A group of 20 AD patients
demonstrated significant
differences in power
spectrum density of
echocardiogram as
compared to 7 volunteer
controls
AD patients demonstrated a
relatively
hypersympathetic,
hypoparasympathetic state
with regard to heart rate,
both when standing and
supine

NA
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The peak-to-peak amplitude
of the tachogram in a
normal subject was about 3
times greater than the peakto-peak amplitude of the
tachogram of the patient
with AD
Algotsson

Described/characterized

Investigators measured

et al. 1995

ANS dysfunction in AD

heart rate variability and

through comparison of

sympathetic skin response

two or more groups of

to electrical stimulation in

individuals

order to assess
parasympathetic and
sympathetic ANS function
in 29 AD patients and 15
controls
Very few patients or
caregivers reported
symptoms of ANS
dysfunction
AD patients had
significantly lower heart
rate reactions to passive
tilting and the Valsalva
maneuver and a
significantly greater
reduction of finger pulse
amplitude during the

NA
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Valsalva maneuver
AD patients also
demonstrated a decreased
response the sympathetic
skin response test
The AD patients showed
signs suggesting autonomic
dysfunction affecting both
parasympathethic and
vasomotor sympathetic
functions
At one-year follow up,
there was a slight
deterioration for relative
beat-to-beat variations
during deep breathing but
there was a slight
improvement in heart
reactions to the tilt test
Szili-Torok

Described/characterized

A group 24 AD patients

et al. 2001

ANS dysfunction in AD

demonstrated significantly

through comparison of

shorter R-R interval length

two or more groups of

on echocardiogram

individuals

recordings as compared to a
group of 22 controls
Baroreflex sensitivity was
also markedly reduced in
AD patients as compared to

NA
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controls
Patients with AD showed
significantly higher basal
heart rate and decreased RR interval oscillation and
increased systolic arterial
blood pressure oscillation
as compared to controls
Idiaquez et

Described/characterized

Investigators examined the

al. 2002

ANS dysfunction in AD

association between

through comparison of

specific neuropsychiatric

two or more groups of

deficits and autonomic

individuals

dysfunction in patients with
AD
Measures of heart rate
variation to deep breathing
were consistently reduced
in a group of 20 AD
patients compared to a
group of 20 age-matched
controls
In those AD patients who
demonstrated abnormal
heart rate variation, there
were significant
abnormalities in the Blessed
score and in the apathy,
delusions, and aberrant

NA
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motor behavior items of the
neuropsychiatric inventory
Zulli et al.

Described/characterized

A group of 33 AD patients

2005

ANS dysfunction in AD

demonstrated significantly

through comparison of

greater QT dispersion (i.e.

two or more groups of

an index of ventricular

individuals

repolarization

NA

inhomogeneity) as
compared to a group of 29
controls
These subjects also
demonstrated significantly
decreased heart rate
variability compared to the
control group
Investigators reported a
positive linear correlation
between the Mini Mental
State Exam and
Alzheimer’s Disease
Assessment Scale –
cognitive subscale scores,
and the measures of QT
dispersion, QT corrected
dispersion, low-frequency
power, and high frequency
power
Toledo and

Described/characterized

Investigators measured

NA

168

Junqueira

ANS dysfunction in AD

cardiac autonomic

Jr, 2008

through comparison of

modulation and

two or more groups of

sympathovagal balance in

individuals

the supine and active
standing positions based on
short-term time- and
frequency-domain heart
interval variability analysis
in 22 AD patients as
compared to 24 controls
The mean high frequency
power showed a significant,
borderline reduction in the
supine posture and was
significantly reduced after
standing in AD
Sympathovagal balance (as
measured by short-term
time and frequency domain
heart interval variability)
was significantly altered
towards relative depression
of parasympathetic and
enhancement of
sympathetic modulation in
the supine but not the
standing posture
AD patients demonstrated
subtle, absolute and relative
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parasympathetic depression
and relative sympathetic
exacerbation
Toledo and

Described/characterized

Investigators examined the

Junqueira

an aspect of ANS

relationship between

Jr,

dysfunction through the

measures of cardiac

examination of a single

sympathogvagal

group of patients with

modulation of heart interval

AD

variability and the cognitive

2010

part of the Cambridge
Examination for Mental
Disorders of the Elderly
(CAMCOG) and the Mini
Mental State Exam
(MMSE) in 22 AD subjects
There was a significant
positive correlation, in both
supine and standing,
between the cognitive
performance and cardiac
autonomic modulation of 5
min heart interval
variability evaluated by
time-and frequencydomain indexes
(parasympathetic
modulation) in 22 AD
patients
Negative trend correlation
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was observed between
absolute sympathetic
modulations in supine
posture
Individuals with higher
cognitive deficiency
showed significantly lower
cardiac parasympathetic
modulation and trend for
sympathetic over activity
Zakrzewska

See Above

See Above

-Pniewska

See
Above

et al. 2012
Individuals

Rainero et

Described/characterized

Investigators analyzed the

with AD also

al. 2000

ANS dysfunction in AD

effects of electrical noxious

demonstrate

through comparison of

stimulation on the ANS of

altered blood

two or more groups of

20 AD subjects compared

pressure and

individuals

with 20 healthy subjects

heart rate
responses to
pain stimuli

Following presentation of
threshold pain stimulation,
there was a dramatic
increase in heart rate in
controls but only a slight
increase in AD patients and
the peak heart rate was
significantly less
pronounced for the AD
patients
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Heart rates increased in
expectation of the pain
stimuli and this was
significantly less
pronounced in the AD
patients
The changes in blood
pressure paralleled the
changes in heart rate but
were not statistically
significant
AD patients reported
experiencing the same pain
intensity as the controls
when the stimulation was at
the pain threshold and just
above the pain threshold.
However, AD patients
reported experiencing
significantly less pain
intensity in response to
stimulation at twice pain
threshold,
Linear regression showed
that pain rating of the twice
pain-threshold stimulus was
closely related to the
severity of AD, as assessed

172

by the Mini Mental State
Exam.
Benedetti et

Described/characterized

Neither stimulus detection

al. 2004

an aspect of ANS

nor pain threshold was

dysfunction through the

correlated with cognitive

examination of a single

status or brain electrical

group of patients with

activity decline

AD

NA

There was a correlation
between heart rate
responses and deterioration
of both cognitive functions
and brain electrical activity
This correlation was also
found for the anticipatory
heart rate increases
preceding pain stimulation.

Autonomic

Allan et al.

nervous system

2007

dysfunction
appears to be
subtle in
patients with
AD when
compared with
other types of
dementia

See Above

See Above

See
Above

Allan et al.

Described/characterized

Investigators examined the

2006

ANS dysfunction in AD

presence and severity of

through comparison of

autonomic symptoms in

two or more groups of

patients with different

individuals

subtypes of dementia (40
with AD) compared to
healthy controls
Individuals with AD had
significantly lower activity

NA
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scores and significantly
worse ADL scores
compared to controls
Individuals with AD scored
similar to controls with
respect to a self-reported
autonomic symptoms scale
All other subtypes of
dementia scored higher on
the self-reported autonomic
symptoms scale
Plasma

Borson et

Described/characterized

Indicators of SNS function

norepinephrine

al. 1989

ANS dysfunction in AD

were examined in 10

levels may be

through comparison of

college educated males with

altered in AD

two or more groups of

AD and 7 education-

individuals

matched, healthy controls
Normal older subjects
responded to mental effort
with a rise in plasma
norepinephrine, plasma
epinephrine, mean arterial
pressure, and heart rate
AD patients responded to
cognitive challenge with a
significant but un-sustained
rise in plasma epinephrine
There were clear

NA
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differences between groups
on 3 measures of
sympathetic nervous system
activity during cognitive
effort, with AD subjects
showing a blunted response
as compared to controls
Raskind et

Described/characterized

Investigators measured

al. 1984

ANS dysfunction in AD

CNS and peripheral

through comparison of

noradrenergic function by

two or more groups of

measuring norepinephrine

individuals

and 3-methoxy-4hydroxyphenylglcol levels
in CSF and plasma
Norepinephrine and 3methoxy-4hydroxyphenylglcol levels
were significantly higher in
both CSF and plasma in
patients with advanced AD
as compared to individuals
with moderate AD or
controls
Heart rate was higher in the
patients with advanced AD
compared with the other
two groups and there was a
tendency for mean arterial
blood pressure to be higher
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in patients with advanced
AD
Lampe et al. See Above

See Above

1989

See
Above

Peskind et

Described/characterized

Cerebrospinal fluid and

al. 1995

ANS dysfunction in AD

plasma norepinephrine

through comparison of

concentrations were

two or more groups of

examined in response to an

individuals

alpha-2 adrenergic

NA

antagonist in individuals
with AD, healthy older
controls, and healthy young
controls
Plasma norepinephrine
concentrations in the
placebo treatment condition
was significantly higher in
normal older and AD
subjects compared with
young subjects
Mean arterial pressure in
the placebo treatment
condition was higher both
normal older and AD
subjects compared with
young subjects
Ahlskog et

Described/characterized

Investigators evaluated

al. 1996

ANS dysfunction in AD

plasma catechols in 15

NA
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through comparison of

patients with Parkinson’s

two or more groups of

disease, 12 AD subjects,

individuals

and 15 controls
A non-significant trend
towards greater median
plasma norephinephrine
concentrations in the AD
group compared with
controls was reported

Peskind et

Described/characterized

Resting CNS adrenergic

al. 1998

ANS dysfunction in AD

activity was evaluated in

through comparison of

AD and normal aging by

two or more groups of

measuring cerebrospinal

individuals

and plasma epinephrine
concentration, as well as
heart rate and blood
pressure in individuals with
AD, healthy older controls,
and healthy young controls
The effects of AD and
aging on the responsiveness
of the CNS adrenergic
systems were measured by
evaluating the changes in
cerebrospinal epinephrine
following administration of
an alpha-2 adrenergic
receptor antagonist and an
alpha-2 agonist
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Plasma epinephrine was
significantly higher in AD
than normal older or normal
younger subjects
Blood pressure was affected
by aging but not AD
Higher heart rates were
observed in the AD group
as compared to the normal
older and normal younger
subjects
Systolic and diastolic blood
pressure measurements
were significantly higher in
the alpha-2 adrenoreceptor
agonist condition in both
older and AD subjects
Pascualy et

Described/characterized

Plasma adrenocorticotropic

al. 2000

ANS dysfunction in AD

hormone, cortisol,

through comparison of

norepinephrine, and

two or more groups of

epinephrine responses to a

individuals

one-minute cold pressor test
were measured in 9 AD
subjects and 9 age-matched
controls
Cortisol response was
increased in the AD group
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but the plasma
adrenocorticotropic
hormone response did not
differ
Basal norepinephrine
concentrations were higher
in the AD group, but
norepinephrine responses to
the cold pressor test did not
differ between groups
The blood pressure
response to the cold pressor
test was higher in the AD
subjects, however there
were no significant
differences in heart rate
Vasomotor

Hornqvist et Described/characterized

Peripheral reactivity to an

function may be al. 1987

ANS dysfunction in AD

alpha1-agonist, a beta-

reduced in

through comparison of

agonist, and cholinergic

individuals with

two or more groups of

agonist was examined in 12

AD

individuals

AD subjects as compared to
16 controls
A reduced response towards
the adrenergic agonists and
for the beta-agonist was
seen in the AD patients
The response to the
cholinergic agonist did not
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differ between individuals
with AD and healthy
controls
Increasing age did not
significantly influence the
cutaneous responses in the
controls
Algotsson

Described/characterized

Investigators studied skin

et al. 1995

ANS dysfunction in AD

vessel reactivity in response

through comparison of

to three vasodilating

two or more groups of

substances in 15 AD

individuals

subjects as compared to 16

NA

age-matched controls
Skin vascular responses of
the AD subjects to
acetylcholine and
isoprenaline (but not
nitroprusside) were greatly
attenuated compared with
controls
Kalman et

See Above

See Above

al. 2002

See
Above

Individuals

Elmstahl

Described/characterized

Investigators evaluated

with AD may

and Winge

ANS dysfunction in AD

sweat electrolyte

demonstrate an

1993

through comparison of

concentrations following

impaired sweat

two or more groups of

pilocarpine iontophoresis

response

individuals

stimulation in 15 females
with AD compared to 29

NA
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healthy female controls
Mean sweat sodium
concentration was
significantly higher among
the AD subjects
There was a higher
proportion of nonresponders among the AD
women than among the
controls
Pupillary

Idiaquez et

Described/characterized

Investigators studied

responses in

al., 1994

ANS dysfunction in AD

cholinergic dysfunction in

AD are altered

through comparison of

the iris in 26 subjects with

in AD

two or more groups of

AD and 23 healthy controls

individuals

NA

AD patients demonstrated
significantly increased
sensitivity to a
parasympathetic agent
(greater change in pupillary
constriction) compared to
controls

Grunberger

Described/characterized

Investigators examined

et al. 1999

ANS dysfunction in AD

pupillary dilatation after

through comparison of

application of an

two or more groups of

acetylcholine transmission

individuals

antagonist in 29 AD
patients and 29 controls
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Initial pupillary diameters
of the AD patients were
significantly smaller than
those of the controls
Both AD patients and
controls responded to the
acetycholine agonist with
pupillary dilation
Patients with AD showed a
larger relative change of
pupillary diameter than the
controls
Fotiou et al.

Described/characterized

Central cholinergic

2009

ANS dysfunction in AD

dysfunction was examined

through comparison of

with pupillometry in 23

two or more groups of

patients with AD and in 22

individuals

patients with PD (11 with
cognitive impairment and
11 without) compared with
23 normal controls
AD patients had
significantly lower levels of
maximum constriction
velocity, maximum
constriction acceleration,
amplitude, and percentage
amplitude compared with
controls
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AD patients had
significantly higher levels
of percentage recovery –
redilatation, latency, time
for maximum velocity, and
time for maximum
constriction compared with
controls
AD patients

Davidson et

Described/characterized

Subjects with AD and

may experience

al. 1991

an aspect of ANS

incontinence scored

constipation and

dysfunction through the

significantly lower on a

urinary

examination of a single

cube copying task than

incontinence

group of patients with

those demonstrating

AD

continence

NA

Qualitative analysis
revealed that the drawings
by incontinent patients
showed features
comparable with those
observed in the drawings by
patients with right-sided
parietal lesions, in
particular, poor
representation of
perspective and spatial
orientation
Del-Ser et

Described/characterized

Investigators followed 73

al. 1996

ANS dysfunction in AD

patients with dementia (29

NA
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through comparison of

autopsy confirmed cases of

two or more groups of

AD) for 5.6 + 2.5 years and

individuals

recorded the date of onset
of urinary incontinence
Loss of continence was
associated with severe
cognitive decline in pure
AD but tended to precede
severe cognitive decline in
Lewy Body dementia

Ransmayr

Described/characterized

Investigators evaluated

et al. 2008

ANS dysfunction in AD

frequency, urgency,

through comparison of

incontinence, and nocturia,

two or more groups of

without major bladder

individuals

outflow obstruction in 31

NA

patients with dementia (16
with AD)
Urge episodes and urge
incontinence were observed
in 12% of the AD patients
and detrusor over activity
occurred in 40% of the AD
patients
Zakrzewska

See Above

See Above

-Pniewska

See
Above

et al. 2012
Heightened

Eisdorfer

Described/characterized

A pilot investigation with

arousal during

and Cohen

an aspect of ANS

13 AD patients compared

NA
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learning may

in 1978

occur in AD

dysfunction through the

data against pre-existing

examination of a single

literature on normative

group of patients with

values for a number of

AD

autonomic function
measures
AD patients demonstrated
heightened ANS activity
during learning situations
that would induce minimal
arousal in normal elderly
males

Salivary flow is

Ship et al.

Described/characterized

Saliva production from the

reduced in AD

1990

ANS dysfunction in AD

major salivary glands was

through comparison of

evaluated in 28

two or more groups of

unmedicated patients with

individuals

early AD and 35 age-

NA

matched controls
Submandibular salivary
flow rates (resting and
stimulated) were
significantly lower among
the AD patients compared
with controls
The

Chu et al.

neuropathology

1997

of AD may
affect central
ANS control

Neuroanatomical
Described/characterized
ANS dysfunction in AD
through comparison of
two or more groups of

Investigators examined the
brains of 20 AD compared
with 7 age-compatible
healthy controls
In all cortical regions, the

NA
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mediated by the

individuals

laminar pattern of

ventromedial

neurofibrillary tangle

frontal cortex

involvement showed a
predilection for layers III
and V
Layer V was most severely
affected with neurofibrillary
tangles, followed by layer
III and then layer VI
Layers II and VI contained
few neurofibrillary tangles
There were significant
differences between
mesocortex and granular
cortex in all 3 layers
The posteromedial
autonomic-related cortical
regions were most severely
affected
The patterns of regional
distribution were consistent
in all AD subjects with
duration of dementia
ranging from 3-15 years
In neuropathologically less
severe cases, pathological
changes involved

186

predominantly autonomicrelated cortex regions and
spared granular areas
entirely.
The

Rub et al.

neuropathology

2000

of AD may
affect central
ANS central
control
mediated by the
pontine regions
of the brainstem

Neuroanatomical
Described/characterized
an aspect of ANS
dysfunction through the
examination of a single

Investigators examined
three nuclei of the pontine
parabrachial region in 27
autopsy confirmed cases of
AD

group of patients with

Cytoskeletal anomalies

AD

emerged early in the nuclei
of the pontine parabrachial
region and in the
intermediate zone of the
medullary reticular
formation
The development of the
neurofibrillary pathology
was found in the medial
parabrachial nucleus,
subpeduncular pigmented
nucleus, and intermediate
zone of the medullary
reticular formation
commences already in
cortical stage I and in the
lateral parabrachial nucleus
in cortical stage II
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At all four sites, the
progression of the lesions
correlated linearly with the
neurofibrillary tangles
cortical staging sequence IVI
Investigators concluded that
neurofibrillary tangles
stages I-VI most probably
reflect not only the progress
of the AD related
cytoskeletal pathology in
cortical areas but also its
evolution in specific
subcortical sites. It is
conceivable that a
progressive deterioration of
cardiovascular and
respiratory functions occurs
with advancing cortical
neurofibrillary tangles
stages
The

Bonthius et

neuropathology

al. 2005

of AD may
affect the insula

Neuroanatomical
Described/characterized
an aspect of ANS
dysfunction through

Insular pathology was
examined in 17 autopsy
confirmed cases of AD
compared with 5 controls

comparison of two or

Investigators observed

more groups of

evidence of AD pathology

NA
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individuals

in the insular cortex in all
17 cases of AD
The control cases had no
neuritic plaques and only
very rare and isolated
neurofibrillary tangles
Density of insular
neurofibrillary tangles, but
not neuritic plaques
correlated with years of
clinical dementia
AD related pathology in the
insula increased as
pathology in the entorhinal
cortex increased
The human insula contains
3 distinct architectonic
areas and severity of AD
pathology varies among the
insula’s cytoarchitectonic
regions

The

Burke et al.

neuropathology

in 1994

of AD may
affect the C-1
neurons of the
rostral
ventrolateral

See Above

See Above

See
Above
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reticular
nucleus
No significant

Khurana

Described/characterized

Investigators measured

differences

and Garcia

ANS dysfunction in AD

ANS function in 2 patients

between

1981

through comparison of

with subacute spongigorm

individuals with

two or more groups of

encephalopathy compared

AD and

individuals

with 2 patients with AD and

controls

NA

2 patients with
Huntington’s disease
Individuals with subacute
spongiform encephalopathy
exhibited autonomic
dysfunctions but the AD
patients did not
Measures included
evaluation of lacrimation,
pupillary responses to
topically applied autonomic
drugs, pulse rate in
response to cold face test
and atropine administration,
and blood pressure in
response to the cold pressor
test
Shankle et
al. 1993

Neuroanatomical
Described/characterized
ANS dysfunction in AD
through comparison of

Investigators measured
enteric neurons in the
myenteric plexus of the
esophagus, stomach, small

NA
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two or more groups of

intestine, colon, and rectum

individuals

in 18 AD subjects, 8 with
other types of dementia,
and 4 non-demented elderly
control subjects
There was age-related loss
of enteric neurons and of
plexus mass in the
Auerbach plexus
The size of the Auerbach
plexus did not differ from
control values for elderly
patients with AD,
suggesting that the neurons
of the enteric nervous
system are not affected by
the degenerative processes
of AD

Wakabayas
hi et al.
1999

Neuroanatomical
Described/characterized
ANS dysfunction in AD
through comparison of
two or more groups of
individuals

Investigators examined
neurofibrillary tangle
formation in the peripheral
nervous system and central
nervous systems in 20 AD
subjects, 8 with progressive
supranuclear palsy, and 100
elderly, non-demented
individuals
Neurofibrillary tangles were
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not identified in the
sympathetic or spinal
ganglia in patients with AD
Taki et al.

Described/characterized

Investigators examined

2001

ANS dysfunction in AD

whether meta-

through comparison of

iodobenzylguanidine

two or more groups of

mysocardial scintigraphic

individuals

study could be used to

NA

explore the contribution of
myocardial accumulation of
meta-iodobenzylguanidine
to the differential diagnosis
between AD and Lewy
body dementia
AD patients demonstrated
successful cardiac uptake of
meta-iodobenzylguanidine
in both early and delayed
images, as compared to
patients with Lewy body
dementia who demonstrated
reduced cardiac
accumulation
Allen et al.

Described/characterized

Investigators evaluated

2004

ANS dysfunction in AD

ANS function in 14 AD

through comparison of

subjects, 80 controls, and

two or more groups of

20 subjects with vascular

individuals

dementia, using power
spectral analysis of heart

NA
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rate variability
There were no differences
in heart rate variability in
patients with AD as
compared with controls
Orimo et al.
2005

Neuroanatomical
Described/characterized
ANS dysfunction in AD
through comparison of
two or more groups of
individuals

Investigators evaluated

NA

whether cardiac
sympathetic denervation
might account for the
decreased uptake of metaiodobenzylguanidine on
meta-iodobenzylguanidine
myocardial scintigraphy in
Parkinson’s disease and
Lewy body disease
Examined frequency and
pattern of cardiac
sympathetic nerve
involvement in 10 subjects
with pure AD
AD patients did not show
depletion of the cardiac
sympathetic nerves

Choi et al.
in 2009

Described/
characterized ANS
dysfunction in AD
through comparison of

Investigators reported no
differences between AD
patients (N=23) and
controls (N=24) on a
variety of measures of

NA
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two or more groups of

cardiovascular autonomic

individuals

function including heart
rate responses to standing
and deep breathing, and
Valsava ratio

Watanabe et Described/characterized

Heart/mediastinum ratio of

al. 2001

ANS dysfunction in AD

meta-iodobenzylguanidine

through comparison of

uptake in 10 patients with

two or more groups of

AD was indistinguishable

individuals

from that in 10 control

NA

subjects
Raskind et

Described/characterized

The effects of normal aging

al. 1999

ANS dysfunction in AD

and AD on cerebrospinal

through comparison of

fluid and plasma catechols

two or more groups of

were assessed using high-

individuals

performance liquid
chromatography
No plasma norepinephrine
differences were found
between groups
Cerebrospinal 3,4dihydroxyphenylalanine
following an alpha-2
adrenoreceptor agonist, was
higher in older and AD than
in young subjects
Cerebrospinal 3,4dihydroxyphenylglycol did
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not differ among groups
Plasma 3,4dihydroxyphenylalanine
following an alpha-2
adrenoreceptor agonist, was
higher in AD than in young
subjects

Appendix E: Meta-Analysis Search Terms
((((((((((((Saliva)) OR (Salivation)) OR (Salivary proteins and peptides)) OR (salivary
duct)) OR (salivary gland)) OR (Parotid gland)) OR (submandibular gland)) OR
(sublingual gland))) AND (healthy OR normal OR "disease free")) AND (aged OR
aging)) AND (flow OR production OR secretion OR secret* OR produc* OR secretory
rate)
Appendix F: Summary of Studies Included in Meta-Analysis Arranged
Chronologically
Study

Salivary
Source &
Condition

Participants*
*(Groups
included in
analysis are in
bold)

Method of

Medication

Salivary

Use

Collection

Results*
= No
difference
- Increased
saliva with
increasing
age
+
Decreasing

195

saliva with
increasing
age
Gutman &

Unstim

N=22, 12

Unstim whole:

Medication use +

Ben-Aryeh,

Whole

Females 10

spitting

not reported

Males

method

1974

Children: n=7

Participants
described as
“healthy” or

Younger adults

“generally

(15-21 years):

healthy”

n=6
Older adults
(60-76 years):
n=9
Examined the
salivary flow
rates of males
and females
separately
Baum, 1981

Stim Parotid

N=208, 85

Modified

95 men were

Females 123

Carlsson-

non-medicated

Males

Crittenden cup

and 48 women

with 2% citric

were non-

acid as

medicated.

Younger
Group (20-39
years): n=29
Middle-Aged
Group (40-59

stimulus

Reported using
data from
cohorts of
community-

=

196

years): n=35

dwelling
volunteers

Older Group,
Non-medicated
(60-88 years):
n=31
Older Group,
Medicated (6088 years):
n=19
Examined the
salivary flow
rates of males
and females
separately
Parvinen &
Larmas, 1982

Stim Whole

N=642, 316

Paraffin

All subjects

Females 326

mastication

were

Males
30-34 years:
n=145
35-39 years:
n=116

reportedly
unmedicated.
Reported
excluding
participants
with health

40-44 years:

problems that

n=93

could affect
salivary flow

45-49 years:
n=77
50-54 years:

=

197

n=60
55-59 years:
n=40
60-64 years:
n=46
65-69 years:
n=41
≥ 70 years:
n=24
Examined the
salivary flow
rates of males
and females
separately
Sonnenberg et

Unstim

N=132 (total)

Unstim whole:

Medication use =

al., 1982

Whole &

n=40* 14

draining

was not

Stim Parotid

Females 26

method

reported

Males

Stim parotid:

*Used the

double

control group

chamber

for data

suction capsule

extraction

(similar to

Younger
Group (mean
age 28 + 3
years): n=20

Lashley
capsule) with
sublingual
perfusion of 2
% citric acid
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Older Group
(mean age 55
+ 7 years):
n=20
Ogura et al.,

Unstim

N=14 All

1983

Whole

males

Peck’s method

No medication

=

use 2 weeks
prior to study.

Younger
Group (mean

Reported

age 22.7

excluding

years): n=7

participants
with health

Older Group

problems that

(mean age 70.6

could affect

years): n=7

salivary flow

Examined the
salivary flow
rates of males
and females
separately
Baum et al.,
1984

Stim Parotid

N=202, 79

Modified

No participants =

Females 23

Carlson-

were taking

Males

Crittenden cup

prescription

with 2% citric

medications.

Younger
Group (20-39
years): n=38M,
28F
Middle-aged

acid as
stimulus

Participants
described as
“healthy” or
“generally
healthy”
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Group (40-59
years): n=44M,
24F
Older Group
(60-88 years):
n=41M, 27F
Examined the
salivary flow
rates of males
and females
separately
Ben-Aryeh et

Unstim &

N=61, 30

Unstim whole:

Participants

+ unstim

al., 1984

Stim Whole

Females 31

spitting

were reported

whole

Males

method

to be

Younger

Stim whole: 2

Group (mean

% citric acid

unmedicated.
Participants

age 26 ± 2

described as

years): n=31

“healthy” or

Older Group
(mean age 69 ±
5 F, 68 + 3 M):
n=30
Examined the
salivary flow
rates of males
and females
separately

“generally
healthy”

= stim
whole
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Heft & Baum,

Unstim &

N=58, 39

Unstim

No participants =

1984

Stim Parotid

Females 46

parotid:

were taking

Males Age

modified

any

Range: 23-81

Carlson-

medications on

years

Crittenden cup

a regular basis.

Younger
Group (20-39

over Stenson’s
duct

Participants
described as

years): n=13M, Stim parotid:

“healthy” or

17F

2% citric acid

“generally

to dorsal

healthy”

Middle-aged
Group (40-59
years): n=14M

surface of
tongue

Older Group
(≥ 60 years):
n=19M, 22F
Examined the
salivary flow
rates of males
and females
separately
Gandara et al., Unstim

N=50 (total),

Unstim whole:

No participants =

1985

Whole &

n=25*

spitting

were taking

Stim Whole

*Used the

method

any

& Parotid

control group

Stim whole:

for data

paraffin

extraction

mastication

medications on
a regular basis.
Reported
excluding

201

Younger

Stim parotid:

Group (mean

via sour lemon

age 44 years):

drops

n=12

stimulation

participants
with health
problems that
could affect
salivary flow

Older Group
(mean age 68
years): n=13
Pedersen et

Unstim &

N=54 Age

Unstim SMSL: No participants +

al., 1985

Stim SMSL

Range: 18-91

novel

were taking

years

collection

medications

device

known to

(Drummond

affect

micropipette

salivation.

Younger
Group (mean
age 25.7
years): n=28
Older Group

holder, 2 ml
amber latex
rubber bulb for

(mean age 81.4 suction, 50
microliter
years): n=26
Van-Lab
Examined the

micropipette

salivary flow

collection

rates of males

chamber) over

and females

Wharton's duct

separately
Stim SMSL: 3
minutes of a
lemon drop
stimulus and
then collection

Participants
described as
“healthy” or
“generally
healthy”
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Yaegaki et al.,

Unstim

N=32, 15

Spitting

Medication use +

1985

Whole

Females 17

method

was not

Males Age

reported

Range: 20-83

Participants

years

described as

Younger

“healthy” or

Group (20-35

“generally

years): n=17

healthy”

Older Group
(50+ years):
n=15
Ben-Aryeh et

Unstim &

N=63, 31

Unstim whole:

Participants

al., 1986

Stim

Females 32

spitting

were reported

Males

method

to be

Younger

Unstim

Group (mean

parotid: Curby

Participants

age 37 ± 10.5

cup

described as

Whole &
Parotid

years): n=39
Older Group

Stim whole
and parotid:

(mean age 66 ± 2% citric acid

=

unmedicated.

“healthy” or
“generally
healthy”

3.3 years):
n=24
Chauncey et

Unstim &

N=203, All

Unstim

Medication use =

al., 1987

Stim Parotid

male Age

parotid:

not reported.

Range: 39-64

vacuum-

years

maintained
metal

Participants
described as

203

<45 years:
n=48

collection

“healthy” or

device

“generally

positioned

healthy”

45-49 years:

over Stensen's

n=40

duct

50-54 years:

Stim parotid:

n=31

sour lemonflavored

55-59 years:

lozenge

n=53
60+ years:
n=41
Tylenda et al.,

Unstim &

N=90 Age

Unstim SMSL: Participants

1988

Stim SMSL

Range: 29-93

Wharton’s

were not

years

duct was

taking any

isolated with

prescription

cotton gauze

medications.

Younger
Group: n=22

and saliva

Middle aged

collected from

Group: n=32

the duct orifice
by use of a

Older Group:

micropipette

n=35

under light

Examined the
salivary flow
rates of males
and females
separately

suction

Reported using
data from
cohorts of
communitydwelling
volunteers

+

204

Ship & Baum,

Stim Parotid

1990

N=50, 23

2% citric acid

Some

Females 27

from a single

medication use

Males

gland

but 24 were

=

not taking

Longitudinal

medication.

Study (over 712 years, mean

Participants

9.7 years, 1.2

described as

(SD))

“healthy” or
“generally

Age Range:

healthy”

29-72 years
Navazesh et

Unstim &

N=42, 18

Unstim whole:

No participants + unstim

al., 1992

Stim Whole

Females 24

draining

were taking

Males

method

medication

Younger

Stim whole:

Group (mean

gum base

age 25.4

mastication

years): n=21

with xerogenic
effects.

whole
- stim
whole

Participants
described as
“healthy” or

Older Group

“generally

(mean age 71.7

healthy”

years): n=21

Shern et al.,

Unstim &

N=51 26

Minor: strips

No participants = labial

1993

Stim Minor

Females 25

cut from

were taking

Males Age

chromatograph

medications

and buccal
+ palatal
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Range: 21-93

y paper at

that would

years

labial, buccal,

influence with

and palatal

oral secretion.

Younger
Group (< 41
years): n=17
Older Group
(>60 years):

sites

Participants

Stim whole:

described as

Parafilm

“healthy” or

mastication

“generally

- stim
whole
= unstim
whole

healthy”

n=18
Examined the
salivary flow
rates of males
and females
separately
Cowman et

Unstim &

N=85 (total),

Parotid:

Participants

+ unstim

al., 1994

Stim

n= 60* 32

modified

were not using

and stim

Females 28

Carlsson-

any medication SMSL and

Males

Crittenden cup

with possible

unstim

Age Range:

SMSL: cotton

salivary gland

parotid

20-81 years

rolls isolate

Parotid &
SMSL

*Used the
control group
for data
extraction
Younger
Group (20-39
years): n=23

Wharton's duct
& saliva
collected by
micropipette
with light
suction
Stim parotid &
SMSL: sterile

effects (control
group only)

= stim
parotid
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Middle-aged
Group (40-59
years): n=15
Older Group

2% citric acid
solution to
dorsal face of
tongue at 30sec intervals

(>60 years):
n=22
Meurman &

Unstim &

N=187 Age

Unstim whole:

Typical

+ unstim

Rantonen,

Stim Whole

Range: 20-60+

draining

population

whole

1994

years

Stim whole:

Younger

paraffin wax

Group (20-40

mastication

years): n=36

with regular
medication
use.

= stim
whole

Reported
recruiting

Middle aged

participants

Group (41-60

from dental

years): n=88

clinic registries

Older Group

where older

(>60 years):

individuals

n=63

appeared to be
free of major

Examined the

systemic

salivary flow

disease, but

rates of males

may have had

and females

some common

separately

age-related
conditions.

Percival et al.,

Unstim

N=116, 61

Unstim whole:

Participants

+ unstim

1994

Whole &

Females 55

spitting

were

whole

207

Stim Parotid

Males

method

reportedly
unmedicated.

mean age

Stim parotid:

26.7+ 1.06

Lashley cup

Participants

years: n=29

with 2% citric

described as

acid

“healthy” or

stimulation

“generally

mean age 50.4
+ 1.08 years:

= stim
parotid

healthy”

n=30
mean age 71.7
+ 1.07 years:
n=28
mean age
84.03 + 0.61
years: n=29
Billings et al.,

Unstim &

N=710, 484

Unstim whole:

Older subjects

1996

Stim

Females 226

Suction

were observed

Males Age

method of

to take

Range: 19-88

Bertram

medications

Whole

years
<30 years:
n=55M, 99F
30-49 years:
n=59M, 166F
50-69 years:
n=61M, 110F
70+ years:
n=51M, 109F

Stim whole:
2% citric acid

=

208

Examined the
salivary flow
rates of males
and females
separately
Eliasson et al., Unstim

N=127, 61

Periotron 6000

Some

1996

Minor

Females 66

model 2 with

medication

(Palatal,

Males Age

standard filter

use.

Buccal, and

Range: 22-89

paper

Labial)

years

=

Reported using
data from

Younger

cohorts of

Group (<40

community-

years): n=14M,

dwelling

12F

volunteers

Middle-aged
Group (40-65
years): n=32M,
25F
Older Group
(>65 years):
n=11M, 13F
Examined the
salivary flow
rates of males
and females
separately
Fischer &

Unstim &

N=28, 14

Unstim

No participants =

209

Ship, 1997;

Stim Parotid

Fischer &
Ship, 1999;

Females 14

parotid:

were being

Males

modified

treated for any

Carlson-

systemic

Crittenden cup

disease or

over Stenson's

taking any

duct-parotid

prescription or

Younger

Ship &

Group (20-35

Fischer, 1997

years): n=14
Older Group
(64-74 years):
n=14

Stim parotid:
2% citric acid
to dorsal

nonprescription
medication.

lateral surface

Participants

of tongue

described as
“healthy” or
“generally
healthy”

Yeh et al.,

Unstim

N=1006 (total)

Unstim whole:

Participants

+ unstim

1998

Whole &

n=247* 562

spitting

were taking

whole

Unstim &

Females 444

method

some

Stim Parotid

Males

& SMSL

*Used the
nonmedicated
group for
Unstim Whole
and Unstim &
Stim SMSL
*35-44 years:

Stim parotid &
SMSL: citrate

medications in
the whole

= unstim
parotid

population.

+ stim

Unstim

Participants

parotid

parotid:

reported taking

modified

no prescribed

+ unstim &

Carlson-

or over the

stim SMSL

Crittenden cup

counter
medications in

n=116

Unstim SMSL: the
micropipette
unmedicated

45-54 years:

connected to

n=198

mini-vacuum

subgroup.
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55-64 years:
n=222
70-74 years:
n=97
*>75 years:
n=75
nonmedicated
35-44 years:
n=55
45-54 years:
n=58
55-64 years:
n=50
65-69 years:
n=41
70-74 years:
n=30
>75 years:
n=13
Examined the
salivary flow
rates of males
and females
separately

pump held
over Wharton's
duct

Reported using
data from
cohorts of
communitydwelling
volunteers
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Ghezzi et al.,

Stim Parotid

N=36, 18

Stim parotid:

No

2000;Ghezzi

& SMSL

Females 18

Modified

prescription

Males

Carlson-

medications

Crittenden cup

(other than

over orifice of

HRT and birth

one gland with

control, and no

2% citric acid

non

applied to the

prescription

dorsal surface

antihistamines

& Ship, 2003

Younger
Group (mean
age 24.3
years): n=18
Older Group

(mean age 69.9 of the tongue
years): n=18

=

within 7 days).

Stim SMSL:

Participants

collected by

described as

light suction

“healthy” or

with 2% citric

“generally

acid applied to

healthy”

the dorsal
surface of the
tongue

Johnson et al.,

Stim Parotid

N=80, 38

Stim parotid:

No participants + stim

2000

& SMSL

Females 42

mastication

were taking

Males Age

and gustatory

medications.

Range: 35-76

stimulation -

years

0.1M citric

35-44 years:
n=19
45-54 years:

acid was
applied to the
lateral surfaces
of the tongue

Reported using
data from
cohorts of
communitydwelling
volunteers

SMSL
= stim
parotid

212

n=20

Stim SMSL:

55-64 years:

0.1M citric

n=19

acid was

65-75 years:
n=22

applied to the
lateral surfaces
of the tongue

Salvolini et

Unstim

N=169, 95

Spitting

No participants =

al., 2000

Whole

Females 59

method

were taking

Males Age

any medication

Range: 10-77

that would

years

interfere with
salivary

10-24 years:

secretion.

n=38

Participants

25-39 years:

described as

n=52

“healthy” or

40-54 years:

“generally

n=40

healthy”

55-69 years:
n=27
>70 years:
n=12
Yeh et al.,

Unstim

N=399, 215

Unstim whole:

Normal

+ unstim

2000

Whole, Stim

Females 184

spitting

population

whole

Parotid, &

Males

method

with

Unstim &
Stim SMSL

Age Range:

Unstim

medication
use.

= stim
parotid

213

34-64 years
Mean Age:
62.8 + 0.6
years
Examined the
salivary flow
rates of males
and females
separately

parotid:
modified
CarlsonCrittenden cup

Reported using

+ unstim &

data from

stim SMSL

cohorts of
community-

Unstim SMSL: dwelling
micropipette

volunteers

over orifices of
Wharton’s
duct and
connected to
mini-vacuum
pump
Stim parotid &
SMSL: 2%
citric acid
swabbed over
the lateral
surfaces of the
tongue

Tanida et al.,

Unstim &

N=105

Unstim whole:

2001

Stim Whole

Healthy

Cotton rolls for was not

controls Age

saliva

Range: 26-89

absorption

years

Stim whole:

3rd decade: n=3 ascorbic acid
4th decade: n=5
5th decade: n=5

Medication use +
reported

214

6th decade:
n=11
7th decade:
n=10
8th decade: n=5
9th decade: n=6
Streckfus et

Stim Whole

al., 2002

N=50 Females

Mastication of

Participants

only

a gum base

were not

+

taking any

Age Range:

prescription

20-90 years

medications.
Participants
described as
“healthy” or
“generally
healthy”

Bakke et al.,

Unstim

2004

Whole

N=26 Females
Younger
Group (mean
age 24 ± 3
years): n=13
Older Group
(mean age 62 ±
4 years): n=13
Examined the

Draining

5 of the

Method

subjects took
prescribed
medications
(birth control,
hormones,
NSAIDs).
Participants
described as

=

215

salivary flow

“healthy” or

rates of males

“generally

and females

healthy”

separately
Bourdiol et

Unstim &

N=45, 22

Unstim whole

Medication use =

al., 2004

Stim

Females 23

& parotid:

not reported.

Males

Cotton rolls for Participants

Whole &
Parotid

Younger
Group (mean

saliva

described as

absorption

“healthy” or

age 27.4 ± 2.3

Stim parotid:

years): n=25

Cotton rolls

Older Group
(mean age 71.2

“generally
healthy”.

and parafilm
chewing

± 2.1 years):

Stim whole:

n=20

meat
mastication

Fenoll-

Unstim

N=159, 107

Spitting

Medication use +

Palomares et

Whole

Females 52

method

not reported.

al., 2004

Males

Reported

Age Range:

excluding

18-75 years

participants
with health

Mean Age:

problems that

44.16 + 14.23

could affect

years

salivary flow

Nagler &

Unstim

N=43, 22

Unstim whole:

Standard age-

Hershkovich,

Whole

Females 21

spitting

related

+

216

2005a, 2005b

Males

method

medication
use, but no

Younger

participant was

Group (mean

using

age 21.2 ± 1.8

antidepressants

years): n=15

or

Older Group

anticholinergic

(mean age 75.8

s.

± 8.2 years):

Reported

n=28

excluding
participants
with health
problems that
could affect
salivary flow

Moritsuka et
al., 2006

Stim Whole

N=117, 84

Paraffin wax

Some

Females 33

mastication

medication use

Males
Younger
Group (20-29
years): n=40
Middle aged
Group (30-59
years): n=37

for 18 subjects
in the elderly
group.
Reported using
data from
cohorts of
communitydwelling

Older Group

volunteers and

(60-88 years):

recruiting

n=40

participants
from dental

+

217

clinic registries
where older
individuals
appeared to be
free of major
systemic
disease, but
may have had
some common
age-related
conditions.
Takada et al.,

Stim Whole

2006

N=185 (total)

Saxon Test

Medication use =

n= 65* All

was not

female

reported

*Used the
control group
for data
extraction
Mean Age:
50.3 + 12 years
Henkin et al.,
2007

Stim Parotid

N=61, 21

Modified

Participants

Females 40

Lashley cup

were not

Males Age

with lemon

taking any

Range: 18-75

juice

medication.

years

stimulation on

<20 years: n=5
21-30 years:

the tongue

Participants
described as
“healthy” or
“generally

=
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n=15

healthy”

31-40 years:
n=23
41-50 years:
n=46
51-60 years:
n=46
61-70 years:
n=37
>70 years:
n=30
Hershkovich

Unstim

N=44 Age

Spitting

No participants +

et al., 2007

Whole

Range: 20-80

method

were taking

years

saliva affecting
drugs (e.g.

Younger

anti-

Group (20-25

cholinergics or

years): n=22

antidepressants
)

Older Group
(70-80 years):

Participants

n=22

described as
“healthy” or
“generally
healthy”

Flink et al.,

Unstim &

N=1427, 758

Unstim whole:

No exclusions

+ unstim

2008

Stim Whole

Females 669

draining

based on

whole

219

Males

method

medication
use.

22-29 years:

Stim whole:

n=90M, 110F

paraffin

Reported using

mastication

data from

30-39 years:

= stim
whole

cohorts of

n=120M, 157F

community-

40-49 years:

dwelling

n=139M, 161F

volunteers and
recruiting

50-59 years:

participants

n=155M, 158F

from dental
clinic registries

60-69 years:

where older

n=165M, 172F

individuals
Examined the

appeared to be

salivary flow

free of major

rates of males

systemic

and females

disease, but

separately

may have had
some common
age-related
conditions.

Malhotra et

Unstim

N=48 Age

Cotton rolls for Medication use =

al., 2009

Whole

Range: 18-77

saliva

years

absorption

not reported.
Participants

Younger

described as

Group (18-40

“healthy” or

years): n=16M

“generally
healthy”

220

Older Group
(>65 years):
n=16M, 16F
Examined the
salivary flow
rates of males
and females
separately
Sawair et al.,

Unstim

N=244, 134

Spitting

No participants +

2009

Whole

Females 110

method

were taking

Males Age

any medication

Range: 15-76

that would

years

interfere with

15-19 years:
n=32
20-29 years:
n=106
30-39 years:
n=32
40-49 years:
n=28
50-59 years:
n=29
≥ 60 years:
n=17

salivary flow.
Participants
described as
“healthy” or
“generally
healthy”.
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Toida et al.,

Stim Whole

2010

N=1188, 815

Modified

Medication use +

Females 373

Saxon Test

was not

Males

reported.

Age Range:

Reported using

20-90 years

data from
cohorts of

Mean Age:

community-

51.4 + 20.0

dwelling

years

volunteers

Examined the
salivary flow
rates of males
and females
separately
Chang et al.,

Unstim &

N=60, 30

Unstim whole:

No participants + unstim

2011

Stim Whole

Females 30

spitting

were taking

Males

method

psychiatric/neu

Younger

Stim whole:

Group (mean

gum base

age 26.4 ± 2.4

mastication

years): n=30
Older Group
(mean age 71.1
± 4.6 years):
n=30
Examined the
salivary flow

rologic
medication or
antihistamines.
Reported
excluding
participants
with health
problems that
could affect
salivary flow

whole M/F
+ stim
whole M
= stim
whole F

222

rates of males
and females
separately
Marotta et al.,

Unstim

N=90 Age

Spitting

No participants +

2012

Whole

Range: 20-65+

method

were taking

years

inhaled,
topical, or

Younger

systemic

Group (20-40

corticosteroids

years): n=30

or other

Middle aged

immune

Group (41-65

modulating

years): n=30

meds.

Older Group

Reported that

(>65 years):

participants

n=30

with common
illnesses such
as
hypertension
and
compensated
diabetes were
NOT excluded

Wang et al.,

Unstim

N=191, 95

Draining

No participants +

2012

Whole

Females 96

method

were using

Males
18-30 years
(mean age 26 ±

medications
that affects
salivary
production.

223

3 years): n=48

Reported

31-40 years:

excluding

n=48

participants
with health

41-50 years:

problems that

n=48

could affect
salivary flow

51-75 years
(mean age 56 ±
4 years): n=47
Yoshikawa et

Unstim &

N=70*, 19

Saxon test

Medication use =

al., 2012

Stim Whole

Females 21

was not

Males Age

reported

Range 42-79
years
* Used healthy
control group
n=30
Younger
(mean age 28.9
years): n=15
Older (mean
age 68.2
years): n=15
Smith et al.,
2013

Stim Whole

N=540, 270

Gauze

No participants +

Females 270

mastication

were taking

Males

medications
known to

224

Younger
Group (mean

affect
salivation.

age 24.0 + 3.1

Reported

years): n=180

excluding

Middle Aged
Group (40-50
years): n=180
Older Group
(mean age 75.2
+ 5.5 years):n=
180
Examined the
salivary flow
rates of males
and females
separately

participants
with health
problems that
could affect
salivary flow
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